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BACKGROUND: EUROCAT is a network of population-based congenital anomaly registries providing stand-
ardized epidemiologic information on congenital anomalies in Europe. There are three types of EUROCAT
membership: full, associate, or afﬁliate. Full member registries send individual records of all congenital
anomalies covered by their region. Associate members transmit aggregate case counts for each EUROCAT
anomaly subgroup by year and by type of birth. This article describes the organization and activities of each
of the current 29 full member and 6 associate member registries of EUROCAT. METHODS: Each registry
description provides information on the history and funding of the registry, population coverage including
any changes in coverage over time, sources for ascertaining cases of congenital anomalies, and upper age
limit for registering cases of congenital anomalies. It also details the legal requirements relating to termina-
tion of pregnancy for fetal anomalies, the deﬁnition of stillbirths and fetal deaths, and the prenatal screening
policy within the registry. Information on availability of exposure information and denominators is pro-
vided. The registry description describes how each registry conforms to the laws and guidelines regarding
ethics, consent, and conﬁdentiality issues within their own jurisdiction. Finally, information on electronic
and web-based data capture, recent registry activities, and publications relating to congenital anomalies,
along with the contact details of the registry leader, are provided. CONCLUSIONS: The registry description
gives a detailed account of the organizational and operational aspects of each registry and is an invaluable
resource that aids interpretation and evaluation of registry prevalence data. Birth Defects Research (Part A)
91:S51–S100, 2011.  2011 Wiley-Liss, Inc.
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AUSTRIA, STYRIA – FULL MEMBER
History and Funding
The registry was set up in 1986 after the Chernobyl
disaster. It registers fetuses/babies with congenital
anomalies born after January 1, 1985. The registry has
been a member of EUROCAT since 1995. It is funded by
research grants provided by the Styrian Government on
an annual basis.
Population Coverage
The registry covers all births to residents of the prov-
ince of Styria (population-based I 5 all mothers resident
in deﬁned geographic area), which amounts to a total of
approximately 10,000 births annually. See Table 1 for
coverage of European birth populations.
Sources of Ascertainment
Pediatric cardiology centers supply systematic case lists
and diagnostic details to the registry.
There is one central cytogenetic laboratory in Styria
that covers the whole population and provides a list of
all abnormal prenatal and neonatal karyotypes annually.
The registry has no direct electronic link to cytogenetics,
but has close contact almost every day. So the local cyto-
genetic database can be used easily, although indirectly.
The registry operates as a research program with vol-
untary participation of hospitals. Information is gathered
from 48 sources once per year. Sources consist of 11
obstetric departments, 2 pathology services, 2 child
health services with specialized departments for diagno-
sis and treatment, and 1 cytogenetic laboratory. Forty-
eight percent of cases are reported by more than one
source. In the remaining 52% of cases, only one source
provided data. Since 2002, most of the information is
gathered electronically (see below). Fetuses/babies with
anomalies are registered if diagnosed before birth, at
birth, or during the ﬁrst year of life.
Maximum Age at Diagnosis
Up to 1 year of age.
Terminations of Pregnancy for Fetal Anomaly
Terminations of pregnancy after prenatal diagnosis of
congenital anomalies are registered. (Termination of
pregnancy for socio-economic reasons is legal up to 12
weeks postconception. It requires special counseling.)
For terminations of pregnancy for fetal anomaly
(TOPFA), there is no upper limit of gestational age by
law, if serious psychological or health problems for the
mother or the fetus were to be expected, and labor has
not started. But if a non-lethal congenital anomaly is
diagnosed late, most obstetricians in Austria would fol-
low the maternal wish for TOPFA only up to the end of
23 weeks’ gestation. Thereafter, pregnancies with severe
anomalies, but with a viable fetus, may be terminated af-
ter fetal analgesia and feticide, if a commission agrees
with the maternal wish to terminate. Non-viable forms of
congenital anomalies may of course be terminated at any
stage of gestation.
Prenatal Screening Policy
The ofﬁcial policy regarding prenatal diagnosis is preg-
nant women are offered three ultrasound scans (8–12,
18–22, and 30–34 weeks’ gestation) according to a booklet
called ‘‘Mother-child Passport.’’ More scans are done in
most cases, like combined testing and late assessment of
fetal growth and wellbeing.
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Stillbirth and Early Fetal Deaths
Stillbirths with congenital anomalies are registered.
Stillbirth deﬁnition by law is late fetal death from a
crown foot length >5 35 cm and from January 1, 1995, a
limit of >5 500 g.
There is no lower gestational age or weight limit for
registration of congenital anomalies in early fetal deaths/
spontaneous abortions. Autopsy rates in 1999 were as fol-
lows: stillbirths 63%, induced abortions 68%, early neona-
tal death (0–7 days) 70% (estimate), later deaths 1 week
to 1 year 70% (estimate), and almost all deaths with con-
genital anomalies.
Exposure Data/Availability
Exposure information (e.g., maternal occupation, intake
of drugs, or illnesses during pregnancy) is not available.
Data about techniques of prenatal screening (ultrasound,
serum markers) and prenatal diagnosis are systematically
collected. Maternal residency is recorded and can be
used for evaluating the subregional pattern of birth
defects.
Denominators and Controls Information
Information on all births is available from birth certiﬁ-
cates, registered nationally by Statistics Austria.
Registry Description References
Haeusler MC, Berghold A, Schoell W, et al. 1992. The
inﬂuence of the post-Chernobyl fallout on birth defects
and abortion rates in Austria. Am J Obstet Gynecol 167(4
Pt 1):1025–1031.
Haeusler MC, Berghold A, Stoll C, et al. 2002. Prenatal
ultrasonographic detection of gastrointestinal obstruction:
results from 18 European congenital anomaly registries.
Prenat Diagn 22:616–623.
Ethics and Consent
The registry did not require ethics committee approval
to collect and store data, but this will be sought in the
near future.
Parental consent is not asked for, and we do not need
maternal informed consent. The reason is that data are
kept conﬁdentially on a university computer for scientiﬁc
use only, and data are published or transferred to central
EUROCAT registry in a nonpersonalized form.
Electronic and Web-based Data Capture
The Styrian Malformation Registry has access since
2002 to the Styrian open Medical Documentation and
Communication System where an annual search for
patients born within the index year with an International
Classiﬁcation of Diseases (ICD) 10-Q-code (i.e., congenital
anomaly) is performed. The hospital chart for each per-
son is then looked up in the Medical Documentation and
Communication System for details. Pathology and genet-
ics institutes use their own electronic documentation sys-
tem which the registry uses indirectly by asking for an
annual search for subjects with congenital anomalies.
Recent Registry Activities and Publications
(2007–2010)
The registry leader is a member of the project manage-
ment committee of EUROCAT.
He presented the registry on various scientiﬁc meet-
ings:
Haeusler M. Praenatale Diagnostik im Spiegel des
Steirischen Fehlbildungsregisters. 32. Ultraschall Drei-
laendertreffen, Davos, 24–27 September 2008.
Haeusler M. European malformation registries. 8th
World Congress in Fetal Medicine, Portoros, Slovenia. 27
June–2 July 2009.
Haeusler M. Prevention of NTDs by folic acid supple-
mentation. 9th World Congress in Fetal Medicine, Rho-
dos. 20–24 June 2010.
Registry Contribution to EUROCAT Collaborative
Papers (2007–2010)
Table 2 shows the registry contribution to EUROCAT
studies.
Address for Further Information
Martin Haeusler, Registry Leader, Styrian Malforma-
tion Registry, Medical University of Graz, Auenbrugger-
platz 14, AT-8036 Graz, Austria. E-mail: martin.haeus-
ler@medunigraz.at.
Andrea Berghold, Head of the Institute for Medical
Informatics, Statistics and Documentation, Medical Uni-
versity of Graz, Auenbruggerplatz 2, AT-8036 Graz, Aus-
tria. E-mail: andrea.berghold@medunigraz.at.
BELGIUM, ANTWERP – FULL MEMBER
History and Funding
The registry started with a pilot study on procedures
for registration of congenital anomalies in 1989. In 1990,
the registry formally started. Since 1997, the whole prov-
ince of Antwerp has been covered. The registry was
developed in collaboration with the Provincial Govern-
ment and the University of Antwerp. The program is
funded by the Provincial Government of Antwerp. The
registry has been a member of EUROCAT since 1990.
Population Coverage
The registry covers about 20,000 births annually; these
are all births in the province of Antwerp, about 18% of
the births in Belgium. The registry is population-based
which means that all mothers resident in the province of
Antwerp at the time of birth of their babies are included.
Sources of Ascertainment
Reports are actively collected form maternity, pediatric,
and neonatologic units by registry staff who visit each
maternity, pediatric, and neonatal unit in the covered
region. We work with 20 participating hospitals. Basic in-
formation on children born with congenital anomalies is
gathered from these hospital departments. More detailed
information on diagnosis and exposure during pregnancy
is gathered from gynecologist and pediatricians’ records.
Information about the parents is obtained from general
practitioners and social welfare nurses. Clinical geneti-
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Table 1
Coverage of European Birth Populations by EUROCAT Full or Associate Member Registries (October 2010)
Country
EUROCAT
registry
Year started
EUROCAT data
transmission
Annual births
2007, registry
Annual births
2007, country1
% Country
covered*
EU
EU (Present EU Member States) 1,347,841 5,249,863 25.7
EU-15 (EU Member Countries since before 2004)
EU-NMS (Countries acceded in 2004–2007)
839,283
508,558
3,325,950
1,923,913
25.2
25.2
Belgium Antwerp 1990 19,874
Hainaut 1980 12,717
Total 32,591 120,664 27.0
Bulgaria 75,257 0.0
Czech Republic Czech Republic2,3 2000 114,947 114,947 100.0
Denmark Odense 1980 5,429 63,731 8.5
Germany Mainz 1990 3,323
Saxony–Anhalt 1987 17,470
Total 20,793 683,214 3.0
Estonia 15,840 0.0
Ireland Cork & Kerry 1996 9,953
Dublin 1980 26,370
South east 1997 7,468
Total 43,791 69,863 62.7
Greece 111,717 0.0
Spain Barcelona 1992 14,862
Basque Country 1990 20,681
Spain hospital network2 1980 102,540
Total 138,083 489,221 28.2
France Isle de la Reunion 2002 15,002
Paris 1981 26,339
Rhone–Alpes2 2006 57,744
Strasbourg 1982 21,962
Total 121,047 814,377 14.9
Italy Emilia–Romagna 1981 40,662
Tuscany 1980 30,957
Total 71,619 561,747 12.7
Cyprus 8,488 0.0
Latvia 23,269 0.0
Lithuania 32,495 0.0
Luxembourg 5,429 0.0
Hungary 97,642 0.0
Malta Malta3 1986 3,898 3,898 100.0
Netherlands Northern 1981 17,678 181,574 9.7
Austria Styria 1985 10,209 76,203 13.4
Poland Wielkopolska 1999 38,302
Rest of Poland2,3 1999 351,411
Total 389,713 389,713 100.0
Portugal South 1990 18,874 102,811 18.4
Romania 215,651 0.0
Slovenia 19,702 0.0
Slovakia 54,476 0.0
Finland Finland2 1993 58,574 58,574 100.0
Sweden Sweden2,3 2001 101,688 101,688 100.0
United Kingdom Northern England 2000 33,054
Thames Valley 1991 29,716
E Mid & S York 1998 72,549
Wales 1998 34,585
Wessex 1994 29,003
Total 198,907 771,923 25.8
Non EU
Candidate countries in EUROCAT
Croatia Zagreb 1983 7,351 41,748 17.6
EFTA countries in EUROCAT
Norway Norway 1980 58,046 58,046 100.0
Switzerland Vaud 1989 7,620 74,337 10.3
Ukraine Ukraine4 2005 29,253 472,657 6.2
1Source: crude birth rate (accessed June 29, 2010) http://epp.eurostat.ec.europa.eu/portal/page/portal/population/data/main_tables.
2Associate EUROCAT Registries (transmit aggregate data only).
3Source of annual births in country provided by registry rather than EUROSTAT.
4http://www.ukrstat.gov.ua/operativ/operativ2007/ds/pp/pp_e/pp1207_e.html (accessed June 29, 2010).
*Including the 6 EUROCAT Afﬁliate registries (French West Indies, Hungary, Campania, Sicily, Slovenia, and South West United
Kingdom) coverage of the EU population increased from 25.7% to 30.5%.
EU, European Union; NMS, New Member States; EFTA, European Free Trade Association.
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cists, surgeons, pathologists, and the center for detection
of metabolic diseases are also contacted for more infor-
mation. Pediatric cardiology centers supply diagnostic in-
formation when requested by the registry for speciﬁc
cases. Cytogenetic information is gathered on the cases
suspected with a genetic anomaly.
All cases with a congenital anomaly diagnosed prena-
tally or in the ﬁrst year of life are registered. Reporting
by hospitals and health workers is voluntary.
Maximum Age at Diagnosis
Up to 1 year of age.
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is registered. Termination of
pregnancy is legal under 13 weeks. If congenital anomaly
is diagnosed, the upper gestational age for termination is
23 to 24 weeks.
Stillbirth and Early Fetal Deaths
The stillbirth deﬁnition for denominators is: a baby
which is not viable with a gestational age of >180 days.
Stillbirths are registered. Early fetal deaths and spontane-
ous abortions with a gestational age of less then 20 weeks
are not registered.
Exposure Data Availability
Exposure information includes maternal drug use,
maternal smoking and alcohol abuse, maternal and pater-
nal diseases and family history, and parental occupation.
Denominators and Controls Information
Background data on births are retrieved from the pop-
ulation databases of the local authorities and from the
study center for perinatal epidemiology in the Flanders
region. Controls are not included in the registry, but data
can be ascertained for speciﬁc studies.
Ethics and Consent
The registry’s procedure was presented to the Belgian
privacy committee. In this procedure, it was agreed that
the registry provides information to the parents on aims
and methods of registration, data protection, and the
right to opt-out. If the parents do not opt-out, the data
are registered. The registry does not require ethics com-
mittee approval to operate. No additional ethics commit-
tee approval is required for studies that use nonidentiﬁ-
able data.
Information on the registration of congenital anomalies
is given to the parents by medically qualiﬁed staff treat-
ing the child and other health care professionals treating
the child.
Electronic and Web-based Data Capture
Not available.
Recent Registry Activities and Publications
(2007–2010)
Registratie van aangeboren afwijkingen, Rapport 1989
to 2008, 2010.
Registry Contribution to EUROCAT Collaborative
Papers (2007–2010)
Table 2 shows the registry contribution to EUROCAT
studies.
Address for Further Information
Vera Nelen, Provinciaal Instituut voor Hygiene, Kro-
nenburgstraat 45, 2000 Antwerpen, Belgium. E-mail:
vera.nelen@pih.provant.be.
BELGIUM, HAINAUT–NAMUR – FULL
MEMBER
History and Funding
The registry of Hainaut–Namur was initiated in 1978
and it started in 1979. It has been a member of EUROCAT
since the beginning. From 1979 to 1990, it was located at
the School of Public Health of the Catholic University of
Louvain (Brussels). Since 1990, it was integrated into the
Centre of Human Genetics of the Institute of Pathology
and Genetics (Charleroi [Gosselies], Belgium). As a part
of the Institute of Pathology and Genetics of Charleroi, it
is supported by an annual grant from the Institute of
Research in Pathology and Genetics of Charleroi. Since
2001, it is also partly supported by the Ministry of Public
Health of Wallonia (www.wallonie.be).
Population Coverage
The registry annually covers approximately 12,000 births
in the provinces of Hainaut (East) and Namur (population-
based II 5 all mothers delivering within deﬁned
geographic area, irrespective of place of residence), which
represented about 11% of all births in Belgium.
Sources of Ascertainment
Prenatal and delivery units, and neonatal and pediatric
departments were divided into 13 hospitals. All cytoge-
netic, genetic, and pathologic data, including the exami-
nation of aborted fetuses, are regionally concentrated in
the Institute of Pathology and Genetics of Charleroi (Gos-
selies). Children with malformations are registered up to
1 year of age.
Maximum Age at Diagnosis
Prenatal diagnosis, ﬁrst week of life with follow-up to
1 year of age.
Termination of Pregnancy for Fetal Anomaly
Voluntary termination of pregnancy is legal in Belgium
up to 12 weeks of gestation. However, if a severe congen-
ital anomaly is diagnosed later, there is no upper age
limit for termination, but this happens under the strict
surveillance of an ethical committee.
Theoretical access to information is available on all
cases of termination of pregnancy as they are registered,
however, in practice, ascertainment is slow to process.
Stillbirth Deﬁnition and Early Fetal Deaths
Stillbirth deﬁnition is: weight 500 g or 22 weeks.
Stillbirths are registered. Early fetal deaths/spontaneous
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abortions are included if the gestational age is greater
than or equal to 20 weeks (weight is not a factor). Early
fetal deaths/spontaneous abortions are registered.
Autopsy rates are as follows: stillbirths 52% for all cases
(95% of cases of malformations), induced abortions virtu-
ally 100%, early neonatal deaths (0–7 days) 52% for all
cases (95% of cases of malformations), later deaths 1
week to 1 year unknown, and deaths with congenital
anomaly 48% in 1992 to 1994 compared to 25% in 1982.
Exposure Data Availability
Exposure information: all that concerns information of
maternal diseases during pregnancy, maternal drugs,
occupations, and genetic data is available.
Denominators and Controls Information
Background data on births are available from national
and regional institutes of statistics. It is also based on our
own statistics in collaboration with the Center of Human
Genetics. Recently, a collaboration with the Centre
d’Epidemiologie Pe´rinatale has been initiated.
Address for Further Information
Christine Verellen – Dumoulin, Centre de Ge´ne´tique
Humaine IPG, Institut de Pathologie et de Ge´ne´tique,
Avenue G. Lemaıˆtre, 25, 6041 Charleroi (Gosselies)
Belgium. E-mail: christine.verellen.dumoulin@ipg.be. Web-
site: www.ipg.be.
CROATIA, ZAGREB – FULL MEMBER
History and Funding
Registration for EUROCAT network started in the
Children’s University Hospital Zagreb in 1983, after the
preliminary favorable results of the pilot project on con-
genital anomaly registration. Collection and transmission
of data was on a voluntary basis until the year 2000. Af-
ter 2000, congenital anomaly registration was funded
within the scientiﬁc project dedicated to epidemiologic
surveillance of congenital anomalies, supported by the
Ministry of Science, Education, and Sports of the Repub-
lic of Croatia.
Population Coverage
The registry is population based (population-based I 5
all mothers resident in deﬁned geographic area). The
registry covers northwestern Croatia – two regions at the
seaside (Pula and Rijeka), and two continental provinces
(Varazˇdin and Koprivnica). Births take place in four re-
gional hospitals with practically no homebirths (only by
accident). Total number of monitored births per year in
these regions is around 7500, approximately 17.14% of
the total annual births in Croatia. In 2009, we have
started a pilot project in two additional delivery units:
Vinkovci and Split, with the prospect to extend registry
coverage in next years for additional 13% of annual
births.
Sources of Ascertainment
In four maternity units, Varazˇdin, Koprivnica, Rijeka,
and Pula, neonatologists and gynecologists record cases
with congenital anomalies among livebirths, stillbirths,
and terminations of pregnancies. Birth and stillbirth cer-
tiﬁcates include notiﬁcation of congenital anomalies and
are used as additional sources of information as well as
hospital discharge lists.
Part of the population (local registry Rijeka) is covered
by the pediatric cardiology diagnostic center. Children
born in this neonatal unit have the cardiac ultrasound
newborn screening. The pediatric cardiology center does
not supply case lists with details and diagnostic details
to the registry. In other local registries, there are no pedi-
atric cardiology centers, but children suspected of having
cardiac defects are referred to a pediatric cardiologist for
evaluation. Cardiac ultrasound and diagnosis are made
by a pediatric cardiologist. Data about patients with con-
genital heart defects are then collected by neonatologists
employed in neonatal units and referred to the registry.
The Zagreb registry, at present, does not have direct
access to cytogenetic laboratories. In local registries, per-
sonnel get data from cytogenetic and molecular laborato-
ries, and, in case of death, from postmortem examina-
tion.
Maximum Age at Diagnosis
Maximum age at diagnosis is up to 1 week.
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is regulated by Croatian law
in 1978 (NN/18/78). The upper limit for termination of
pregnancy for serious fetal anomaly is 24 gestational
weeks.
Stillbirth Deﬁnition and Early Fetal Deaths
Ofﬁcial stillbirth deﬁnition in Croatia is 22 completed
gestational weeks/500 g weight. The registry collects
data about stillbirths and fetal deaths/spontaneous abor-
tions from 20 weeks. The local registries also record
results of autopsy of all termination of pregnancies after
prenatal diagnosis, stillbirths, and early neonatal deaths
(0–7 days). Autopsy rates in these cases are generally
high, around 90 to 100%.
Exposure Data Availability
Exposure information includes: data on parental occu-
pation, maternal drug use, maternal smoking and alcohol
abuse, and maternal diseases before and during preg-
nancy.
Data about techniques of prenatal screening (ultra-
sound, serum markers) and assisted reproduction meth-
ods are collected as well and are available for most of the
recorded cases.
Denominators
Information on annual births and maternal age distri-
bution is obtained from the population databases and
statistical units of the local authorities.
Ethics and Consent
To collect and store data, the registry requires ethics
committee approval from the Ethics Committee of the
Children’s University Hospital Zagreb and Ethics
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Committee of Medical School University of Zagreb.
Approval is renewed every 5 years.
National legislation will probably require informed
consent to register a baby with a congenital anomaly in
the near future. At present, the registry collects data as
hospital statistics needed for public health planning; for
this we do not need informed consent for each case.
There is a possibility of case identiﬁcation at the local
level to avoid duplicate registration, to allow updating of
information or diagnosis, and to assist children and their
families in the future. The Zagreb Registry sends anony-
mous computerized data with a local serial number for
each case for the use in communication with the local
registries to the Central Registry. Safety measures are
established to prevent unauthorized use of the records.
Electronic and Web-based Data Capture
The Zagreb registry does not receive electronic data or
perfom web-based data capture.
Recent Registry Activities and Publications
(2007–2010)
The Zagreb registry is a part of the referral center of
the Ministry of Health and Social Welfare for Surveil-
lance of Congenital Anomalies in the Republic of Croatia,
located at the Children’s University Hospital Zagreb.
Activities in our registry include:
 Epidemiologic surveillance of congenital anomalies
in Croatia.
 Center of expertise for rare genetic disorders in chil-
dren – diagnostics (including clinical evaluation,
cytogenetic, and molecular testing), multidisciplinary
care for children affected with genetic disorders, and
genetic counseling of families at risk.
 Primary prevention of congenital anomalies (investi-
gation of fetal alcohol syndrome and use of folic acid
supplementation in Croatia).
 Research in the ﬁeld of genetic disorders (interna-
tional projects EUROCAT, EUROPLAN, Projects of
the Croatian Ministry of Science Education and
Sports: Research on the Genetic Basis of Diseases in
Childhood – Epidemiologic and Genetic Basis of
Birth Defects, Telomeres, and chromosomal aberra-
tions in childhood developmental disorders, celiac
disease in children, and prevention and pathogenesis
of chromosome instability).
 Participation in graduate and postgraduate training
in genetics at Zagreb University School of Medicine,
Zagreb University School of Pharmacy and Biochem-
istry, and Zagreb University School of Education
and Rehabilitation Sciences.
 Organization of continuous medical training in the
ﬁeld of genetics at the University of Zagreb School
of Medicine.
 Organization of congresses and symposia (Balkan
Meeting of Human Genetics, 2009; Genes and Au-
tism, 2010).
 Development of information for patients, health
professionals, and the general public on genetic dis-
orders.
 Partnership and collaboration with patients´ organiza-
tions (e.g., The Croatian Society of Patients with Rare
Diseases, Prader Willi Association, Croatian Associa-
tion for Osteogenesis Imperfecta, Croatian Epider-
molysis Bullosa Association, etc).
 Development of the National Plan for Rare Diseases
(registry leader is a president of the interdisciplinary
Committee for the Development and Implementation
of the National Plan for Rare Diseases in Croatia).
A list of registry publications is available at the website
of Croatian scientiﬁc bibliography: http://bib.irb.hr/lista-
radova?sif_proj5072-1083107-0365&period52007&lang5
EN.
Registry Contribution to EUROCAT Collaborative
Papers (2007–2010)
Table 2 shows the registry contribution to EUROCAT
studies.
Address for Further Information
Ingeborg Barisic, Registry Leader and Medical Geneti-
cist, Children’s University Hospital Zagreb, Department
of Pediatrics, Klaiceva 16, 10-000 Zagreb, Croatia. E-mail:
ingeborg.barisic@kdb.hr.
CZECH REPUBLIC – ASSOCIATE MEMBER
History and Funding
The unofﬁcial registration of congenital anomalies
started in 1961 but the ofﬁcial population-covering regis-
tration in former Czechoslovakia started in 1964. The
registration itself is compulsory and ﬁnanced by the
Government (Ministry of Health). The registry joined
EUROCAT in 2009.
Population Coverage
The registry is population-based. Currently the Czech
Republic is consisting of 13 regions and the capital,
Prague (with regional status). The regions can be further
divided into 76 districts in total. The population of the
Czech Republic is approximately 10,509,377 inhabitants
(March 31, 2010). The annual number of livebirths has
increased to the current annual 120,000 livebirths
(119,570 livebirths in 2008).
Sources of Ascertainment
The registry has multiple sources. The cases of the con-
genital anomalies are reported via the ofﬁcial reporting
form. The reporting form is ﬁlled in by the medical doc-
tor who ﬁrst diagnosed the anomaly – most of the
reports come from delivery units, pediatric and neonatol-
ogy departments, departments of medical genetics
(including cytogenetic and molecular-genetic laborato-
ries), departments of ultrasound diagnostics, and surgery
departments (cardio surgery, plastic surgery). Pediatric
cardiology centers supply systematic case lists and some
diagnostic details to the registry. Cytogenetic laboratories
provide reports on both prenatally and postnatally diag-
nosed cases of congenital anomalies. All diagnoses from
the XVII chapter of the ICD-10 (group Q00-Q99) are
reported. We do not receive the verbal description of the
reported anomalies, nor do we receive the complete lists
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of pathologic karyotypes from cytogenetic laboratories.
The ICD-10 (sub)code is the key. The age limit for the
registration is 15 years; the prenatally diagnosed cases,
cases in stillbirths, and cases in spontaneous abortions
weighing over 500 g are also reported.
The reporting forms are collected in the Institute of
Health Information and Statistics of the Czech Republic
(UZIS CR, http://www.uzis.cz/), where the data are
cleaned and the central database is created. The National
Registry of the Congenital Anomalies is the part of The
National Health Information System of the Czech Repub-
lic administered by UZIS. The reporting of a congenital
anomaly is compulsory and does not require an informed
consent.
Termination of Pregnancy
Termination of pregnancy is legal in the Czech Repub-
lic. After the 12th week of gestation, the termination of
pregnancy is limited to the genetic indications. After the
24th week of gestation, the pregnancy can be terminated
only if the mother’s life is at risk.
Stillbirth Deﬁnition and Early Fetal Deaths
Stillbirth deﬁnition: non-viable fetuses, >28 weeks and
>1000 g of weight. Early fetal deaths/spontaneous abor-
tions deﬁnition: fetuses showing no signs of life, <28
weeks and <1000 g of weight, or fetuses showing one or
more signs of life but <500 g and not surviving 24 hours
after birth.
Cases in stillbirths and some cases in spontaneous
abortions weighing over 500 g are also reported.
Exposure Data Availability
Maternal and paternal age and occupation, drugs in
pregnancy (coded with the ATC (Anatomical Therapeutic
Chemical classiﬁcation system)), gravidity, and parity
order.
Denominators and Controls Information
The information on all newborns born in the Czech
Republic is available in the Czech Statistical Institute
(http://www.czso.cz/) and Institute of the Health Infor-
mation and Statistics of the Czech Republic (UZIS). The
following information is available: birth weight, birth
length, maternal and paternal age, birth date, and birth
place.
Registry Description References
Sipek A, Gregor V, Hora´cek J, Masa´tova´ D. 2003. [Rou-
tine monitoring of congenital defects in children in the
Czech Republic. History and present status]. [Article in
Czech] Ceska Gynekol 68:71–80.
Sı´pek A, Gregor V, Hora´cek J, et al. 2009. [History and
present of registration of congenital anomalies in the
Czech Republic]. [Article in Czech] Cas Lek Cesk
148:505–509.
Ethics and Consent
The registry does not require ethics committee
approval to collect and store data. Ethics committee
approval is only required for some projects that use iden-
tiﬁable registry data (more complex studies, where other
data sources are used).
National legislation does not require informed consent
to register a baby with a congenital anomaly. Data from
the National Registry of Newborns and from the
National Registry of Mothers are also used. These regis-
tries do not require informed consent for data collection.
Data collection is compulsory according to the internal
law of the Ministry of Health of the Czech Republic.
Electronic and Web-based Data Capture
The registration process is based on the paper forms
and paper reports. The electronic/web-based data collect-
ing system is in preparation.
Recent Registry Activities and Publications
(2007–2010)
Calda P, Sı´pek A, Gregor V. 2010. Gradual implemen-
tation of ﬁrst trimester screening in a population with a
prior screening strategy: population based cohort study.
Acta Obstet Gynecol Scand 89:1029–1033.
Gregor V, Sı´pek A, Calda P, et al. 2008. [Ultrasound pre-
natal diagnostics of birth defects in the Czech Republic in
1994-2007]. [Article in Czech] Ceska Gynekol 73:340–350.
Gregor V, Sı´pek A, Hora´cek J, et al. 2008. [The analysis
of incidence of selected types of bird defects in the Czech
Republic according to a multiplicity of pregnancy]. [Arti-
cle in Czech] Ceska Gynekol 73:199–208.
Gregor V, Sı´pek A, Sı´pek A Jr, et al. 2009. [Prenatal
diagnostics of chromosomal aberrations Czech Republic:
1994-2007]. [Article in Czech] Ceska Gynekol 74:44–54.
Sı´pek A, Gregor V, Hora´cek J. 2007. [Birth defects in
the Czech Republic in the period 1994 - 2005–perinatol-
ogy data]. [Article in Czech] Ceska Gynekol 72:103–109.
Sı´pek A, Gregor V, Hora´cek J, et al. 2009. [Birth defects
incidence in children from single and twin pregnancies
in the Czech Republic–current data]. [Article in Czech]
Ceska Gynekol 74:369–382.
Sı´pek A, Gregor V, Sı´pek A Jr, et al. 2010. [Incidence of
congenital heart defects in the Czech Republic–current
data]. [Article in Czech] Ceska Gynekol 75:221–242.
Sı´pek A, Malis J, Ste˘rba J, et al. 2009. [Tumors in chil-
dren with birth defects. Current data from the Czech
Republic]. [Article in Czech] Ceska Gynekol 74:105–117.
Quarterly reports are published electronically and are
available on the registry’s website: http://www.vrozene-
vady.cz/congenital-anomalies/index.php?co5reports.
Registry Contribution to EUROCAT Collaborative
Papers (2007–2010)
None yet.
Address for Further Information
Antonin Sipek, Program Director, National Registry of
Congenital Anomalies of the Czech Republic, Department
of the Medical Genetics, Thomayer University Hospital,
Videnska 800, 140 59 Prague 4, Czech Republic. E-mail:
registrvvv@vrozene-vady.cz. Website: http://www.
vrozene-vady.cz/.
Jiri Horacek, E-mail: jiri.horacek@gennet.cz.
Vladimir Gregor, E-mail: vladimir.gregor@ftn.cz.
Antonin Sipek Jr., E-mail: admin@vrozene-vady.cz.
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DENMARK, ODENSE – FULL MEMBER
History and Funding
The registry started in 1979 and joined the EUROCAT
network from the beginning of EUROCAT. The registry
has been approved by the ‘‘Data Tilsynet’’ as a private
registry for the purpose of research. There is no speciﬁc
funding.
Population Coverage
The registry covers the island of Funen with surround-
ing small islands, situated in the middle of Denmark
(population-based I 5 all mothers resident in deﬁned ge-
ographic area). The total number of births per year in
Funen County is around 5600. Births take place in three
hospitals with homebirths <1% of all births.
Sources of Ascertainment
The registry is based on active case ﬁnding. Data sour-
ces for the registry include electronic discharge and out-
patient diagnosis from obstetric and pediatric depart-
ments, obstetric and pediatric hospital records with data
on surgeries, and examinations performed on the cases
(x-ray, magnetic resonance scans, and echocardiography),
birth notiﬁcations, death certiﬁcates, postmortem exami-
nations, and data from the cytogenetic laboratory.
The registry receives an annual list of all abnormal
karyotypes diagnosed prenatally.
The outpatient list of diagnosis from the pediatric
department includes diagnosis from the pediatric cardiol-
ogy center.
Maximum Age at Diagnosis
Up to 5 years for cases seen at a pediatric department.
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is legal before 12 weeks
gestation without special permission. After 12 weeks of
gestation, termination of pregnancy may be performed
after permission from a local committee. If a congenital
anomaly is diagnosed, the upper gestational age for
termination is usually before viability. If a lethal malfor-
mation is diagnosed after fetal viability, it may be possi-
ble to have permission to induce the birth. Terminations
of pregnancy for fetal anomalies are registered in the
EUROCAT registry.
Stillbirth Deﬁnition and Early Fetal Deaths
From the beginning of the registry, stillbirth deﬁnition
was gestational age 28 weeks. From April 2004, the
stillbirth deﬁnition was changed to gestational age 22
weeks. Stillbirths and fetal deaths/spontaneous abortions
from 20 weeks are registered in the EUROCAT registry.
The autopsy rate in stillbirths is around 70%.
Exposure Data Availability
Exposure information: maternal occupation, medication
during ﬁrst trimester, maternal illness before and during
pregnancy.
Denominators and Controls Information
Data on births per year and maternal age distribution
covering Funen County is available from National Danish
Statistics (www.statistikbanken.dk).
Registry Description References
Garne E. 2004. Congenital heart defects – occurrence,
surgery and prognosis in a Danish County. Scand Cardi-
ovasc J 38:357–362.
Garne E. 2006. Atrial and ventricular septal defects -
epidemiology and spontaneous closure. J Matern Fetal
Neonatal Med 19:271–276.
Ethics and Consent
The registry does not require ethics committee ap-
proval to collect and store data. The registry needs ofﬁ-
cial approval for the database www.datatilsynet.dk.
National legislation does not require informed consent
to register a case with a congenital anomaly.
Address for Further Information
Ester Garne, Pediatric Department, Hospital Lillebaelt,
Kolding, Skovvangen 2-6, DK26000 Kolding, Denmark.
E-mail: egarne@health.sdu.dk.
FINLAND – ASSOCIATE MEMBER
History and Funding
The national Malformation Register was established in
1963 and regular monitoring started in 1977. In 1974, the
registry became a full member of the International Clear-
inghouse of Birth Defects Surveillance and Research
(ICBDSR), and in 1998, it became an associate member of
EUROCAT. The registry system (data collection) has
been changed three times, in 1985, in 1993 and in 2005.
The activities of the registry are regulated by speciﬁc law
and statute on national health care registers that hold
personal data. It is run and ﬁnanced by THL (the govern-
mental National Institute for Health and Welfare), under
the Ministry of Social Affairs and Health.
Population Coverage
The registry is national and population-based I: all
mothers resident in deﬁned geographic area. All births in
Finland are covered, representing approximately 60,000
births annually. Selective terminations of pregnancy and
spontaneous abortions with malformations have been
included since 1993.
Sources and Ascertainment
Notiﬁcation to the registry is compulsory. Reports are
obtained from delivery units, neonatal, pediatric and pa-
thology departments, death certiﬁcates, and cytogenetic
laboratories (conﬁrmation of the cases). The Pediatric
Cardiology Center operating all pediatric heart defects
supplies systematic case data with diagnostic details to
the registry. Case information is also received from the
national Medical Birth Register, Abortion Register, Hospi-
tal Discharge Register, and the Cause-of-Death Register.
The diagnoses of the malformation cases received from
other sources are conﬁrmed from the hospitals. Informa-
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tion on malformations is principally collected up to 1
year of age, but later information is also included. Aggre-
gated data is transmitted to ICBDSR and EUROCAT.
Maximum Age at Diagnosis
Up to 1 year of age for surveillance purposes, but later
diagnoses are also registered.
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is legal. Termination of
pregnancy for fetal reasons (severe congenital anomaly,
other birth defect, or disease) can only be granted by a
special permission from the National Supervisory
Authority for Welfare and Health (Valvira). At the gesta-
tional age from >20 1 0 up to 24 1 0 weeks, termina-
tion of pregnancy can only be granted by Valvira’s
permission when a severe fetal malformation or disease
has been detected by reliable prenatal diagnostics.
Stillbirth Deﬁnition and Early Fetal Deaths
Prior to 1987, stillbirths of 28 weeks or more were
registered. At present, stillbirths of at least 22 weeks of
gestation (22 1 0) or 500 g of birth weight (500 g) are
registered. All notiﬁed early fetal deaths have been regis-
tered since 1993 but are only included for transmission to
EUROCAT if >20 1 0 gestational weeks.
Exposure Data Availability
Before 1986, extensive exposure information was
obtained from maternity health centers and by personal
interview for selected malformations and their controls.
From 1987 to 1992, only parental occupation was
reported. Exposure information, like maternal occupa-
tion, medication, x-rays, and diseases, has been obtained
since 1993. Some exposure information on all births is
also available in the Medical Birth Register since 1987.
Denominators and Controls Information
Epidemiologic background data are available on all
births in the Medical Birth Register and in the Statistics
Finland.
Registry Description References
More information on the registry can be found in the
THL website in English: http://www.thl.ﬁ/statistics/con-
genitalmalformations.
Ethics and Consent
According to the Act on Nationwide Health Care
Registers and the Person Data Act, no informed consent
is needed for collection of identiﬁable case data into the
national health care registers (these registers are speciﬁed
by the law and statutes). Thus, no informed consent is
required to register a baby with a congenital anomaly
into the registry. It is not allowed for the registry to con-
tact the registered persons or their families. Because of
the legislation, ethics committee approval to collect and
store data in the national health care registers is neither
required. It is obligatory for the health care personnel to
notify the malformed cases.
It is possible to use the case data in the national health
care registers for scientiﬁc studies with speciﬁc permis-
sion from the register administrators (governmental
authorities like THL). The data protection authority also
gives a statement on each study. Studies using only
register data from national registers 1/- hospital regis-
ters do not require ethical approval, but while it is not
obligatory, it usually is highly recommended. Encrypted
unidentiﬁable data are always preferably given out by
THL instead of identiﬁable case data.
Address for Further Information
Annukka Ritvanen, THL, National Institute for Health
and Welfare, Lintulahdenkuja 4, P.O. Box 30, FI-00271
Helsinki, Finland. E-mail: annukka.ritvanen(at)thl.ﬁ.
Website: http://www.thl.ﬁ.
FRANCE, ILE DE LA REUNION – FULL
MEMBER
History and Funding
The registry was established in 2001 and has contrib-
uted data to EUROCAT from 2002 onward. The registry
was funded by a private organization – Conseil General
du Department (Provincial Council) until 2005, and since
2006, by a public organization: Agence Re´gionale d’Hos-
pitalization regional agency for hospital care, and is run
under guidance from a steering committee. Its qualiﬁca-
tion was obtained from INSERM and French Institute of
Disease Monitoring (INVS) since November 18, 2008, and
the registry was held by INVS and INSERM since 2009.
The main purposes of the registry are to produce preva-
lence statistics, audit prenatal screening, assess reported
clusters of environmental exposures, and to detect new
teratogenic exposures.
Population Coverage
The registry is population-based III which is all moth-
ers delivering in Isle of Reunion excluding non-residents.
The registry covers an average of 14,650 births per year.
Sources of Ascertainment
Reporting is voluntary. Notiﬁcation of cases to the
registry comes from hospitals and other private institu-
tions. Ascertainment is assisted by active searching of
patient notes by registry staff. Ascertainment of cases by
hospital doctors is thought to be virtually 100%. Sources
include maternity units, pediatric departments, prenatal
screening, pathology laboratories, cytogenetic laborato-
ries, medical genetics, pediatric surgery, and cardiology
units. Cases are registered if diagnosed before birth, at
birth, or during the ﬁrst year of life. All malformed
babies are followed up until 1 year of age, especially
cases with cardiac and urinary malformations, but ascer-
tainment of these cases may be incomplete if the malfor-
mation is not prenatally diagnosed or the case is not seen
at a hospital.
Maximum Age at Diagnosis
Up to 1 year of age.
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Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy has been legal in Isle of
Reunion since 1975 and recorded by the registry since
2002. There is no upper limit on gestation age at termina-
tion. Information on terminations is provided by ofﬁcial
legal pluridisciplinary prenatal diagnosis centers. There
is a national prenatal screening policy.
Stillbirth Deﬁnition and Early Fetal Deaths
The ofﬁcial stillbirth deﬁnition is: gestational age >20
weeks of pregnancy. Gestational age of 14 weeks is the
lowest age to be included as a fetal death/spontaneous
abortion in the register. Autopsies may be carried out
on stillbirths, early fetal deaths, and termination of preg-
nancies.
Exposure Data Availability
Exposure data (occupation of mother, assisted concep-
tion, illness before and during pregnancy, and drug use
throughout pregnancy) are routinely recorded to a good
degree of completeness and accuracy.
Denominators and Controls Information
National birth statistics are obtained from INSEE, the
National Institute of Statistics and Economic Studies.
Denominators can be provided by both maternal age and
monthly distribution. Information is not available on
controls.
Ethics and Consent
We propose a consent to parents before registration,
with a respect of anonymous case, and without ethic ap-
proval. Informed consent is asked.
Electronic and Web-based Data Capture
Electronic and web-based data capture is not available
for the registry.
Recent Registry Activities and Publications (2007–
2010)
Bourdial H, Jamal-Bey K, Randrianaivo H, et al. Con-
genital cardiac malformations in Reunion Island from
2002 to 2007.
Letter N830 of 20 November 2009 co-edited by ORS
(Observatoire Re´gional de la Sante´) and association
‘‘Naitre Aujourd’hui’’: indicators of trisomy 21 in Reun-
ion Island during the period of 2003 to 2006. (National
journey of the trisomy 21 of 22nd November 2009).
Letter N82 of 11 February 2010 co-edited by ORS
(Observatoire Re´gional de la Sante´) and association
‘‘Naitre Aujourd’hui’’: indicators of congenital cardiopa-
thy in Reunion Island (Journey of 14 February 2010 for
sensibilisation to conge´nital cardiopathy).
Report on the register of congenital malformations of
Reunion Island during the period 2002 to 2007. Co-edi-
tied by the Association ‘‘Naıˆtre Aujourd’hui’’ and the
ORS.
Dietary request on the consommation of folates by
women in age to procreation in Reunion Island for tube
neural defects.
December 2008 saw the ﬁrst meeting of the ﬁve French
registries of conge´nital malformations. The program
included presentations by J. L. Alessandri on Foetopathy
with valproate, and Congenital diaphragmatic hernia and
associated malformations by H. Randrianaivo on Foetop-
athy with Cytotec and by L. Lagarde and J. Baron on
Trisomy 21 in Reunion Island.
Registry Contribution to EUROCAT Collaborative
Papers (2007–2010)
Table 2 shows the registry contribution to EUROCAT
studies.
Address for Further Information
Hanitra Randrianaivo, Scientiﬁc director of the registry,
Association Reunionnaise pour le Depistage et la Preven-
tion des Maladies Metaboliques et des Handicaps de
l’Enfant, Naitre Aujourd’hui, BP 904 – 97478 Saint Denis
Cedex, Ile de la Reunion. E-mail: naitreajd@wanadoo.fr.
FRANCE, PARIS – FULL MEMBER
History and Funding
The registry was created in 1981 and it has been a
member of EUROCAT since 1982. The registry is part of
a research unit of INSERM (National Institute of Health
and Medical Research). The registry has been ofﬁcially
recognized by the French National Committee of Regis-
tries, and regularly renewed, most recently in 2008 for 4
years (2009–2012). The activities of the registry are
partially supported by an annual grant from INSERM
and Institut de la Veille Sanitaire (Institute for Health
Surveillance).
Population Coverage
Until 2000, the registry population included all women
residing in greater Paris (Paris and its surrounding sub-
urbs) who delivered a baby in Paris maternity units
(38,000 annual births). Beginning in 2001, the Paris popu-
lation data for EUROCAT included only women residing
in Paris and delivering in a Parisian maternity unit. The
estimation of the coverage of the registry is around 95%.
Sources of Ascertainment
Notiﬁcation to the registry is voluntary. Reports are
actively collected from delivery units, pediatric depart-
ments, cytogenetic laboratories, and pathology depart-
ments. Terminations of pregnancy are included. Case
information is also received from the health certiﬁcates of
the ﬁrst week of life, the maximum age at diagnosis.
Birth certiﬁcates include notiﬁcation of congenital anoma-
lies and are used as a source of notiﬁcation. The registry
systematically (at least once a year) consults the three
main cytogenetic laboratories in Parisian hospitals.
By far, most cases of major congenital heart defects
(CHDs) are diagnosed by specialized pediatric cardiology
departments in our population or by prenatal ultrasound
and/or autopsy reports for pregnancy terminations and
fetal deaths. In addition, pediatric cardiology centers
supply diagnostic conﬁrmation when requested by the
registry for speciﬁc cases.
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Maximum Age at Diagnosis
Up to 1 week of age (or later if discharged from a ma-
ternity ward at a later date).
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is legal and there is no
upper gestational age limit for termination after diagnosis
of congenital anomaly. All terminations of pregnancy
regardless of the gestational age at termination are regis-
tered.
Stillbirth Deﬁnition and Early Fetal Deaths
Stillbirths of 22 weeks after the last menstrual period
or more are registered. Early fetal deaths/spontaneous
abortions are registered and included when the gesta-
tional age is 16 weeks.
Exposure Data Availability
Information on maternal drug use, maternal and pater-
nal diseases and occupations, and outcome of previous
pregnancies, is available for the malformed cases.
Denominators and Controls Information
Background data on births are available from the
National Institute of Statistics (INSEE).
Registry Description References
Detailed description of the registry may be found in
the following publications:
De Vigan C, Khoshnood B, Cadio E, et al. Le Registre
des malformations de Paris : un outil pour la surveillance
des malformations et l’e´valuation de leur prise en charge.
BEH Juillet 2008. (http://www.invs.sante.fr/beh/2008/
28_29/index.htm).
De Vigan C, Khoshnood B, Lhomme A, et al. 2005.
[Prevalence and prenatal diagnosis of congenital malfor-
mations in the Parisian population: twenty years of
surveillance by the Paris Registry of congenital malfor-
mations.] J Gynecol Obstet Biol Reprod (Paris) 34(1
Pt 1):8–16.
Khoshnood B, Lelong N, Vodovar V, et al. Surveillance
e´pide´miologique et diagnostic pre´natal des malforma-
tions: Evolution sur vingt-sept ans (1981–2007), Registre
des malformations conge´nitales de Paris, Juillet 2010
(http://www.u953.idf.inserm.fr/page.asp?page54247).
Ethics and Consent
The registry requires ethics committee approval from
the French National Committee of Freedom and
Informatics (CNIL) to collect and store data. Review of
procedures regarding conﬁdentiality of data of the Paris
Registry is overseen by both the French National Com-
mittee of Registries and the French National Committee
of Informatics and Freedom.
The registry is allowed to register cases without
explicit written consent of parents. Information letters are
sent to chief of services for them to post in waiting
rooms, patient rooms, or other areas of the maternity
ward to inform parents that anonymous data are
recorded for cases of congenital anomalies.
Electronic and Web-based Data Capture
None at this time.
Recent Registry Activities and Publications
(2007–2010)
Our previous studies included population-based evalu-
ations of prenatal diagnosis and pregnancy terminations
for Down syndrome (Khoshnood et al., 2008; BJOG, 2004,
Am J Public Health, 2004, Am J Public Health, 2006). In
particular, we examined socioeconomic differences in the
prenatal diagnosis and livebirth prevalence of Down syn-
drome. We also studied trends in prenatal diagnosis,
pregnancy termination, and perinatal mortality of new-
borns with CHDs (Khoshnood et al., 2008; Pediatrics,
2005).
Our main focus of research activities in the coming
years will be on CHDs and particularly analysis of a
cohort study of outcomes for children with CHD (the
EPICARD study). We are also looking at the prevalence,
prenatal diagnosis, and pregnancy terminations for CHD
in both our registry data and in EPICARD. Another pro-
ject is focused on studying the risks associated with
assisted reproductive technologies; two ongoing studies
are related to CHD and neural tube defects. We will also
pursue our studies of the modalities of prenatal testing
for Down syndrome and for CHD, in particular popula-
tion-based evaluations of the performance of various
prenatal tests/strategies of testing, in our population.
Registry Publications (2007–2010)
Bloch J, Cans C, deVigan C, et al. 2008. [Feasibility of
the foetal alcool syndrome surveillance]. [Article in
French] Arch Pediatr 15:507–509.
del Carmen Saucedo M, DeVigan C, Vodovar V, et al.
2009. Measurement of nuchal translucency and the pre-
natal diagnosis of Down syndrome. Obstet Gynecol
114:829–838.
de Vigan C, Khoshnood B, Cadio E, et al. 2008. [Pre-
natal diagnosis and prevalence of Down syndrome in the
Parisian population, 2001-2005]. [Article in French] Gyne-
col Obstet Fertil 36:146–150.
Khoshnood B, De Vigan C, Blondel B, et al. 2008.
Long-term trends for socio-economic differences in pre-
natal diagnosis of Down syndrome: diffusion of services
or persistence of disparities? BJOG 115:1087–1095.
Verret C, Jutand MA, De Vigan C, et al. 2008. Repro-
ductuve health and pregnancy outcomes among French
gulf war veterans. BMC Public Health 8:141.
Registry Contribution to EUROCAT Collaborative
Papers (2007–2010)
Table 2 shows the registry contribution to EUROCAT
studies.
Address for Further Information
Babak Khoshnood, Paris Registry of Congenital Malfor-
mations, INSERM U953, Hoˆpital Saint Vincent de Paul,
82 av Denfert-Rochereau, 75014 Paris. E-mail: babak.-
khoshnood@inserm.fr.
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FRANCE, RHONE–ALPS – ASSOCIATE
MEMBER
History and Funding
The Central East Registry began in 1973 within the
Rhone–Alps area – the Auvergne region was added in
1983, the Jura area in 1985, the Cote d’Or & Nievre in
1989, and Saone-et-Loire in 1990. The registry joined
EUROCAT as an associate member in 1999, and sent
data backdated to 1980. In 1998, the registry was split up
and the Auvergne region became ﬁnancially independent
under the responsibility of Christine Francannet. The col-
laboration between Auvergne and the rest of the Central
East France Registry is maintained and common results
are to be published. At the start of 2007, the registry was
renamed REMERA and limited to Rhone–Alpes region.
Since January 2007, the ﬁnancial support is provided
only by public funds: by the Rhone–Alpes Region author-
ity, the INVS, the French Health Products Safety Agency
(AFSSAPS), the National Institute of Health and Medical
Research (INSERM), and the Conseil Ge´ne´ral of Ise`re.
Population Coverage
The registry is population-based II where all mothers
delivering within a deﬁned geographic area, irrespective
of place of residence. Approximately 1.5% of non-resi-
dent mothers deliver within the registry area. Mothers
living in the deﬁned area who are later transferred out-
side the area for delivery because of prenatal diagnosis
of malformation made in the deﬁned area are included
as well. The registry covers the Rhone–Alps region, with
approximately 57,500 births annually which represents
about 7% of all births in France. The geographic region
changed over time as follows: Rhone–Alps was included
from 1976 onward, Auvergne from 1983 to 1999, Jura
from 1985 onward, Cote d’Or and Nievre from 1989
onward, and Saone-et-Loire from 1990 onward. From
2007, the registry is limited to a part of Rhone–Alpes
region: Rhoˆne, Loire, Ise`re, Savoie.
Sources of Ascertainment
Notiﬁcation to the registry is voluntary. Reports are
collected from multiple sources: maternity unit records,
pediatric records, cytogenetic laboratory, pathology
laboratory, child health services, specialized departments
for medical genetics, pediatric surgeons, and birth
notiﬁcations. We have difﬁculties accessing the pediatric
cardiology department of one hospital in our region.
Consequently, there will be some cases that are not
reported. Active registration is performed by four data
collectors assigned speciﬁcally to about 35 sources each.
Conﬁrmatory sources: every year a list of abnormal
karyotypes is sent by cytogenetic laboratories, and copies
of pathology reports are systematically sent to the regis-
try if malformations are present. At least more than 145
sources collaborate with the registry. Infants up to the
age of 1 year old are registered, as well as fetuses deliv-
ered after medical abortion. A cutoff for notiﬁcation is
applied: for children born in year x, notiﬁcations are
taken into account until March x12. There is no follow-
up procedure. Children are notiﬁed when noticed by the
persons in charge of data collection in hospitals. The
following speciﬁc anomalies are excluded: balanced chro-
mosomal anomalies, pyloric stenosis, metabolic disorders,
minor malformations (small angiomas or naevi, hip sub-
dislocation, small foot deformities, ill-deﬁned facial
anomalies, and inguinal and umbilical hernias). Aggre-
gated data is transmitted to EUROCAT.
Maximum Age at Diagnosis
Up to 1 year of age.
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is legal and there is no
upper gestational age limit for any cause whatsoever. In
the case of termination after diagnosis of a congenital
anomaly, agreement is sought from a multidisciplinary
committee. Terminations for fetal malformation have
been registered since 1985. Notiﬁcation of terminations of
pregnancy is provided by obstetric units, cytogenetic
laboratories, and pathology reports.
Stillbirth Deﬁnition and Early Fetal Deaths
Currently, stillbirths and early fetal death/spontaneous
abortions are registered from 20 weeks’ gestation
onward. Before 1997, stillbirths were registered at 28
weeks or more after the last menstrual period. Stillbirth
and infant death certiﬁcates are not routinely available as
a source. Autopsy rates for spontaneous abortions are
not registered, stillbirths 90%, induced abortions 90%,
and early neonatal deaths (0–7 days) 80%. These numbers
are only available to the registry as autopsy rates for
malformed infants/fetuses. Most autopsies of stillborn
babies are performed by a fetal pathologist.
Exposure Data Availability
Information on maternal and paternal occupation, drug
use, and diseases is collected by interviews of the moth-
ers of the malformed infants. This is not transmitted to
Central Registry. No controls are interviewed.
Denominators and Controls Information
Birth statistics are provided by the National Institute of
Statistics. The same population deﬁnition is used for the
birth statistics except for induced abortions. Some back-
ground information is also available from the general
population statistics. No information on controls is col-
lected.
Registry Description References
See the description in the following link: http://
www.invs.sante.fr/beh/2008/28_29/beh_28_29_2008.pdf.
Ethics and Consent
The registry does require ethics committee approval to
collect and store data and this approval comes from the
Commission Nationale Informatique et Liberte (CNIL) 1
Comite Consultatif du Traitement de l’Information Re-
cherche en Sante. Approval has to be checked or
renewed when there is a change in the database.
National legislation requires informed consent to regis-
ter a baby with a congenital anomaly. Parents have to
ask for removal of the child from the register (opt-out).
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Electronic and Web-based Data Capture
The registry does not receive any electronic down-
loads. Nurses or midwives gather data on a daily or
weekly basis in public and private hospital units using a
laptop computer. To address the problem of security and
management of the database, the registry decided to
delegate the installation, conﬁguration, hosting, mainte-
nance, and monitoring of the server to the company
Altitude Telecom, which provides a dedicated high
security server REMERA. An integrated REMERA ‘‘all
web’’ system has been developed internally to better
meet the requirements of the profession, the aim being to
have a unique up-to-date register reference available at
all times to authorized persons. This highly secure intra-
net consists of management applications and query
options to the database of registry tables and references
(medical and geographical).
Like any web solution, it is based on a client/server
system. The server is a DELL 1950 1U Linux housed in a
clean room on a site with secure access, with proactive
supervision, a 99.9% availability rate, 4H guaranteed
recovery time, and with progressive and corrective main-
tenance. A production environment and an environment
of pre-production exist and separate daily backups are
performed.
Exchanges between client and server takes place
through a virtual private network that guarantees
the sealing of data trafﬁc ﬂow. We also use the web
applications in secure mode, which requires a certiﬁcate
of authenticity of the client and encryption. In addition,
all personal information is encrypted in the database.
Recent Registry Activities and Publications
(2007–2010)
Cordier S, Lehe´bel A, Amar E, et al. 2010. Maternal
residence near municipal waste incinerators and the risk
of urinary tract birth defects. Occup Environ Med 67:493–
499.
Garne E, Dolk H, Kra¨geloh–Mann I, et al. 2008.Cerebral
palsy and congenital malformations. Eur J Paediatr Neu-
rol 12:82–88.
Tomson T, Battino D, French J, et al. 2007. Antiepileptic
drug exposure and major congenital malformations: the
role of pregnancy registries. Epilepsy Behav 11:277–282.
Perthus I, Amar E, De Vigan C, et al. 2008. E´tat des
lieux des registres de malformations conge´nitales en
France en 2008. BEH 28–29:246–248.
Amar E. 2008. Cre´ation d’un registre: exemple du
Registre des malformations en Rhoˆne-Alpes (Remera).
BEH 28–29:249.
Perthus I, de Brosses L, Amar E, Francannet C. 2008.
La ve´riﬁcation du caryotype fetal est-elle justiﬁe´e devant
la de´couverte ante´natale de pieds varus e´quins isole´s?
BEH 28–29:258–260.
Leoncini E, Baranello G, Orioli IM, et al. 2008. Fre-
quency of holoprosencephaly in the International Clear-
inghouse Birth Defects Surveillance Systems: searching
for population variations. Birth Defects Res A Clin Mol
Teratol 82:585–591.
Weber–Schoendorfer C, Hannemann D, Meister R,
et al. 2008. The safety of calcium channel blockers during
pregnancy: a prospective, multicenter, observational
study. Reprod Toxicol 26:24–30.
Chevrier C, Bahuau M, Perret C, et al. 2008. Genetic
susceptibilities in the association between maternal expo-
sure to tobacco smoke and the risk of nonsyndromic oral
cleft. Am J Med Genet A 146A:2396–2406.
Cordier S, Lehe´bel A, Amar E, et al. 2008. Maternal
residence near municipal waste incinerators and risk of
urinary tract birth defects. Epidemiology 19:S234.
Cordier S, Le´hebel A, Amar E, et al. 2010. Maternal
residence near municipal waste incinerators and risk of
urinary tract birth defects. Occup Environ Med 67:493–
499.
Rankin J, Cans C, Garne E, et al. 2010. Congenital
anomalies in children with cerebral palsy: a population-
based record linkage study. Dev Med Child Neurol
52:345–351.
Registry Contribution to EUROCAT Collaborative
Papers (2007–2010)
Table 2 shows the registry contribution to EUROCAT
studies.
Address for Further Information
Emmanuelle Amar (leader of REMERA registry from
2007), Registre des Malformations en Rhoˆne Alpes, Fac-
ulte´ de me´decine Laennec, 7-9 rue Guillaume Paradin,
69372 Lyon, France. E-mail: emmanuelle.amar@remera.fr.
FRANCE, STRASBOURG – FULL MEMBER
History and Funding
The registry was started in 1979 and became a member
of EUROCAT in 1982. The registry has been ofﬁcially rec-
ognized by the French National Committee of Registries
in 2007 for the next 3 years (2008–2010). It is partially
supported by an annual grant from INSERM and Institut
National de Veille Sanitaire (Institute for Health Surveil-
lance).
Population Coverage
The registry is population-based III and includes all
mothers delivering in the covering area, excluding non-
residents. A total of 3.5% of non-residents give birth in
the covered hospitals and 2% of the residents deliver out-
side the area. Up until 2004, the geographic area covered
by the registry was the ‘‘Department of Bas-Rhin’’,
Northeastern France, including Strasbourg, and covered
about 13,500 births. Since 2005, the geographic area
concerns the two departments of Alsace, ‘‘Bas-Rhin’’ and
‘‘Haut-Rhin’’, including urban and rural areas. The
registry covers about 23,000 births which represents
approximately 3% of all births in France.
Sources of Ascertainment
Registration is active. Sources of information are multi-
ple including reports obtained from pediatricians, hospi-
tal discharge records, maternity records, fetal ultrasound
screening, laboratory records (cytogenetic, molecular, and
pathology), and specialized departments. Birth certiﬁcates
include notiﬁcation of congenital anomaly and are also
used as a source of notiﬁcation. The registry has direct
access to cytogenetics laboratories; the laboratories do not
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send data, but all prenatal and postnatal karyotypes are
actively veriﬁed. Concerning heart malformations, there
are two pediatric cardiology departments. The lists of all
consultations including date and place of birth and
parental address, age at the time of consultation, and
diagnosis are easily available and compared to other
pediatric or surgical reports.
Maximum Age at Diagnosis
Up to 2 years of age.
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is legal and there is no
upper gestational age limit set for either social termina-
tions or terminations as a result of a diagnosis of a con-
genital anomaly. Terminations of pregnancy are regis-
tered.
Stillbirth Deﬁnition and Early Fetal Deaths
Before 1993, stillbirths were deﬁned as 180 days, and
since 1993, the deﬁnition has been set at 22 weeks of
amenorrhea (20 weeks of gestation) gestation. There is no
limit with regard to either gestational age or weight that
impedes notiﬁcation of a fetal death/spontaneous abor-
tion to the registry. Stillbirths and fetal death/spontane-
ous abortions are registered. All autopsies are carried out
by fetopathologists.
Exposure Data Availability
Information on maternal drug use, maternal and pater-
nal diseases and occupations, and outcome of previous
pregnancies is available for the malformed cases. The
children are followed to the age of 2 years old.
Denominators and Controls Information
Background data on births are available from the
National Institute of Statistics (INSEE).
Ethics and Consent
The registry does not require ethics committee ap-
proval to function but has approval of both Comite Con-
sultatif du Traitement de l’Information Recherche en
Sante and CNIL.
Individual parental consent is not systematically asked
for but a parental information form is available in all
care units.
Electronic and Web-based Data Capture
Our electronic database corresponds to the EUROCAT
Data Management Program (EDMP) with some minor
local modiﬁcations. Moreover, we collect data from sev-
eral electronic sources of information:
 Electronic database from gynecologists named
DIAMM (Dossier Informatise´ Adaptatif Monde Me´d-
ical).
 Local website from Strasbourg Hospital.
Recent Registry Activities and Publications
(2007–2010)
Osteosclerotic bone dysplasia in siblings with a
Fam20C mutation.
Fradin M, Stoetzel C, Muller J, et al. 2010. Osteoscler-
otic bone dysplasia in siblings with a Fam20C mutation.
Clin Genet [Epub ahead of print].
Cocchi G, Gualdi S, Bower C, et al. 2010. International
trends of Down syndrome 1993–2004: births in relation to
maternal age and terminations of pregnancies. Birth
Defects Res A Clin Mol Teratol 88:474–479.
Sananes N, Guigue V, Vayssiere C, et al. 2010. Contri-
bution of 3D ultrasound and fetal face studies to the pre-
natal diagnosis of Pallister-Killian syndrome. J Matern
Fetal Neonatal Med 23:558–562.
Bloch J, Cans C, de Vigan C, et al. 2008. [Feasibility of
the fetal alcool syndrome surveillance]. [Article in
French] Arch Pediatr 15:507–509. French.
Leoncini E, Baranello G, Orioli IM, et al. 2008. Fre-
quency of holoprosencephaly in the International Clear-
inghouse Birth Defects Surveillance Systems: searching
for population variations. Birth Defects Res A Clin Mol
Teratol 82:585–591.
Doray B, Dott B, Cordier C, Dollfus H. 2008. Epide´mio-
logie, ge´ne´tique et diagnostic pre´natal des malformations
diaphragmatiques en Alsace, France. BEH 28–29:254–258.
International Meetings
Doray B. 2009. Fetal alcohol syndrome. Knowledge,
training and experience of pediatricians, gynecologists
and midwives in the care of fetal alcohol syndrome.
EUROCAT Registry Leader Meeting. Bilbao.
Doray B. 2008. Fetal alcohol syndrome. Knowledge,
training and experience of pediatricians and gynecolo-
gists in the care of fetal alcohol syndrome. Communica-
tion orale: 35th Annual Meeting of the International
Clearinghouse for Birth Defects Surveillance and
Research Padoue 13–17 September 2008.
Doray B, Dott B, Cordier C, et al. Ten years of congeni-
tal eye malformations in Alsace, north-eastern France
(1995–2004). Epidemiologic and genetic study of 140
cases and evaluation of prenatal diagnosis. ISGEDR
Strasbourg, 28–30 August 2008.
Doray B. 2008. Fetal alcohol syndrome. Animation
d’un workshop sur le syndrome d’alcoolisation fetale a`
l’occasion du EUROCAT Registry Leaders’ Meeting, Hel-
sinki, June 2008.
Doray B, Dott B, Rinkenbach R, Dollfus H. 2007. Epide-
miologic and genetic study and evaluation of prenatal di-
agnosis of oral clefts in Alsace, north-eastern France
(1995-2004): analysis of 266 cases.
EUROCAT Registry Leaders’ Meeting, Naples, 7–9
May 2007.
Doray B. Registry of Congenital Malformations of
Alsace, France. EUROCAT Registry Leaders’ Meeting,
Graz, 9–10 June 2006.
National Meetings
Doray B. Microce´phalies syndromiques et me´taboli-
ques. XIIe`mes Journe´es de la SOFFOET Strasbourg Octo-
ber 2008.
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Doray B. Registre de Malformations et De´pistage. Com-
munication orale dans le cadre du Se´minaire Pierre
Royer, Paris, 13–14 March 2008.
Doray B. Embryologie, Epide´miologie et Ge´ne´tique des
Malformations Oesophagiennes. Communication orale
dans le cadre de la Socie´te´ Franc¸aise de Chirurgie Pe´dia-
trique Mont Saint-Odile, 4–5 December 2006.
Local and Regional Seminars
Doray B. Trisomie 21. Epide´miologie, ge´ne´tique, clini-
que et prise en charge. Communication dans le cadre
d’un colloque sur les nouvelles proce´dures nationales de
de´pistage. CMCO, Schiltigheim. 16 October 2009.
Doray B. Syndrome d’Alcoolisation fetale. Re´seau
Maternite´ et Addictions. Journe´es de formation Erstein,
24 October 2008.
Doray B. Syndrome d’Alcoolisation Fetale. Communi-
cation orale dans le cadre d’une FMC Me´decins Ge´ne´ral-
istes, Strasbourg, 24 January 2008.
Doray B. Syndrome d’Alcoolisation Fetale. Communi-
cation orale dans le cadre d’une FMC Me´decins
Pe´diatres. Molsheim, 25 January 2007.
Doray B. Cardiologie et Ge´ne´tique. Communication
orale dans le cadre d’une FMC Me´decins Cardiologues.
Schiltigheim, December 2006.
Doray B. Ge´ne´tique et Me´decine Fetale. La queˆte de
l’Enfant parfait? Communication orale dans le cadre des
se´minaires de re´ﬂexion e´thique, Rosheim, May 2006.
Posters
Doray B, Badila–Timbolschi D, Cordier C, et al. Twelve
years of esophageal malformations in Alsace (France):
epidemiologic, genetic and clinical study and evaluation
of prenatal diagnosis. First International Workshop about
esophageageal atresia. Lille 27–28 May 2010.
Doray B, Badila–Timbolschi D, Dott B, et al. Etude e´pi-
de´miologique et ge´ne´tique et e´valuation du diagnostic
pre´natal de la Trisomie 21 en Alsace: Analyze de 274 cas
entre 1995 et 2004. Assises de Ge´ne´tique Humaine et
Me´dicale. Strasbourg, January 2010.
Doray B, Badila–Timbolschi D, Dott B, et al. Etude e´pi-
de´miologique et e´valuation du diagnostic pre´natal des
dysgonosomies en Alsace entre 1995 et 2004. Assises de
Ge´ne´tique Humaine et Me´dicale. Strasbourg, January
2010.
Doray B, Cordier C, Dott B, et al. Etude e´pide´miologi-
que et ge´ne´tique des malformations oculaires: analyze de
140 cas entre 1995 et 2004 a` partir du Registre de Malfor-
mations Conge´nitales d’Alsace. Assises de Ge´ne´tique
Humaine et Me´dicale. Strasbourg, January 2010.
Doray B, Dott B, Cordier C, et al. Etude e´pide´miologi-
que et ge´ne´tique et e´valuation du diagnostic pre´natal de
la trisomie 21 en Alsace: analyze de 279 cas entre 1995 et
2004. Communication afﬁche´e aux Journe´es de Me´decine
Fetale. Morzine, March 2009.
Doray B, Dott B, Cordier C, et al. Syndrome d’alcooli-
sation fetale : Connaissances et pratiques des pe´diatres,
gyne´cologues et sages-femmes d’Alsace. Communication
afﬁche´e aux Journe´es de Me´decine Fetale. Morzine,
March 2009.
Doray B, Dott B, Cordier C, et al. Ten years of dia-
phragmatic malformations in Alsace, North-Eastern
France: epidemiologic and clinical study and evaluation
of prenatal diagnosis. Clearing House (ICDBMS) meeting,
Padova, September 2008.
Doray B, Dott B, Favre R, et al. Etude e´pide´miologique
et ge´ne´tique et e´valuation du diagnostic pre´natal des
malformations diaphragmatiques en Alsace: analyze de
65 cas entre 1995 et 2004. Communication afﬁche´e aux
Journe´es de Me´decine Fetale Morzine, April 2008.
Doray B, Dott B, Favre R, et al. Etude e´pide´miologique
et ge´ne´tique et e´valuation du diagnostic pre´natal des
malformations diaphragmatiques en Alsace: analyze de
65 cas entre 1995 et 2004. Communication afﬁche´e aux
deuxie`mes Assises de Ge´ne´tique Humaine et Me´dicale.
Lille, January 2008.
Doray B, Dott B, Rinkenbach R, et al. Etude e´pide´mio-
logique et ge´ne´tique et e´valuation du diagnostic pre´natal
des fentes oro-faciales en Alsace: analyze de 266 dossiers
entre 1995 et 2004. Communication afﬁche´e aux deux-
ie`mes Assises de Ge´ne´tique Humaine et Me´dicale. Lille,
January 2008.
Registry Contribution to EUROCAT Collaborative
Papers (2007–2010)
Table 2 shows the registry contribution to EUROCAT
studies.
Address for Further Information
Berenice Doray, Service de Genetique Medicale, Hopital
de Hautepierre, Avenue Moliere, F-67098 Strasbourg
Cedex, France. E-mail: Berenice.Doray@chru-strasbourg.fr;
berenice.doray@neuf.fr.
GERMANY, MAINZ – FULL MEMBER
History and Funding
The Mainz Model was launched in 1990. The aim of
this screening project was to determine prevalence and
etiologic causes of birth defects. The registry and its asso-
ciated research are funded by the Ministry of Health of
the Federal Republic of Germany from 1990 to 1995 and
by the Ministry of Labor, Social Affairs and Health of
Rhineland–Palatine from 1990 until now. The registry
joined EUROCAT in 1992.
Population Coverage
The registry covers births in three maternity hospitals
which serve the Mainz district and area of Rheinhesse
(370,000 inhabitants; population coverage 94.7% in 2008
according to federal statistics ofﬁce) of Rhineland–Palati-
nate in southwest Germany with approximately 3300
births per year. Births to non-residents of the area are
excluded (population-based III).
Sources of Ascertainment
The registry employs three pediatricians specially
trained in clinical genetics, neonatology, and pediatric
ultrasonography who examine each baby born in the par-
ticipating hospitals twice within the ﬁrst week of life.
Routine sonography of hips and kidneys are performed.
For particular indications (e.g., microcephaly or heart
murmur) further ultrasound examinations of the heart,
the brain, and other investigations are made. Both major
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and minor anomalies are recorded according to a stand-
ard examination protocol, but only major anomalies
are transmitted to the EUROCAT Central Registry.
Information concerning stillbirths and terminations of
pregnancy (voluntary) are also obtained from pathology
reports. Information concerning terminations of preg-
nancy is obtained from pathology reports and from the
one center in the district doing the ﬁnal prenatal diagno-
sis. Cases of microcephaly are not transmitted to the
EUROCAT Central Registry. Cases of hydronephrosis are
available in more detailed diagnoses. Karyotyping in all
suspicious and prenatally diagnosed cases in the moni-
tored area is initiated by the registry. All cytogenic labo-
ratory results are available for all relevant cases. All cases
with prenatally detected signs or relevant medical his-
tory, as well as all suspicious children (clinics, persisting
cardiac murmur for more than 3 days), are referred to
the cardiology department for diagnosis. Pediatric cardi-
ology centers supply diagnosis when requested by the
registry.
Maximum Age at Diagnosis
Up to 1 week of age.
Termination of Pregnancy for Fetal Anomaly
Terminations of pregnancy after prenatal diagnosis are
registered. Terminations of pregnancy for fetal malforma-
tion are performed in one of the hospitals and included
in the data. It is relatively common for prenatal diagnosis
of congenital anomalies not to result in a decision to
terminate the pregnancy. Sixty percent of terminations
have an autopsy examination as this is on a voluntary
basis and these are not legally registered.
Stillbirth Deﬁnition and Early Fetal Deaths
The ofﬁcial stillbirth deﬁnition in Germany is a baby
born with no signs of life weighing >5 500 g. The regis-
try records information on all fetal deaths (including
both stillbirths and spontaneous abortions) from 16
weeks’ gestation. Autopsy rates were as follows in 1995:
in stillbirths 70%, in induced abortions 70%, in early neo-
natal deaths (0–7 days) 55%, in later deaths 1 week to 1
year – not applicable, and in deaths with congenital
anomaly – not known.
Exposure Data Availability
Exposure information on the EUROCAT form is
obtained for both malformed and non-malformed babies.
Sources: the pregnancy pass ﬁlled out throughout preg-
nancy by the obstetrician and his staff and data collected
by midwives 6 to 8 weeks before birth. Additional expo-
sure data is held which is not transmitted to EUROCAT.
Drugs are ATC coded.
Denominators and Controls Information
There is comparable information on all non-malformed
babies in the population from the same process of pediat-
ric examination and information gathering. The number
of births is taken from this database. Information on the
total number of fetal deaths from 16 weeks is available
and included in ‘‘stillbirth’’ statistics.
Registry Description Reference
Queisser–Luft A, Stolz G, Wiesel A, et al. 2002. Malfor-
mations in newborn: results based on 30,940 infants and
fetuses from the Mainz congenital birth defect monitoring
system (1990–1998). Arch Gynecol Obstet 266:163–167.
Ethics and Consent
Informed consent to use all routinely acquired data for
scientiﬁc research is part of the admission contract
between the patient and the hospital and thus given (opt-
in).
The registry requires approval from the ethics commit-
tee of Rhineland Palatinate since its beginning. The ap-
proval does not have to be checked or renewed periodi-
cally. The registry includes only pseudonymous data. An
approval of the data protection committee is necessary
ever since.
Electronic and Web-based Data Capture
Electronic data capture has been designed, planned
implementation is scheduled in 2011.
Recent Registry Activities and Publications
(2007–2010)
 Birth defects in the vicinity of nuclear power plants
(2006–2009, under review 2010).
 Occupational maternal exposure to ionizing radiation
in health care and birth defects in their offspring
(under review 2010).
 Artiﬁcial reproductive techniques and birth defects
(continuous).
 Feasibility on recruiting pregnant women in the
second trimester (2008, for publication 2010).
 Gestational diabetes over time (2010, for publication
2011).
 Follow-up of a birth cohort (started January 2010).
 Developing a survey system to avoid familial/social
child health dangers as soon as possible (started
November 2010).
Registry Contribution to EUROCAT Collaborative
Papers (2007–2010)
Table 2 shows the registry contribution to EUROCAT
studies.
Address for Further Information
Annette Queisser–Wahrendorf, and Awi Wiesel, Birth
Registry Mainz Model, Children’s Hospital, University
Medical Center of the Johannes Gutenberg University
Mainz, Langenbeckstr. 1, 55131 Mainz, Germany. E-mail:
queisser@kinder.klinik.uni-mainz.de.
GERMANY, SAXONY–ANHALT – FULL
MEMBER
History, Funding, and Legal Legitimacy
The registry joined EUROCAT in 1992. The registry
started in 1980. The years 1980 to 1989 were funded by
the Ministry of Health of former German Democratic
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Republic. The years 1990 to 1992 were funded by the
Academy of Medicine, Magdeburg, whereas the period
between 1993 and 1995 was sponsored by the Ministry of
Health, Federal Republic of Germany. Since 1995, the
registry has been funded by the Ministry of Health and
Social Affairs State of Saxony Anhalt, Germany. On De-
cember 11, 2009, a new law by the parliament of Saxony–
Anhalt was unanimously adopted. In § 7 states: ‘‘The
Federal state of Saxony–Anhalt promotes the widespread
detection of birth defects in babies under a permanent
observation. The task of this observation was to identify
data on the prevalence of congenital malformations and
watch over a deﬁned period of time, to analyze the scien-
tiﬁc data, and to evaluate the effectiveness of measures
for primary and secondary prevention.’’
Population Coverage
The registry started in 1980 in the city of Magdeburg
with about 4000 annual births. After that, there was a
successive enlargement of the registry from 1981 to 1986.
In 1981, we expanded to include some rural districts
around the city of Magdeburg and this process continued
until 1987 when we registered the whole area of the for-
mer ‘‘District of Magdeburg’’ (about 17,000 births per
year). Then we had a stable system from 1987 to 1989,
and then in 1990 there was a dramatic political change.
Since the reuniﬁcation, there has been a two-third
decrease in the number of births in the so-called`new`
Federal states of Germany. After the reuniﬁcation, a simi-
lar process of territorial enlargement took place. In the
year 2000, registration expanded to the entire Federal
State of Saxony–Anhalt (21 districts and 3 major cities).
In the year 2007, a reform reduced the 21 districts to 11
districts.
Saxony–Anhalt has 2.375 million inhabitants (March
31, 2009) and annual births at a rate of about 17,200 chil-
dren (2009).
By comparison to 1987, we currently survey a much
larger area in our registry with approximately twice as
many inhabitants but the births rate is the same as the
1980s. Registration concerns deliveries within surveyed
regions excluding non-residents (population-based III).
Sources of Ascertainment
Multiple sources, such as delivery units (January 1,
2010: 27 clinics), pediatric departments, laboratories, pre-
natal diagnostic centers, departments of pathology, and
other specialities report children/fetuses with malforma-
tions and healthy children as a control group.
The registration of a child requires the informed con-
sent of the parents. The registration sheet does not
include much personal identiﬁable data, thus making fol-
low-up investigations almost impossible. Exposure infor-
mation of the mother (including drug intake before and
during pregnancy, including periconceptional folic acid
intake) and the father is documented on a standardized
documentation sheet. From 1987 onward, cases are regis-
tered if diagnosed with a congenital anomaly up to 1
year of age. The registry receives some results from cyto-
genetic laboratories but not through direct access or via
electronic transfer. Some are received indirectly via gyne-
cology or pediatric notes.
We get notiﬁcation from the pediatric cardiology
department and a regional cardiology outpatient clinic
via our standardized form twice a year.
Maximum Age at Diagnosis
Up to 1 year of age.
Termination of Pregnancy for Fetal Anomaly
Terminations of pregnancy (‘‘medical indication’’) have
no time limitation by law in Germany. We have had
complete information about terminations of pregnancy
after prenatal diagnosis of fetal malformations since 1987.
Stillbirth Deﬁnition and Early Fetal Deaths
Stillbirths and spontaneous abortions with malforma-
tions from 16 weeks gestation are registered. The still-
birth deﬁnition has been >5 500 g from January 4, 1994,
and >5 1000 g before 1994.
Exposure Data Availability
Maternal and paternal occupation, drugs in pregnancy
(ATC coded), alcohol, nicotine, and drug abuse.
Denominators and Controls Information
Statistics on the total number of births comes from
Statistical Ofﬁce Saxony–Anhalt. There is the opportunity
to exclude non-resident mothers with assistance of the
postal code. A woman who gives birth outside Saxony–
Anhalt, but is a result here is included in the statistics.
The denominators include only livebirths and stillbirths.
Information about maternal age for all births is available
at the level of the entire state of Saxony–Anhalt and also
the single counties.
Information is also reported about two control infants
per malformed child. The two control infants, theoreti-
cally, are those born directly before and directly after the
malformed child. The information about the control chil-
dren is the same as malformed because a standardized
documentation sheet is used.
Additional Services
Since January 8, 2006, the Malformation Monitoring
Center is collecting and tracking the results of the new-
born hearing screening in Saxony–Anhalt. This test is
made regular in the delivery units.
We closely collaborate with the newborn screening
center Saxony–Anhalt which is located at the Medical
Faculty of Otto-von-Guericke University Magdeburg.
An annual report is available with results of malforma-
tion interpretation, newborn hearing screening, and
newborn metabolic screening (in German). The report
can be downloaded from our website.
Registry Description References
Krause H, Po¨tzsch S, Hab HJ, et al. 2009. Ventrale Bauch-
wanddefekte – Darstellung der Entwicklung in Pra¨valenz
und operativem Vorgehen anhand von Gastroschisis und
Omphalozele. Zentralblatt fu¨r Chirurgie 6:524–531.
Po¨tzsch S, Hoyer–Schuschke J. 2009. Angeborene
Fehlbildungen – Hintergrundwissen fu¨r die Beratung der
Eltern. Die Hebamme 2:88–94.
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Bade A, Rohden L von, Hoyer–Schuschke J, Po¨tzsch S.
2008. Ultraschallscreening des Scha¨dels bei Neugeborenen –
Pro und Kontra. Pa¨d Praktische Pa¨diatrie 3:178–188.
Ethics and Consent
The registry has the ethics committee approval from the
Medical Faculty, Otto-von-Guericke University, Magdeburg.
Because of the data protection law in Germany, since
1992, national legislation requires informed consent to
register a baby with a congenital anomaly. Parents have to
agree to the inclusion of the child on the Register (opt-in).
Electronic and Web-based Data Capture
The registry does not receive web-based data because
of the data protection law.
Recent Registry Activities and Publications
(2007–2010)
Lindinger A, Schwedler G, Hense HW, for the partici-
pants of the PAN study. 2010. Prevalence of congenital
heart defects in newborns in Germany: results of the ﬁrst
registration year of the PAN study (July 2006 to June
2007). Klinische Pa¨diatrie 5:321–326.
Po¨tzsch S. 2010. 5. Einsendertreffen des Fehlbildungs-
monitoring Sachsen–Anhalt. A¨rzteblatt Sachsen–Anhalt
1:19–20.
Po¨tzsch S, Bretschneider D, Hoyer–Schuschke J, et al.
2010. Neugeborenes mit frontonasaler Schwellung. Mon-
atsschrift Kinderheilkunde 5:427–429.
Krause H, Po¨tzsch S, Hab HJ, et al. 2009. Ventrale
Bauchwanddefekte – Darstellung der Entwicklung in Pra¨-
valenz und operativem Vorgehen anhand von Gastro-
schisis und Omphalozele. Zentralblatt fu¨r Chirurgie
6:524–531.
Po¨tzsch S, Hoyer–Schuschke J. 2009. Angeborene Fehl-
bildungen – Hintergrundwissen fu¨r die Beratung der
Eltern. Die Hebamme 2:88–94.
Bade A, Rohden L von, Hoyer–Schuschke J, Po¨tzsch S.
2008. Ultraschallscreening des Scha¨dels bei Neugeborenen –
Pro und Kontra. Pa¨d Praktische Pa¨diatrie 3:178–188.
Hoyer–Schuschke J, Po¨tzsch S, Bo¨ttger R, et al. 2008.
Kongenitale alveolar-kapilla¨re Dysplasie. Seltene Ursache
der persistierenden pulmonalen Hypertension beim Neu-
geborenen. Monatsschrift Kinderheilkunde 1:57–62.
Mohnike K, Blankenstein O, Pfu¨tzner A, et al. 2008.
Long-term non-surgical therapy of severe persistent con-
genital hyperinsulinism with glucagon. Hormon Research
1:59–64.
Mohnike K, Starke I, Po¨tzsch S. 2008. Metabolische
Krisen im Kindesalter. Intensivmedizin 3:229–244.
Po¨tzsch S, Hoyer–Schuschke J, Ko¨hn A, et al. 2008. Jah-
resbericht des Bundeslandes Sachsen–Anhalt zur Ha¨uﬁg-
keit von congenitalen Fehlbildungen und Anomalien
sowie genetisch bedingten Erkrankungen 2007. Fehlbil-
dungsmonitoring Sachsen–Anhalt an der Medizinischen
Fakulta¨t der Otto-von-Guericke-Universita¨t Magdeburg.
Ministerium fu¨r Gesundheit und Soziales des Landes
Sachsen–Anhalt. Magdeburg.
Po¨tzsch S, Jira P. 2008. Smith-Lemli-Opitz-Syndrom –
von der Diagnose zur Therapie. In: Starke I, Mohnike K,
editors. (Hrsg.): Cholesterin – zwischen Mangel und
U¨berﬂuss. 20. Jahrestagung 2006 der Arbeitsgemeinschaft
fu¨r Pa¨diatrische Stoffwechselsto¨rungen (APS). Fulda:
APS. pp 46–63.
Po¨tzsch S, Vorwerk W, Rasinski C, et al. 2008. Angebor-
ene Ho¨rsto¨rungen unter besonderer Beru¨cksichtigung der
Einfu¨hrung des Neugeborenenscreening–Tracking in Sach-
sen–Anhalt. A¨rzteblatt Sachsen–Anhalt 5:18–20 1 49–50.
Rohden L von, Po¨tzsch S. 2008. Muskelultraschall bei
Kindern. Ausschluss-, Vermutungs- und Differenzialdiag-
nose sowie Verlaufskontrolle bei neuromuskula¨ren Erk-
rankungen. Kind & Radiologie 1:24–32.
Registry Contribution to EUROCAT Collaborative
Papers (2007–2010)
Table 2 shows the registry contribution to EUROCAT
studies.
Address for Further Information
Anke Rissmann, Malformation Monitoring Centre Sax-
ony–Anhalt, Medical Faculty, Otto-von-Guericke Univer-
sity, Leipziger Strasse, Haus 39, D-39120 Magdeburg,
Germany. E-mail: monz@med.ovgu.de. Website: http://
www.angeborene-fehlbildungen.com.
IRELAND, CORK, AND KERRY – FULL
MEMBER
History and Funding
The registry started in 1996 and was granted approved
membership of EUROCAT in 1998. The Clinical Research
Ethics Committee of the Cork Teaching Hospitals
approved the registry for research. Stafﬁng includes a part-
time nurse/researcher plus a part-time specialist in public
health medicine and surveillance scientist support. The
Department of Health and Children through the Health
Services Executive provides funding for the registry.
Population and Coverage
The registry covers the counties of Cork and Kerry in
the southwest of Ireland (population-based, all mothers
resident in a geographic area). In 2002, <1% of resident
mothers gave birth outside the registry area. The total
number of births each year is around 9950.
Sources of Ascertainment
The registry is based on active case ﬁnding. Data for
the registry includes hospital records from obstetric and
neonatal departments, antenatal and orthopedics outpa-
tient letters, pediatric cardiology center (local outreach
clinic), supplies systematic case lists, and diagnostic
details to the registry, Hospital In-patient Enquiry Data
(HIPE), birth notiﬁcations, stillbirth certiﬁcates, CSO data
on deaths in children up to the age of 2 years and post-
mortem examinations. There is no direct access to a cyto-
genetics laboratory.
Maximum Age at Diagnosis
Seven years of age (this is under review at present).
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Termination of Pregnancy for Fetal Anomaly
Abortion is illegal in Ireland. However, women in Ire-
land have the option to travel outside of Ireland for ter-
mination of pregnancy after prenatal diagnosis. Where
information is available to the registry about these cases,
they are included.
Stillbirth Deﬁnition and Early Fetal Deaths
Babies born without signs of life with a gestational age
of >5 24 weeks or a weight of >5 500 g are registered.
Early fetal deaths/spontaneous abortions are not regis-
tered. National autopsy rates for stillbirths and early neo-
natal death (0–7 days) have decreased due to controversy
arising from the issue of consent.
Exposure Data Availability
Information on parental occupation, maternal drug
use, smoking and alcohol use, illness during pregnancy,
and outcome of previous pregnancies is gathered.
Denominators and Controls Information
Denominator data is available from the national CSO.
The CSO now publishes national perinatal statistics in
respect of all births annually and provides rates for the
Republic of Ireland and is broken down by county.
Registry Description Reference
http://www.lenus.ie/hse/bitstream/10147/68034/1/Con-
genital%20Anomalies%20Newsletter%20%28ﬁnal%29.pdf.
Ethics and Consent
Approval is required from an ethics committee repre-
senting medical, paramedical, legal, lay, and academic
interests and is reviewed as indicated. Additional ap-
proval would be required for any studies that require
identiﬁable patient data or the merging of data sources.
To date, no such studies have been done.
National legislation does not require informed consent
to register a baby with a congenital anomaly. No plans to
introduce a requirement for informed consent – in ac-
cordance with long established practice for longitudinal
population-based registers. Balance is in favor of public
interests as minimal individual risk.
Electronic and Web-based Data Capture
Electronic download from:
1. HIPE once a year with 2 year delay.
2. CSO – Stillbirth certiﬁcates once a year with a 3 year
delay and vital statistics data once a year with a 1 year
delay.
Recent Registry Activities and Publications
(2007–2010)
No journal articles, book chapters, or books. A local
newsletter is published.
Registry Contribution to EUROCAT Collaborative
Papers (2007–2010)
Table 2 shows the registry contribution to EUROCAT
studies.
Address for Further Information
Mary O’Mahony, Specialist in Public Health Medicine,
Department of Public Health, Health Service Executive –
South, Sarsﬁeld House, Sarsﬁeld Road, Wilton, Cork, Ire-
land. E-mail: maryt.omahony@hse.ie.
IRELAND, DUBLIN – FULL MEMBER
History and Funding
The registry was established in 1979 and joined EURO-
CAT in 1980. The registry is located within the Quality
and Clinical Care Directorate (Health Intelligence) of the
Health Service Executive. Stafﬁng includes a full-time pe-
diatric nurse/researcher and a specialist in public health
medicine who works part-time with the registry. In addi-
tion, there is limited secretarial support. Funding is pro-
vided by the Department of Health through the Health
Service Executive.
Population Coverage
The registry is population-based I, which includes all
mothers resident in the Health Service Executive area
covering the counties of Dublin, Wicklow, and Kildare
in the east of Ireland. A little more than one-third
(25,000 births) of all births in Ireland occur in the area of
coverage.
Sources of Ascertainment
There is surveillance of all livebirths and stillbirths.
Children with a congenital anomaly are included in the
registry when diagnosed up to the age of 5 years. Multi-
ple sources of ascertainment are used, including informa-
tion from maternity and pediatric hospitals, governmen-
tal vital statistics, medical genetics services, and hospital
discharge information. As a consequence of data protec-
tion restrictions, most of the data used by the registry in
the ascertainment of cases is anonymized. This is more a
passive process than the active approach formerly used
by the registry. As such, the use of multiple sources of
ascertainment is, therefore, essential in the veriﬁcation
and validation of cases, but is more time consuming and
has led to a time-delay in the ascertainment of many cat-
egories of anomaly. There is no electronic data access or
transfer by the registry from data sources, nor web trans-
fer process. The registry receives an anonymized case list
with diagnoses from the local pediatric cardiology center;
the center would include virtually all cases resident in
the registry catchment area. The cytogenetic center within
the region supplies an annual anonymized list to the
registry of samples tested, with karyotyping and diagnos-
tic details. The center includes the majority of samples
tested within the registry population, although not all.
Maximum Age at Diagnosis
Up to the age of 5 years.
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Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy for congenital anomaly is
not legal in Ireland.
Stillbirth Deﬁnition and Early Fetal Deaths
Babies born without signs of life with a gestational age
of >5 24 weeks or a weight of >5 500 g are registered.
Early fetal deaths/spontaneous abortions are not regis-
tered. National autopsy rates only were available for
1999 for the following: stillbirths 50 to 60% and early
neonatal death (0–7 days) 50 to 60%. There has been a
decrease in the proportions having an autopsy in the
registry catchment area to approximately 50% due to
controversy arising from the issue of consent.
Exposure Data Availability
For each malformed infant reported, very limited or no
information is given on certain exposures.
Denominators and Controls Information
Denominator data are supplied by the government
body – the CSO. No information is available on controls.
Ethics and Consent
The registry operates according to Data Protection
Legislation in Ireland/European Union. As the data on
the vast majority of cases held by the registry are
received on an anonymized basis, no consent is currently
sought or required. No data are provided to third parties
and any reports or papers using registry data are on an
aggregate basis.
New national legislation on information governance in
relation to all health data (including that obtained and
held, and analyzed by registries) will be published by the
Irish Government in late 2010. The legislation will pro-
vide the basis for the obtaining and use of all aspects of
data/information, including ethical and conﬁdentiality
considerations. The precise contents of the Bill in relation
to congenital anomaly registries were unknown by mid-
2010, although submissions were made by the registry
during the prior consultation period.
Electronic and Web-based Data Capture
The registry does not have access to electronic data
held by other organizations. Likewise, there is no elec-
tronic data transfer, nor web transfer process, to the
registry from its data sources.
Recent Registry Activities and Publications
(2007–2010)
The main activity of the registry is to monitor trends
and clusters on an ongoing basis in its catchment area.
The registry has also been involved for many years in a
number of collaborative research projects with EURO-
CAT and the International Clearinghouse for Birth
Defects and Research, and has co-authored a number of
research articles.
At a local level, the registry has carried out surveys on
the use of folic acid by women in the periconceptional
period, consequent to a high birth prevalence of neural
tube defects historically in Ireland. The ﬁndings are
documented in a number of journal publications in past
years.
The registry has also examined the epidemiology of a
number of other congenital anomalies over the past that
have shown changes in trend or have been of special sig-
niﬁcance in an Irish context, including Down syndrome,
gastroschisis, and neural tube defects.
Registry Contribution to EUROCAT
Collaborative Papers (2007–2010)
The registry collaborates on a regular and ongoing ba-
sis with EUROCAT in research projects on congenital
anomalies and related issues. Recent collaborative pub-
lished articles resulting from such research are shown in
Table 2.
Address for Further Information
Bob McDonnell/Virginia Delany, Health Service
Executive (HSE) Registry of Congenital Anomalies – East,
Quality and Clinical Care Directorate, Room G29, Health
Service Executive, Dr. Steeven’s Hospital, Dublin 8,
Ireland. E-mail: bob.mcdonnell@hse.ie/virginia.delaney@
hse.ie.
IRELAND, SOUTH EAST – FULL MEMBER
History and Funding
The Southeast Ireland Congenital Anomaly Register
was established in the year 2000 and data was retrospec-
tively collected from 1997 onward. The Department of
Health and Children funds the registry through the HSE.
Population Coverage
The registry is population-based and includes babies
born to all mothers resident in the southeast. The registry
covers approximately 6500 births per year, which repre-
sents 11% of all births in the Republic of Ireland.
Sources of Ascertainment
The registry is based on active case ﬁndings. A child
with a malformation, born after January 1, 1997, can be
registered at any age. There is no upper age limit
imposed for registration of a case.
Multiple sources of data are used in ascertainment and
veriﬁcation of cases. They include:
 Child Health Information System.
 Death and Still Birth Certiﬁcates.
 Postmortem Examinations.
 Disability Care Allowance systems.
 Hospital Inpatient Enquiry System (HIPE).
 Cytogenetic Laboratories – no direct access, informa-
tion received on an annual basis.
 Information from maternity and pediatric hospitals.
Pediatric cardiology centers do not supply information
to the registry, but other sources of information cover pe-
diatric cardiac surgery (i.e., copies of letters from pediat-
ric cardiology centers in respect of each case are always
available in medical notes at hospital level).
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Medical notes are reviewed in each instance to assist in
the conﬁrmation of the diagnosis.
Registration covers babies born with prenatally
diagnosed anomalies, affected fetuses spontaneously
lost from 24 weeks gestation, or with a birth weight
>500 g.
EUROCAT guidelines are adhered to in respect of
inclusions and exclusions.
There has been a decrease in the proportions of still-
births and early neonatal death (0-7 days) having an
autopsy, due to controversy arising from the issue of
consent.
Maximum Age at Diagnosis
There is no upper age limit.
Terminations of Pregnancy for Fetal Anomaly
Induced abortions are illegal in Ireland. We do not
currently obtain information about terminations of
pregnancy for fetal anomaly carried out under other
jurisdictions.
Stillbirth Deﬁnition and Early Fetal Deaths
Registration covers affected fetuses spontaneously lost
from 24 weeks’ gestation or with a birth weight >500 g.
Exposure Data Availability
Maternal health, drug, and lifestyle exposure data is
collected primarily from pediatric medical records.
Denominators and Controls Information
Denominator data is available from the national CSO.
Ethics and Consent
The registry requires ethics committee approval to col-
lect and store data. This approval was sought at the time
of setting up the registry and there has been no require-
ment for renewal of the approval.
Currently, consent is not obtained for inclusion of
cases on the register. Women are given information
antenatally, telling them about the register. New
legislation (The Health Information Bill) due to be pub-
lished in autumn 2010 will place new requirements on
registers in the areas of data protection and consent.
Electronic and Web-based Data Capture
We currently have three electronic downloads of notiﬁ-
cations:
1. HIPE (Hospital inpatient enquiry) system. We
receive HIPE downloads on cases of congenital
anomalies as soon as the data has been collected
and quality audited at hospital level. This is con-
ducted in a timely manner, for example, 2008 year’s
data will be available to us within the ﬁrst 6
months of 2009. Any cases that do not have a con-
ﬁrmed diagnosis at that stage will be followed up
by registry staff at a later date.
2. Cytogenetic laboratory electronic reports. We receive
electronic reports on neonates, infants, and older
children from the cytogenetic laboratories on an an-
nual basis via another registry.
3. Oral clefts. We receive electronic reports on neonates
and infants on an annual basis from a tertiary refer-
ral hospital that specializes in these cases.
Recent Registry Activities and Publications
(2007–2010)
In addition to data collection and transmission to
EUROCAT Central Registry, and contribution to studies
via EUROCAT Central Registry, the Southeast Ireland
registry is involved in educational activities, is linked in
with EUROPLAN activities in Ireland, and is part of a
national group with the other Irish EUROCAT registries
under the auspices of the HSE National Directorate for
Quality and Clinical Care.
‘Congenital Anomalies in the East of Ireland 1997–
2001’. Published by Eastern Regional Health Authority
2004; Authors Eastern Regional Health Authority, North
Eastern Health Board, South Eastern Health Board.
Registry Contribution to EUROCAT Collaborative
Papers (2007–2010)
Table 2 shows the registry contribution to EUROCAT
studies.
Address for Further Information
Carmel Mullaney/Johanna Costigan, Department of
Public Health, Health Service Executive – South, Lacken,
Kilkenny, Ireland. E-mail: carmel.mullaney@hse.ie/johan-
na.costigan@hse.ie.
ITALY, EMILIA–ROMAGNA – FULL MEMBER
History and Funding
The registry started its activities in 1978 with the par-
ticipation of a few collaborating centers rising to cover all
delivery units in the region.
Since 1980, the registry is recognized and supported by
the Emilia–Romagna region with the following objectives:
 To produce prevalence data on congenital malforma-
tions.
 To provide temporal and spatial surveillance and
management for alarms.
 To conduct studies to evaluate health interventions
(pre-natal and neonatal screening).
 To provide a reference center, both clinical and epi-
demiologic, for congenital malformations.
The registry joined EUROCAT in 1980 and in 1981
transmitted the ﬁrst birth year of data to EUROCAT. The
registry joined the International Clearinghouse for Birth
Defects in 1995. The Emilia–Romagna Registry also par-
ticipates in the coordination of the Italian Congenital
Malformation Registries set up by The Italian National
Institute for Health (l’Istituto Superiore di Sanita`) with
the aim of sharing the experiences of the various regis-
tries, create common lines of research, and produce epi-
demiologic data on congenital malformations at a
national level (http://www.iss.it).
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Since 2003, the registry has been in collaboration with
the health information systems service and social policy
body of the Emilia–Romagna region formally involved in
the Scientiﬁc Steering Committee.
In 2004, a link with the Regional Medical Genetics
Service network was formed (www.geneter.it) with the
aim of providing genetic counseling and evaluating
genetic conditions diagnosed within the network.
Population Coverage
The Emilia–Romagna region covers an area of 22,123
square killometers with a population of around 4 million
people. The total number of births in the Emilia–Roma-
gna region is growing with 42,397 births in 2008. The
registry includes in its coverage the Republic of San Mar-
ino with 349 births in 2008.
The program is population-based II (includes all moth-
ers delivering within the region of Emilia–Romagna, irre-
spective of place of residence). In 2008, 92.3% of births
were to resident mothers. Since 2006, the registry, in col-
laboration with the Regional births database (CeDAP)
has reached a population coverage 100% involving all
34 delivery units in the region. In recent years, immigra-
tion has created an important demographic change with
an increase in births. The births to non-Italian citizens
represented 26.1% of the total births in the region in
2008.
Sources of Ascertainment
The Emilia–Romagna Registry has multiple sources of
ascertainment:
1. Voluntary hospital participation. Reporting is car-
ried out using the Emilia–Romagna Registry form
by neonatologists, pediatricians, and obstetricians
during the ﬁrst week of the infant’s life. We do not
have speciﬁc notiﬁcation from pediatric cardiology
units. Pediatric cardiology centers supply diagnostic
conﬁrmation when requested by the registry for spe-
ciﬁc cases. Notiﬁcation of a congenital anomaly is
recorded up to 1 week. Selected malformations are
followed up (e.g., Down syndrome, cardiovascular
defects, and clefts). The clinical activities and genetic
counseling conducted by medical geneticists who
form part of the registry staff provides an opportu-
nity to stimulate colleagues to notify cases.
2. The Regional Births database (CeDAP) also provides
the registry with a source of denominator and
control data.
3. The hospital discharge database Scheda di Dimis-
sione Ospedaliera (SDO) provides further sources of
ascertainment. This source can be used to investi-
gate pediatric surgery cases for speciﬁc studies.
Birth certiﬁcates do not notify congenital anomalies.
Death certiﬁcates do not allow for the notiﬁcation of a
congenital anomaly as a cause of death. We do not cur-
rently have direct access to cytogenetic laboratory results
across the region but we are working toward this objec-
tive with the Regional Health Authority.
Maximum Age at Diagnosis
Up to 1 week of age.
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy became legal in Italy in
1978. Termination is legal when there is no possibility of
autonomous life for the fetus. The Italian law (L.N. 194/
78) states that termination is allowed in the case of diag-
nosis of serious fetal pathology which may detrimentally
affect the woman’s physical or psychological health. The
upper gestational age limit for terminations is 23 weeks.
Induced abortions after prenatal diagnosis of birth
defects are systematically included. Data for induced
abortions ﬁrst became available in 1982.
A ministerial decree (decreto 10.09.1998 GU no. 245 del
20.10.98) details a protocol covering laboratory and diag-
nostic tests for pregnant women (ultrasound, amniocente-
sis, chorionic villus sampling, and AFP/triple test). Three
ultrasound examinations at 10, 20, and 30 weeks gesta-
tion are foreseen in the protocol. Cytogenetic testing is
provided routinely for women over 35 years of age. After
genetic counseling, cytogenetic and genetic testing are
offered independent of age; these services are free of
charge.
Stillbirth Deﬁnition and Early Fetal Deaths
The ofﬁcial deﬁnition of stillbirth in this registry is
now 180 gestational days in line with the Regional Births
database (CeDAP). Fetal deaths of 20 weeks or more ges-
tation are systematically included (with no lower weight
limit exclusion criteria). The autopsy rates in 2008 were:
50% in stillbirths, 60% in induced abortions, 90% in
early neonatal deaths (0–7 days), 90% in later deaths 1
week to 1 year, and 90% in deaths with congenital
anomalies. A regional project on perinatal deaths is
ongoing.
Exposure Data Availability
Exposure information is obtained by interviews of the
mothers of malformed infants. From 2003, data regarding
maternal drugs in the ﬁrst trimester is recorded as ATC
codes and jobs are recorded using the International Stand-
ard Classiﬁcation of Occupations (ISCO) work codes.
Previously, these data were recorded using internal codes.
Denominators and Controls Information
Birth statistics are provided by the Regional births
database (CeDAP) recorded by maternal age group and
birth month. This source also provides information for
control cases. General demographic information is avail-
able for all births in the area (e.g., mean maternal and pa-
ternal ages, percentage of mothers 35 years or older). In
recent years, immigration has created an important de-
mographic change with an increase in births. As births to
non-Italian citizens represented 26.3% of the total births
in the region in 2006, the nationality of the mother is
now coded for all births.
Further information regarding the reference population
can be gained from the Emilia–Romagna region websi-
tehttp://www.regione.emilia-romagna.it/index.htm.
Ethics and Consent
The registry is recognized as part of the health system
information ﬂow and regulated by regional laws. The
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parents have to agree to the inclusion of the child on the
register (opt-in).
Electronic and Web-based Data Capture
The registry website allows the participating centers to
download a pdf of the case notiﬁcation form but does
not allow electronic data transmission. The majority
of cases (75%) are still received from neonatologists,
pediatricians, and obstetricians using the paper form.
The Regional Births database (CeDAP) provides the
registry with a source of denominator and control data
and we receive an annual download of malformed cases.
In November, we receive the ﬁle of the previous year so
it has an 11-month delay. We also receive an electronic
download annually for terminations during the second
trimester. The delay for receiving data is around 9
months from year-end. The centers are then alerted to
integrate the cases with further details from this sum-
mary data. Around 20% of cases are provided by this
source. We do not receive regular downloads of data
from the hospital discharge database (Scheda di Dimis-
sione Ospedaliera) but we can request data for speciﬁc
studies.
Recent Registry Activities and Publications
(2007–2010)
II8 IMER course: ‘‘Aggiornamento sulla epidemiologia
e percorsi diagnostico-assistenziali congenite’’ Ferrara. 14
April 2007.
XXI IMER Congress ‘‘30 anni di indagine sulle malfor-
mazioni congenite in Emilia Romagna’’ Bologna. 11 April
2008.
XXII IMER Congress ‘‘Le problematiche assistenziali
del concepito con anomalie congenite multiple’’ Bologna.
27 March 2009.
Neville A, Calzolari E. 2007.Womens knowledge of
and uptake of folic acid for the prevention of neural tube
defects. Workshop Network Italiano Promozione Acido
Folico Prevenzione primaria di Difetti Congeniti. Istituto
Superiore di Sanita` Roma ISTISAN Congressi. Abstracts.
Astolﬁ G, Calzolari E, Cocchi G, et al. 2009. Rapporto
annuale sulle malformazioni congenite – 2006. IMER
Number 19.
Astolﬁ G, Calzolari E, Cocchi G, et al. 2008. Rapporto
annuale sulle malformazioni congenite – 2005. IMER
Number 18.
Astolﬁ G, Calzolari E, Cocchi G, et al. 2007. Rapporto
annuale sulle malformazioni congenite – 2004. IMER
Number 17.
Lisi A, Botto LD, Robert–Gnansia E, et al. 2010. Surveil-
lance of adverse fetal effects of medications (SAFE-Med):
ﬁndings from the international Clearinghouse of birth
defects surveillance and research. Reprod Toxicol 29:433–
442.
Ghirri P, Scaramuzzo RT, Bertelloni S, et al. 2009. Prev-
alence of hypospadias in Italy according to severity, ges-
tational age and birthweight: an epidemiologic study. Ital
J Pediatr 35:18.
Rittler M, Lo´pez–Camelo JS, Castilla EE, et al. 2008.
Preferential associations between oral clefts and other
major congenital anomalies. Cleft Palate Craniofac J
45:525–532.
Leoncini E, Baranello G, Orioli IM, et al. 2008. Fre-
quency of holoprosencephaly in the International Clear-
inghouse Birth Defects Surveillance Systems: searching
for population variations. Birth Defects Res A Clin Mol
Teratol 82:585–591.
Registry Contribution to EUROCAT Collaborative
Papers (2007–2010)
Table 2 shows the registry contribution to EUROCAT
studies.
Registry Staff and Computing
Professor Elisa Calzolari – Registry Leader (part time).
Dr. Gianni Astolﬁ – Database management (full time).
Dr. Amanda J Neville – EUROCAT coordinator (part
time).
Address for Further Information
Elisa Calzolari, Istituto di Genetica Medica, Via Fossato
di Mortara 74, 44100 Ferrara, Italy. E-mail: cls@unife.it or
imer@unife.it. Website: REGISTRO IMER.
ITALY, TUSCANY – FULL MEMBER
History and Funding
The registry started in 1979 in the province of Florence
and from 1992 in the whole Tuscany region. The registry
is a surveillance program included in the Regional Statis-
tics System; it is formally recognized and supported by
the Tuscany Region Health Authority. The registry joined
EUROCAT in 1979.
Population Coverage
The program is population-based I which includes all
mothers resident in the region of Tuscany. It involves all
the regional hospitals and the coverage is around 95% of
all births in the Tuscany region (approximately 3.5 mil-
lion inhabitants and 29,000 births per year). Exchanges
between regional informative systems indicate that 3.3%
of resident mothers gave birth in a hospital outside
Tuscany in 2007.
Sources and Ascertainment
Multiple sources are used to ascertain malformed
infants; records are obtained from all obstetrical and ma-
ternity units, pediatric departments, pediatric cardiology
departments, pediatric cardiac surgery units, prenatal
diagnostic centers, medical genetics units, and pathology
services. Pediatric cardiology centers covering part of the
registry population supply systematic case lists and diag-
nostic details to the registry. Cytogenetic laboratories
only conﬁrm karyotype for cases already known. Moth-
ers are interviewed by using a standardized question-
naire. Malformed babies diagnosed within the ﬁrst year
of life are also registered.
Maximum Age at Diagnosis
Up to 1 year of age.
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Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy became legal in Italy in
1978. Termination of pregnancy is legal when there is
no possibility of autonomous life for the fetus. The
Italian law (L.N. 194/78) lays down that termination is
allowed in the case of diagnosis of serious fetal
pathology which may detrimentally affect the women’s
physical or psychological health. Induced abortions after
prenatal diagnosis of birth defects are systematically
included. Data for induced abortions ﬁrst became
available in 1982.
Stillbirth Deﬁnition and Early Fetal Deaths
The ofﬁcial deﬁnition of stillbirth in this registry is 180
gestational days. Fetal deaths of 20 weeks or more gesta-
tion are systematically included, with no lower weight
limit exclusion criteria.
Exposure Data Availability
Maternal and paternal occupation, life-style and socio-
economic characteristics are obtained by interviews of
mothers of malformed infants.
Denominators and Controls Information
Vital statistics and other epidemiologic information is
obtained by the birth medical records collected by the
Regional Bureau of Statistics. Selected information is
obtained from the control material collected.
Ethics and Consent
The registry does not require ethics committee
approval to collect and store data.
At the moment informed consent is not required by
national legislation, but the registry asks for oral authori-
zation from the mother, the parents have to agree to the
inclusion of the child on the register (opt-in).
Electronic and Web-based Data Capture
Until 2009, personal and diagnosis information were
transmitted separately by hard copy; from 2010,
appointed gynecologists, neonatologists, and/or pediatri-
cians of the maternity units and the centers of Pediatrics,
Medical Genetics, Pediatric Cardiology, and Pediatric
Cardiosurgery have a personal account and send data via
web. Sensitive data are kept separate from medical infor-
mation. For security, data are encrypted and transmitted
across the internet network using the secure http protocol
HTTPS, instead of the standard HTTP.
Recent Registry Activities and Publications
(2007–2010)
Cocchi G, Gualdi S, Bower C, et al. 2010. International
trends of Down syndrome 1993–2004: births in relation to
maternal age and terminations of pregnancies. Birth
Defects Res A Clin Mol Teratol 88:474–479.
Leoncini E, Botto LD, Cocchi G, et al. 2010. How valid
are the rates of Down syndrome internationally? Findings
from the International Clearinghouse for Birth Defects
Surveillance and Research. Am J Med Genet A 152A:
1670–1680.
Mastroiacovo P, Working Group IP. 2010. Prevalence at
birth of cleft lip with or without cleft palate. Data from
the International Perinatal Database of Typical Oral Clefts
(IPDTOC). Cleft Palate Craniofac J [Epub ahead of print].
Lisi A, Botto LD, Robert–Gnansia E, et al. 2010. Surveil-
lance of adverse fetal effects of medications (SAFE-Med):
ﬁndings from the International Clearinghouse of
birth defects surveillance and research. Reprod Toxicol
29:433–442.
EUROCAT. 2010. Special report: prenatal screening
policies in Europe 2010. EUROCAT Central Registry,
University of Ulster. http://www.eurocat-network.eu/
content/Special-Report-Prenatal-Screening-Policies.pdf.
Salerno P, Bianchi F, Pierini A, et al. 2008. [Folic acid
and congenital malformation: scientiﬁc evidence and
public health strategies]. [Article in Italian] Ann Ig
20:519–530.
Registry Contribution to EUROCAT Collaborative
Papers (2007–2010)
Table 2 shows the registry contribution to EUROCAT
studies.
Address for Further Information
Fabrizio Bianchi (Project Leader)/Anna Pierini (Database
Management), Unit of Epidemiology, CNR Institute of Clin-
ical Physiology, Via Moruzzi 1, I-56124 Pisa, Italy. E-mail:
fabriepi@ifc.cnr.it, apier@ifc.cnr.it. Website: www.rtdc.it.
MALTA – FULL MEMBER
History and Funding
The registry started in 1985 as a research project of the
University of Malta. It started as a hospital-based register
collecting data regarding congenital anomalies diagnosed
in babies born at the main general hospital. It became a
member of EUROCAT in 1986. Funding for the research
project was stopped in 1995, and in January 1997, the
Department of Health Information resumed the functions
of the registry increasing coverage to all hospitals on the
islands making it a national population-based register.
The registry is now run and funded by the Government
Department of Health Information and Research. The
aim of the registry is to provide accurate epidemiologic
information regarding the occurrence of congenital
anomalies in Malta and Gozo.
Population Coverage
The registry is population-based 1: covering all resi-
dent mothers in Malta, Gozo, and Comino, and presently
covers about 4000 births per year. The number of resi-
dent mothers giving birth in a hospital outside the area
is considered to be negligible as Malta is an island and
population movement is limited. It is unlikely that moth-
ers will go abroad to give birth. It is precisely for this
reason that the registry is considered to cover close to
100% of births.
Sources of Ascertainment
Reporting is voluntary. Several new sources of infor-
mation have been used since 1997 and the registry has
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backdated its information to include these sources of in-
formation from 1993. For this reason, data since 1993
may be considered most complete and reliable. The regis-
try now uses active data collection from multiple sources
including delivery, obstetric, and pediatric wards, pediat-
ric echo cardiology records, genetic clinics records,
National Mortality Register, National Obstetric System
database, Hospital Activity Analysis database, National
Cancer Register, and the hypothyroid screening program.
Voluntary reporting by doctors is also available. These
sources cover the whole population of the Maltese
Islands. Registry staff regularly visits the pediatric echo
cardiology department to go through their records and
identify cases. Consultant geneticists send the registry a
list of positive genetic results on an annual basis.
Babies with a congenital anomaly may be diagnosed
and registered up to 1 year of age. Minor anomalies (as
deﬁned by EUROCAT) are not registered unless in com-
bination with other major defects. There is no legal
requirement for notiﬁcation of congenital anomalies with-
out parental consent.
Maximum Age at Diagnosis
Up to 1 year of age.
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is illegal in Malta.
Stillbirth Deﬁnition and Early Fetal Deaths
The ofﬁcial deﬁnition of stillbirth is a baby born with
no signs of life at gestational age of 22 weeks or more, or
a birth weight equal to or >500 g. Stillbirths are regis-
tered. All early fetal deaths of 20 weeks’ gestation and
over which have been diagnosed as having a congenital
anomaly are included. Autopsy rates for 2009 were 57%
for stillbirths and 32% for infant deaths.
Exposure Data Availability
Information regarding maternal disease and exposure
to medicinal drugs, smoking, alcohol and drug abuse, as
well as parental occupation are collected for all mal-
formed infants.
Denominators and Controls Information
Epidemiology background data on all births are avail-
able from the National Obstetric Information Systems
database and the National Statistics Ofﬁce.
Registry Description Reference
https://ehealth.gov.mt/HealthPortal/strategy_policy/
healthinfor_research/registries/birth_defects.aspx.
Ethics and Consent
The Superintendant of Public Health, within his legal
responsibility, requires that a Malta Congenital Anoma-
lies Register be kept in the interest of public health (DH
circular 36/09). Ethics committee approval is needed
before data is released for individual studies, projects, or
theses.
Malta became a member of the European Union in
2004 and complies with directive EC95/46. There is no
national legislation requiring informed consent to register
a baby with a congenital anomaly.
Electronic and Web-based Data Capture
Not yet available.
Recent Registry Activities and Publications
(2007–2010)
Recent registry activities and publications for the Malta
Registry can be found at: https://ehealth.gov.mt/Health-
Portal/strategy_policy/healthinfor_research/registries/
birth_defects.aspx.
Registry Contribution to EUROCAT Collaborative
Papers (2007–2010)
Table 2 shows the registry contribution to EUROCAT
studies.
Address for Further Information
Miriam Gatt, Malta Congenital Anomalies Registry,
Department of Health Information and Research, 95
Guardamangia Hill, Guardamangia PTA 1313, Malta.
E-mail: miriam.gatt@gov.mt.
NETHERLANDS, NORTH – FULL MEMBER
History and Funding
EUROCAT Northern Netherlands started in 1981, and
was a member of the EUROCAT network since that year.
The registry is funded by the Dutch Ministry of Health,
Welfare, and Sports and is associated with the Depart-
ment of Genetics of the University Medical Centre of
Groningen (UMCG).
Population Coverage
The registry is population-based, including all mothers
resident in the registration area. In the beginning, the
program covered 7500 births annually in the province of
Groningen and the northern part of the province of
Drenthe. From 1989 onward, coverage was gradually
increased to 20,000 births annually in the provinces of
Groningen, Friesland, and Drenthe. In recent years, the
number of births in the region decreased to 18,500,
approximately 10% of all births in The Netherlands.
Home deliveries (35% of births per year) are included
and it is estimated that only a few percent of resident
mothers would give birth outside the deﬁned registry
area.
Sources of Ascertainment
Children and fetuses with congenital anomalies diag-
nosed before or after birth are eligible for registration at
the EUROCAT Northern Netherlands registry, if the
mother lived in the region at the time of birth and the
child has not reached the age of 16 at notiﬁcation. There
is no lower limit for gestational age, spontaneous and
induced abortions are included. Notiﬁcation of children
and fetuses with congenital anomalies is voluntary.
Registry personnel are actively involved in case ascertain-
ment, using multiple sources such as obstetric records,
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hospital administration data, and pathology records.
Cytogenetic laboratory results are electronically down-
loaded from the genetics department and include all
abnormal karyotype reports, both from prenatal and
postnatal samples. For cases reported to the registry, it is
veriﬁed whether any genetic tests were performed
and test results are registered in the database. The only
pediatric cardiology center in the registration area, also
part of the UMCG, supplies systematic case lists and
diagnostic details to the registry. A number of frequently
occurring mild anomalies is not registered unless they
occur in combination with other serious congenital
anomalies. If new information becomes available for reg-
istered children before 16 years of age, the ﬁles are
updated.
Maximum Age at Diagnosis
Up to 16 years of age.
Termination of Pregnancy for Fetal Anomaly
TOPFA is legal. The upper age limit for termination of
pregnancy (for social reasons and for fetal anomaly) is 24
weeks, based on the viability criteria. Termination of
pregnancy after 24 weeks is allowed when the fetus is
affected with a congenital anomaly that is considered le-
thal.
Stillbirth Deﬁnition and Early Fetal Deaths
A stillbirth is deﬁned as a fetus of at least 24 weeks’
gestation that died in the uterus or during birth. There
are no age or weight limits for inclusion of early fetal
deaths/spontaneous abortions. Autopsy rates per year
are not available.
Exposure Data Availability
Since 1997, parents have been asked to ﬁll out a ques-
tionnaire including questions on occupational activities,
smoking habits, alcohol consumption, recreational drug
use, and socioeconomic status. In addition, data from
community pharmacies are used to collect data on medi-
cation dispensed in the period from 3 months before and
during pregnancy. After the information of the pharmacy
is received, a telephone interview with the mother is
done to verify whether she has actually taken the medi-
cation dispensed from the pharmacy and if she has taken
any over-the-counter medication. The response rate to
the questionnaire is 80%.
Denominators and Controls Information
General statistics are available from the Central Bureau
of Statistics. No information on non-malformed infants is
collected.
Ethics and Consent
The registry does not require ethics committee ap-
proval to collect and store data. The registry operates
within the scope of the Dutch data protection act (Wbp)
and the Code of Good Conduct, set up by the Dutch Fed-
eration of Biomedical Scientiﬁc Societies. National legisla-
tion requires informed consent to register a baby with a
congenital anomaly. Parents have to agree to the inclu-
sion of the child on the register (opt-in). The positive
response rate is 80%.
Electronic and Web-based Data Capture
Although the ascertainment of cases uses electronically
derived lists of children with certain clinical diagnoses or
cytogenetic laboratory results, no automatically electronic
or web-based data capture has been implemented so far.
Recent Registry Activities and Publications
(2007–2010)
The research activities are focused in particular on
knowledge and use of folic acid and its protective effect
on congenital malformations and on medication use in
pregnancy. Selected local publications in international
journals include:
Bakker MK, de Walle HE, Dequito A, et al. 2007. Selec-
tion of controls in case-control studies on maternal medi-
cation use and risk of birth defects. Birth Defects Res A
Clin Mol Teratol 79:652–656.
de Walle HE, de Jong-van den Berg LT. 2007. Growing
gap in folic acid intake with respect to level of education
in the Netherlands. Community Genet 10:93–96.
Felix JF, Steegers–Theunissen RP, de Walle HE, et al.
2007. Esophageal atresia and tracheoesophageal ﬁstula in
children of women exposed to diethylstilbestrol in utero.
Am J Obstet Gynecol 197:38.e1–38.e5.
Bakker MK, Ko¨lling P, van den Berg PB, et al. 2008.
Increase in use of selective serotonin reuptake inhibitors
in pregnancy during the last decade, a population-based
cohort study from the Netherlands. Br J Clin Pharmacol
65:600–606.
De Walle HE, de Jong–van den Berg LT. 2008. Ten
years after the Dutch public health campaign on folic
acid: the continuing challenge. Eur J Clin Pharmacol
64:539–543.
Bakker MK, De Walle HE, Wilffert B, de Jong–van den
Berg LT. 2010. Fluoxetine and infantile hypertrophic py-
lorus stenosis: a signal from a birth defects-drug expo-
sure surveillance study. Pharmacoepidemiol Drug Saf
19:808–813.
Bakker MK, Kerstjens–Frederikse WS, Buys CH, et al.
2010. First-trimester use of paroxetine and congenital
heart defects: a population-based case-control study.
Birth Defects Res A Clin Mol Teratol 88:94–100.
Jentink J, Bakker MK, Nijenhuis CM, et al. 2010. Does
folic acid use decrease the risk for spina biﬁda after in
utero exposure to valproic acid? Pharmacoepidemiol
Drug Saf 19:803–807.
van Beynum IM, Kapusta L, Bakker MK, et al. 2010.
Protective effect of periconceptional folic acid supple-
ments on the risk of congenital heart defects: a registry-
based case-control study in the northern Netherlands.
Eur Heart J 31:464–471.
Registry Contribution to EUROCAT Collaborative
Papers (2007–2010)
Table 2 shows the registry contribution to EUROCAT
studies.
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Address for Further Information
Marian Bakker, EUROCAT Northern Netherlands,
Department of Genetics, University Medical Center
Groningen, P.O. Box 30.001, 9700 RB Groningen, The Neth-
erlands. E-mail: eurocat@medgen.umcg.nl. Website: www.
eurocatnederland.nl or www.geneticsgroningen.nl.
NORWAY – FULL MEMBER
History and Funding
The program ie, the Medical Birth Registry of Norway
was started in 1967. The program is run and funded by
the governmental National Institute of Public Health. The
registry joined EUROCAT in 1998.
Population Coverage
The program is population-based and covers all moth-
ers delivering within Norway, irrespective of place of
residence, with approximately 58,000 annual births. Non-
resident mothers delivering with the registry area
account for approximately 0.2% of all births.
Sources of Ascertainment
Reporting to the registry is compulsory. The registry is
based on the notiﬁcation of births from the delivery units
and, since 1999, also from the neonatal units for infants
transferred to such units after birth. Congenital anoma-
lies are registered up to 1 year of age and there is no
maximum age for registration of mortality. Autopsy
reports are collected for stillbirths with birth weight >500
g, and for TOPFAs where autopsy has been done.
The Medical Birth Registry of Norway (MBRN) does
not currently receive direct notiﬁcation from cytogenetic
laboratories or speciﬁc notiﬁcation from pediatric cardiol-
ogy departments.
Maximum Age at Diagnosis
Up to 1 year of age.
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is legal and is the mother’s
decision up to 12 weeks’ gestation. After 12 weeks’ gesta-
tion, permission is required from the commission and
these have been recorded from 1999 onward. If a congen-
ital anomaly is diagnosed, the upper gestational age limit
is 18 weeks (with exemptions). Since December 1, 1998,
all TOPFAs are registered in the MBRN database. Au-
topsy reports are collected.
Stillbirth Deﬁnition and Early Fetal Deaths
Early fetal deaths/spontaneous abortions of 16 weeks
or more were included between the years 1967 to 2001
inclusive. This has been decreased to a gestational age of
12 weeks or more from 2002 onward. Ofﬁcial birth rates
are published for births 22 weeks (or 425 g). Autopsy
rates were reported as follows: 50% in stillbirths, 50% in
induced abortions, 80% in early neonatal deaths (0–7
days), 90% in later deaths 1 week to 1 year, and 80% in
deaths with congenital anomaly.
Exposure Data Availability
Some basic information, such as maternal disease
and, since 1999, smoking and occupation (with consent)
is collected on all infants, malformed or not.
Denominator and Controls Information
All information available for the reported malformed
infants is also available for the total population of births.
Registry Description Reference
Irgens LM. 2000. The Medical Birth Registry of Nor-
way. Epidemiologic research and surveillance throughout
30 years. Acta Obstet Gynecol Scand 79:435–439.
Ethics and Consent
Research using anonymized data from the Medical
Birth Registry are exempt from institutional review board
approval in Norway. All studies must be approved by
the Publication board at the Medical Birth Registry.
Electronic and Web-based Data Capture
Electronic notiﬁcation to the registry was made com-
pulsory from 2006, and by June 2010 was adopted for
82% of births. Notiﬁcations are transmitted as encrypted
XML messages using the ‘‘National Health Net’’ for
transportation, and with unique, speciﬁc certiﬁcates for
all delivery units, neonatal intensive care units (NICUs),
and the Medical Birth Registry. Notiﬁcations should be
sent from delivery units to the Birth Registry within the
ﬁrst month after birth, and is usually sent daily, depend-
ing on the size of the delivery unit. Notiﬁcations from
NICUs should be sent within 1 month after discharge.
Reminders of missing notiﬁcations (based on records in
the Central Population Registry, to which the MBRN is
routinely linked) are sent to the delivery units each
month.
In September 2010, there were three different software
packages in use at the delivery units providing medical
birth notiﬁcations, while all NICUs providing neonatal
notiﬁcations used the same software.
Recent Registry Activities and Publications
(2007–2010)
The main registry activities, outside research work,
have been to establish electronic notiﬁcation of births
from all delivery units in the country, and to rebuild the
registry’s local database. Electronic notiﬁcation is a pre-
requisite for another major goal at present: to publish
updated institution-speciﬁc statistics, which may be used
for quality work at the institutions. Some validation stud-
ies have been done, in addition to research activities in
several ﬁelds, both within obstetrics and neonatology,
birth defects, genetic epidemiology, and within the ﬁeld
of ‘‘fetal origin of adult diseases’’.
Eskedal LT, Hagemo PS, Eskild A, et al. 2007. A popu-
lation-based study relevant to seasonal variations in
causes of death in children undergoing surgery for con-
genital cardiac malformations. Cardiol Young 17:423–431.
Harville EW, Wilcox AJ, Lie RT, et al. 2007. Epidemiol-
ogy of cleft palate alone and cleft palate with accompany-
ing defects. Eur J Epidemiol 22:389–395.
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Nguyen RH, Wilcox AJ, Moen BE, et al. 2007. Parent’s
occupation and isolated orofacial clefts in Norway: a
population-based case-control study. Ann Epidemiol
17:763–771.
Sivertsen A, Lie RT, Wilcox AJ, et al. 2007. Prevalence
of duplications and deletions of the 22q11 DiGeorge
syndrome region in a population-based sample of infants
with cleft palate. Am J Med Genet A 143:129–134.
Wilcox AJ, Lie RT, Solvoll K, et al. 2007. Folic acid sup-
plements and risk of facial clefts: national population
based case-control study. BMJ 334:464.
DeRoo LA, Wilcox AJ, Drevon CA, Lie RT. 2008. First-
trimester maternal alcohol consumption and the risk of
infant oral clefts in Norway: a population-based case-con-
trol study. Am J Epidemiol 168:638–646.
Engesaeter IØ, Lie SA, Lehmann TG, et al. 2008. Neo-
natal hip instability and risk of total hip replacement in
young adulthood: follow-up of 2,218,596 newborns from
the Medical Birth Registry of Norway in the Norwegian
Arthroplasty Register. Acta Orthop 79:321–326.
Gjessing HK, Lie RT. 2008. Biometrical modelling in
genetics: are complex traits too complex? Stat Methods
Med Res 17:75–96.
Shi M, Mostowska A, Jugessur A, et al. 2009. Identiﬁca-
tion of microdeletions in candidate genes for cleft lip
and/or palate. Birth Defects Res A Clin Mol Teratol
85:42–51.
Beaty TH, Murray JC, Marazita ML, et al. 2010. A ge-
nome-wide association study of cleft lip with and with-
out cleft palate identiﬁes risk variants near MAFB and
ABCA4. Nat Genet 42:525–529.
Registry Contribution to EUROCAT Collaborative
Papers (2007–2010)
Table 2 shows the registry contribution to EUROCAT
studies.
Address for Further Information
Stein Emil Vollset, Medical Birth Registry of Norway,
Kalfarveien 31, N-5018 Bergen, Norway. E-mail: stvo@f-
hi.no.
Kari Klungsøyear, E-mail: kmel@fhi.no.
POLAND – ASSOCIATE MEMBER
History and Funding
The Polish Registry of Congenital Malformations
(PRCM) has been in operation since 1997. It was founded
as a scientiﬁc project ordered by the Polish Ministry of
Health and ﬁnanced by the State Committee for Scientiﬁc
Research. Since July 1, 2000, it has been part of the Gov-
ernment Programme of Monitoring and Primary Prophy-
laxis of Congenital Malformations in Poland, ﬁnanced by
the Polish Ministry of Health. As part of this program,
the registry provides the Polish Ministry of Health with
important information needed in health care manage-
ment. In 2003, it was decided that data for the Wielkopol-
ska region, which is part of the territory covered by the
PRCM, would be transferred to EUROCAT separately
and treated as full member registry data.
Population Coverage
The PRCM is a population-based registry of type I (all
mothers resident in deﬁned geographic area). For the
years 1998 to 2000, data for Poland (Associate registry)
comes from nine provinces of Poland: Pomorskie,
Zachodniopomorskie, Arminsko–Mazurskie, Kujawsko–
Pomorskie, Wielkopolskie, Lubuskie, Lodzkie, Dolno-
slaskie, and Opolskie. In 2001, the Slaskie Province (Sile-
sia) was added, in 2002, the Lubelskie and Podkarpackie
regions joined the registry, and in 2004 – Mazowieckie.
In 2006, the next two provinces joined the PRCM – Swie-
tokrzyskie and Podlaskie. In 2007, Malopolskie Province
joined the PRCM. Since 2007, all of Poland has been cov-
ered by the registry. Since the year 2007, the whole of
Poland has been covered by the Polish Registry, and in
2010, data for 15 provinces has been transferred to the
EUROCAT (the data for the 16th province – Wielkopol-
ska – is sent separately). In 2008, in these 15 provinces,
375,304 livebirths and stillbirths occurred which corre-
sponds to 90.12% of all births in Poland.
Sources of Ascertainment
Notiﬁcation is recommended by the Ministry of Health
(as an ofﬁcial government program, however, notiﬁcation
is not obligatory) and consists of multi-source reporting.
The sources include: delivery unit staff, ultrasound staff,
postnatal ward staff, pediatric intensive care unit staff, fe-
tal medicine unit staff, pediatricians, postmortem reports,
regional genetic and cytogenetic services (direct access to
cytogenetic laboratories and genetic clinic), and pediatric
cardiology referral centers. The main source of informa-
tion is a double-sided notiﬁcations form ﬁlled out by a
physician responsible for diagnosing the malformations.
The notiﬁcation forms are sent immediately to the PRCM
Central Working Group. Additionally, all birth records in
Wielkopolska are reviewed and abstracted by trained
staff with the aim of ascertainment of cases. Birth certiﬁ-
cates do not record congenital anomalies. Death certiﬁ-
cates allow for notiﬁcation of congenital anomaly as a
cause of death and, therefore, they are used as a source.
Electronic and web-based data capture has been imple-
mented (about 15% of all notiﬁcations). Well visited web-
site www.rejestrwad.pl.
Maximum Age at Diagnosis
Up to 2 years of age.
Termination of Pregnancy for Fetal Anomaly
Although termination of pregnancy is legal, it can only
be performed by a physician when: (1) a pregnancy
poses danger to health or life of the pregnant women; (2)
prenatal diagnosis or other medical evidence indicates
high probability of serious and irreversible damage to a
fetus or it is an untreatable life-threatening disease; and
(3) there is a plausible suspicion the pregnancy has arisen
from a prohibited act. The upper gestational age limit for
termination of a severe congenital anomaly-affected preg-
nancy is 24 weeks. Although the termination of preg-
nancy is legal, in Poland there is public pressure not to
perform such a procedure and that is why the data on
pregnancy terminations might be underestimated. Hence,
the registry currently does not register terminations of
pregnancy after prenatal diagnosis.
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Stillbirth Deﬁnition and Early Fetal Deaths
The ofﬁcial stillbirth deﬁnition is as follows: fetal death
(stillbirth) is a death before the complete expulsion or
extraction of a product of conception from a mother, irre-
spective of pregnancy duration; the death is indicated by
the fact that after separation, the fetus does not breathe,
or shows no other evidence of life, such as heart beating,
pulsation of the umbilical cord, or deﬁnite movement of
voluntary muscles. For statistical purposes, we include
all fetuses weighing at least 500 g at the moment of birth,
having reached the 22nd week of gestational age, if the
weight is unknown, or reaching 25 cm of the body length
(crown-heel). We do not include early fetal deaths or
spontaneous abortions. Autopsy rates vary between
regions or even between health care units, the ranges for
performance are as follows: stillbirths 10 to 30%, early
neonatal deaths 20 to 30%, later deaths 1 week to 1 year
10 to 20%, and deaths with congenital anomaly 30 to
40%.
Data Availability
The following data is gathered by way of registration
forms, although its availability may be limited, depend-
ing on the source of registration: chronic illness in
mother, pregnancy-induced conditions in mother, acute
maternal illness during pregnancy, therapeutic and rec-
reational drugs taken during pregnancy, invasive tests in
pregnancy, folic acid use in pregnancy, smoking habits,
alcohol use, mother’s obstetric history, the country of res-
idence, family history of congenital malformations, and
genetic conditions in family members, father’s and moth-
er’s occupational and environmental hazards, and the
father’s and mother’s education.
Denominators and Controls Information
Information on all births (live and stillbirths) is
available from birth certiﬁcates gathered by the Central
Statistical Ofﬁce for Poland. Since 2005, information on
controls has been gathered by the registry.
Registry Description Reference
Latos–Bielen´ska A, Materna–Kiryluk A, PRCM Work-
ing Group. 2005. Polish Registry of Congenital Malforma-
tions – aims and organization of the registry monitoring
300,000 births a year. J Appl Genet 46:341–348.
Ethics and Consent
The registry does not require ethics committee
approval for all studies based on the registry data solely,
but requires an approval for other projects (using registry
data but focusing on genetic or clinical studies).
Electronic and Web-based Data Capture
Electronic and web-based data capture has been imple-
mented (about 15% of all notiﬁcations).
Recent Registry Activities and Publications
(2007–2010)
‘‘Genetic studies on congenital urinary system
malformations’’ collaborative project with Division of
Nephrology, Columbia University. PRCM main investiga-
tor – Dr. A. Materna–Kiryluk.
‘‘Identiﬁcation of novel genes for limb malformations’’
collaborative project with Development & Disease
Working Group, Max Planck Institute for Molecular
Genetics in Berlin. PRCM main investigator: Dr. A.
Jamsheer.
Publications (2007–2010)
Materna–Kiryluk A. 2010. Genetyczne aspekty najc-
ze˛stszych wrodzonych wad rozwojowych układu moczo-
wego u dzieci (Genetic aspects of common malformations
of the kidney and urinary tract in children). Standardy
Medyczne (in press).
Wis´niewska K, Wysocki J. 2010. [Primary prevention of
neural tube defects by means folic acid supplementation
– a summary of current recommendations in some Euro-
pean countries]. Standardy Medyczne (in press).
Jezela–Stanek A, Ciara E, Małunowicz E, et al. 2010.
The Smith-Lemli-Opitz syndrome (SLOS) Collaborative
Group. Differences between predicted and established
diagnoses of Smith-Lemli-Opitz syndrome in the Polish
population: underdiagnosis or loss of affected fetuses? J
Inherit Metab Dis (Epub ahead of print).
Latos-Bielen´ska A, Materna-Kiryluk A. 2010. [Congeni-
tal malformations in Poland in 2003–2004. Data from the
Polish Registry of Congenital Malformations]. II ed. (Ed.
A. Latos-Bielen´ska, A. Materna-Kiryluk), Os´rodek
Wydawnictw Naukowych PAN, Poznan´.
Materna–Kiryluk A, Wis´niewska K, Badura–Stronka M,
et al. 2009. Parental age as a risk factor for isolated con-
genital malformations in a Polish population. Paediatr
Perinat Epidemiol 23:29–40.
Jamsheer A, Materna–Kiryluk A, Badura–Stronka M,
et al. 2009. Comparative study of clinical characteristics
of amniotic rupture sequence with and without body
wall defect: further evidence for separation. Birth Defects
Res A Clin Mol Teratol 85:211–215.
Engels H, Eggermann T, Caliebe A, et al. 2008. Genetic
counseling in Robertsonian translocations der13,14: fre-
quencies of reproductive outcomes and infertility in 101
pedigrees. Am J Med Genet A 146A:2611–2616.
Jamsheer A, Materna–Kiryluk A, Latos–Bielen´ska A.
2008. Valproic acid and pregnancy: clinical presentation
of 3 cases with valproate embryopathy. Archives of Peri-
natal Medicine 14:57–60.
Mazurczak T, Latos–Bielen´ska A. 2007. Wady wrod-
zone. (Congenital Malformations) ,,Raport: Zdrowie
Kobiet w wieku prokreacyjnym 15-49 lat. Polska 2006.’’
(Report: Women’s reproductive health in Poland 2006)
Program Narodo´w Zjednoczonych ds. Rozwoju. Wars-
zawa 93–98:148–151.
Registry Contribution to EUROCAT Collaborative
Papers (2007–2010)
Table 2 shows the registry contribution to EUROCAT
studies.
Address for Further Information
Anna Latos–Bielenska, Registry Director; Anna
Materna–Kiryluk, Organizing Coordinator, Polish Regis-
try of Congenital Malformations, Department of Medical
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Genetics, ul. Grunwaldzka 55 paw. 15, 60-352 Poznan,
Poland. E-mail: alatos@ump.edu.pl.
POLAND, WIELKOPOLSKA – FULL MEMBER
History and Funding
The PRCM has been in operation since 1997. It was
founded as a scientiﬁc project ordered by the Polish Min-
istry of Health and ﬁnanced by the State Committee for
Scientiﬁc Research. Since July 1, 2000, it has been part of
the Government Program of Monitoring and Primary
Prophylaxis of Congenital Malformations in Poland,
ﬁnanced by the Polish Ministry of Health. As part of this
Program, the registry provides the Polish Ministry of
Health with important information needed in health care
management. In 2003, it was decided that data for the
Wielkopolska Region, which is part of the territory cov-
ered by the PRCM, would be transferred to EUROCAT
separately and treated as full member registry data.
Population Coverage
The PRCM is a population-based registry of type I (all
mothers resident in deﬁned geographic area). In the year
2009, Wielkopolska Region had a population of 34,083
people (8.93% of Poland) spread over an area of 29,827
square kilometers (9.54% of the Poland territory) with
41,043 births per year (livebirths and stillbirths), corre-
sponding to 9.79% of total births in Poland.
Sources of Ascertainment
Notiﬁcation is recommended by the Ministry of Health
as an ofﬁcial government program; however, notiﬁcation
is not obligatory and consists of multi-source reporting.
The sources include: delivery unit staff, ultrasound staff,
postnatal ward staff, pediatric intensive care unit staff, fe-
tal medicine unit staff, pediatricians, postmortem reports,
regional genetic and cytogenetic services (direct access to
cytogenetic laboratories and genetic clinics), and pediatric
cardiology referral centers. The main source of informa-
tion is a double-sided notiﬁcations form ﬁlled out by a
physician responsible for diagnosing the malformations.
The notiﬁcation forms are sent immediately to the PRCM
Central Working Group. Additionally, all birth records in
Wielkopolska are reviewed and abstracted by trained
staff with the aim of ascertainment of cases. Birth certiﬁ-
cates do not record congenital anomalies. Death certiﬁ-
cates allow for notiﬁcation of congenital anomaly as a
cause of death and, therefore, they are used as a source.
Electronic and web-based data capture has been imple-
mented (about 15% of all notiﬁcations). Well visited web-
site www.rejestrwad.pl.
Maximum Age at Diagnosis
Up to 2 years of age.
Termination of Pregnancy for Fetal Anomaly
Although termination of pregnancy is legal, it can only
be performed by a physician when: (1) a pregnancy
poses danger to health or life of the pregnant women; (2)
prenatal diagnosis or other medical evidence indicates
high probability of serious and irreversible damage to a
fetus or it is an untreatable life-threatening disease; and
(3) there is a plausible suspicion the pregnancy has arisen
from a prohibited act. The upper gestational age limit for
termination of a severe congenital anomaly-affected preg-
nancy is 24 weeks. Although the termination of preg-
nancy is legal in Poland, there is public pressure not to
perform such a procedure and that is why the data on
pregnancy terminations might be underestimated. Hence,
the registry currently does not register terminations of
pregnancy after prenatal diagnosis.
Stillbirth Deﬁnition and Early Fetal Deaths
The ofﬁcial stillbirth deﬁnition is as follows: fetal death
(stillbirth) is a death before the complete expulsion or
extraction of a product of conception from a mother, irre-
spective of pregnancy duration; the death is indicated by
the fact that after separation, the fetus does not breathe,
or shows no other evidence of life, such as heart beating,
pulsation of the umbilical cord, or deﬁnite movement of
voluntary muscles. For statistical purposes, we include
all fetuses weighing at least 500 g at the moment of birth,
having reached the 22nd week of gestational age, if the
weight is unknown, or reaching 25 cm of the body length
(crown-heel). We do not include early fetal deaths or
spontaneous abortions. Autopsy rates vary between
regions or even between health care units, the ranges for
performance are as follows: stillbirths 10 to 30%, early
neonatal deaths 20 to 30%, later deaths 1 week to 1 year
10 to 20%, and deaths with congenital anomaly 30 to
40%.
Data Availability
The following data is gathered by way of registration
forms, although its availability may be limited depending
on the source of registration: chronic illness in mother,
pregnancy-induced conditions in mother, acute maternal
illness during pregnancy, therapeutic and recreational
drugs taken during pregnancy, invasive tests in preg-
nancy, folic acid use in pregnancy, smoking habits, alco-
hol use, mother’s obstetric history, the country of resi-
dence, family history of congenital malformations,
genetic conditions in family members, father’s and moth-
er’s occupational and environmental hazards, and the
father’s and mother’s education.
Denominators and Controls Information
Information on all births (live and stillbirths) is avail-
able from birth certiﬁcates, gathered by the CSO for
Poland. Since 2005, information on controls has been
gathered by the registry.
Registry Description Reference
Latos–Bielen´ska A, Materna–Kiryluk A, PRCM Work-
ing Group. 2005. Polish Registry of Congenital Malforma-
tions – aims and organization of the registry monitoring
300,000 births a year. J Appl Genet 46:341–348.
Ethics and Consent
The registry does not require ethics committee ap-
proval for all studies based on the registry data solely,
but requires an approval for other projects (using registry
data but focusing on genetic or clinical studies).
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Electronic and Web-based Data Capture
Since July 2005, electronic reporting of malformations
has been made possible on the PRCM website (www.re-
jestrwad.pl).
Currently, at least 15% of all notiﬁcations are elec-
tronic.
Recent Registry Activities and Publications (2007–
2010)
Genetic studies on congenital urinary system malfor-
mations. Collaborative project with Division of Nephrol-
ogy, Columbia University. PRCM main investigator – Dr.
A. Materna–Kiryluk.
Identiﬁcation of novel genes for limb malformations.
Collaborative project with Development & Disease Work-
ing Group, Max Planck Institute for Molecular Genetics
in Berlin. PRCM main investigator: Dr. A. Jamsheer.
Registry Publications (2007–2010)
Materna–Kiryluk A. 2010. [Genetic aspects of common
malformations of the kidney and urinary tract in chil-
dren]. Standardy Medyczne (in press).
Wis´niewska K, Wysocki J. 2010. [Primary prevention of
neural tube defects by means folic acid supplementation
– a summary of current recommendations in some Euro-
pean countries]. Standardy Medyczne (in press).
Jezela–Stanek A, Ciara E, Małunowicz E, et al. 2010.
,,The Smith-Lemli-Opitz syndrome (SLOS) Collaborative
Group. Differences between predicted and established
diagnoses of Smith-Lemli-Opitz syndrome in the Polish
population: underdiagnosis or loss of affected fetuses?’’ J
Inherit Metab Dis (Epub ahead of print).
Latos–Bielen´ska A, Materna–Kiryluk A. 2010. [Congeni-
tal malformations in Poland in 2003–2004. Data from the
Polish Registry of Congenital Malformations]. II ed. In:
Latos–Bielen´ska A, Materna–Kiryluk A, editors. Os´rodek
Wydawnictw Naukowych PAN.
Materna–Kiryluk A, Wis´niewska K, Badura–Stronka M,
et al. 2009. Parental age as a risk factor for isolated con-
genital malformations in a Polish population. Paediatr
Perinat Epidemiol 23:29–40.
Jamsheer A, Materna–Kiryluk A, Badura–Stronka M,
Latos–Bielen´ska A. 2009. ,,Comparative study of clinical
characteristics of amniotic rupture sequence with and
without body wall defect: further evidence for separa-
tion.’’ Birth Defects Res A Clin Mol Teratol 85:211–215.
Engels H, Eggermann T, Caliebe A, et al. 2008.
‘‘Genetic counseling in Robertsonian translocations
der13,14: frequencies of reproductive outcomes and infer-
tility in 101 pedigrees.’’ Am J Med Genet A 146A:2611–
2616.
Jamsheer A, Materna–Kiryluk A, Latos–Bielen´ska A.
2008. Valproic acid and pregnancy: clinical presentation
of 3 cases with valproate embryopathy. Archives of Peri-
natal Medicine 14:57–60.
Mazurczak T, Latos–Bielen´ska A. 2007. [Congenital
Malformations. Report: Women’s reproductive health in
Poland 2006]. Program Narodo´w Zjednoczonych ds. Roz-
woju 93–98:148–151.
Registry Contribution to EUROCAT Collaborative
Papers (2007–2010)
Table 2 shows the registry contribution to EUROCAT
studies.
Address for Further Information
Anna Latos–Bielenska, Registry Director; Anna
Materna–Kiryluk, Organizing Coordinator, Polish Regis-
try of Congenital Malformations, Department of Medical
Genetics, ul. Grunwaldzka 55 paw. 15, 60-352 Poznan,
Poland. E-mail: alatos@ump.edu.pl.
PORTUGAL, SOUTH – FULL MEMBER
History and Funding
The registry started in 1988 and it became a member of
EUROCAT in 1989. The registry is funded by the
National Institute of Health, a body within the Ministry
of Health.
Population Coverage
The registry is population-based which includes all
mothers resident in the regions of Algarve, Alentejo, and
part of the Lisboa e Vale do Tejo Region (Setubal and
part of Santarem Districts). It covers approximately
18,000 births annually representing 14% of the total num-
ber of births in Portugal.
Sources of Ascertainment
Pediatricians, obstetricians, and clinical geneticists are
responsible for case notiﬁcation in each region, up to the
end of the neonatal period. Other sources of ascertain-
ment are fetal pathology hospital departments. At this
moment, only two pediatric cardiology departments par-
ticipate in the registry, but no cytogenetic laboratory.
Data are validated and coded at the central level in
Lisbon.
Maximum Age at Diagnosis
Up to 1 month of age.
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is legal up to 24 weeks’ ges-
tation and requires the permission of a technical commit-
tee. Non-viable anomalies have no upper limit. Termina-
tions as results of diagnosis of a congenital anomaly are
included in the registry.
Stillbirth Deﬁnition and Early Fetal Deaths
The deﬁnition is 22 weeks of gestation of 500 g. Most
stillborn fetuses in the covered area have an autopsy per-
formed. Stillbirths with congenital anomalies are
included in the registry. Fetal deaths of earlier gestation
or lower weight are not included.
Exposure Data Availability
Information about maternal drug use, maternal dis-
eases, maternal occupation, and obstetric history is avail-
able for cases.
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Denominators and Controls Information
Demographic information is available from the
National Statistic Ofﬁce.
Registry Description Reference
The operation of the registry is described in the web-
site of the National Institute of Health.
Ethics and Consent
Data on cases is transmitted by attending doctors at
hospital departments to the Central Registry and regis-
tered centrally without personal information. A speciﬁc
numeric code permits linking registry data with clinical
data at local levels by the attending medical doctor.
Electronic and Web-based Data Capture
Approximately 30% of all EUROCAT registries from
the South Portugal region come through an electronic
web-based system. Data is input at local levels by partici-
pating physicians into the central database template. This
has the same variables than the paper-based question-
naire. Each participating center can use and download
only data from that center. The web-based tool has data
input, data analysis, and data transfer capabilities. Data
from the remaining centers is received in paper and cen-
trally input into the informatics database.
Recent Registry Activities and Publications
(2007–2010)
Portugal, Registo Nacional de Anomalias Conge´nitas.
Relato´rio 2000–2001. Lisboa, Instituto Nacional de Sau´de,
2008.
Portugal, Registo Nacional de Anomalias Conge´nitas.
Nota Informativa 1. Lisboa, Instituto Nacional de Sau´de,
2009.
Portugal, Registo Nacional de Anomalias Conge´nitas.
Nota Informativa 2. Lisboa, Instituto Nacional de Sau´de,
2009.
Portugal, Registo Nacional de Anomalias Conge´nitas.
Relato´rio 2002–2007. Lisboa, Instituto Nacional de Sau´de,
2010.
Registry Contribution to EUROCAT Collaborative
Papers (2007–2010)
Table 2 shows the registry contribution to EUROCAT
studies.
Address for Further Information
Carlos Matias Dias, Departamento de Epidemiologia,
Registo Nacional de Anomalias Conge´nitas, Av Padre
Cruz, 1649-016, Lisbon, Portugal. E-mail: carlos.dias@in-
sa.min-saude.pt.
SPAIN, BARCELONA – FULL MEMBER
History and Funding
The Barcelona Birth Defects Registry (Registre de
Defectes Conge`nits de Barcelona –REDCB) was initiated in
1990 and reached a population-based status by 1992, when
it became a member of the EUROCAT. The REDCB is part
of the Service of Health Information Systems (Servei de
Sistemes d’Informacio´ Sanitaria) in the Public Health
Agency of Barcelona (Age`ncia de Salut Pu´blica de Barce-
lona). It is funded by Regional (Generalitat de Catalunya)
and Local (Ajuntament de Barcelona) Administrations.
Population Coverage
The REDCB is population-based and covers pregnan-
cies of women resident in Barcelona City ending in live
or stillborn babies of 221 weeks of gestation or in
induced abortions (IAs) due to prenatal detection of birth
defects (i.e., the registry does not include birth defects in
spontaneous abortions –<22 weeks of gestation, or IAs
not due to prenatal detection of birth defects).
Some 3% of residents’ newborns occur at maternity
units of the city limits. The REDCB controls 50% of these
newborns (1.5%), delivering in a hospital near the city.
Since Barcelona City is a pole of attraction for at risk
pregnancies, the remaining 1.5% of newborns not con-
trolled by the registry probably provides <1% of cases.
Currently, (2008) the REDCB covers about 14,500 births
annually. In the last 5 years, the number of births has
increased from about 12,500, mainly due to a higher fer-
tility rate among immigrant women of developing coun-
tries coming to the city.
Sources of Ascertainment
General information on cases and controls, as well as
clinical information on cases, is collected using question-
naires speciﬁcally made for the registry. An interview
with the mother is the main source of general informa-
tion. Delivery units, pediatric departments, cytogenetic
laboratories, pathology departments, prenatal diagnosis
units, and pediatric cardiology services are the main
sources of clinical information. The registry has direct
access to some cytogenetic laboratories, but not to all.
Some of the collaborating laboratories send their data by
e-mail, but for most of them, registry staff personally go
to collect the case information.
Direct Access to Cytogenetic Laboratories Covers
only Part of our Population
Pediatric cardiology centers covering part of the regis-
try population supply systematic case lists and diagnostic
details to the registry.
Maximum Age at Diagnosis
Up to 3 days of age. When a suspicion of birth defect
exists, follow-up is made until a diagnosis or normality
is stated. This affects mainly birth defects as CHD.
Termination of Pregnancy for Fetal Anomaly
IA after prenatal detection of a birth defect is legal in
Spain until 22 weeks of gestation. A probable future
modiﬁcation in the Spanish IA law will affect birth
defects: some fetuses with major birth defects detected in
the third trimester of pregnancy (i.e., after 22 weeks)
could be induced for abortion.
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Case Deﬁnition
Cases are deﬁned as fetuses or newborns with at least
1 major or 21 minor anatomic birth defects or with
unbalanced chromosomal anomalies. The follow-up pe-
riod is 2 to 3 days after delivery. Due in part to this short
follow-up period, poor ascertainment exists for birth
defects as mild hypospadias, some cardiovascular
defects, and other anomalies of internal organs not
detected using prenatal ultrasounds. The ascertainment
of unbalanced chromosomal anomalies without neonatal
anatomic defects (as some sexual chromosome anomalies
like XXX, XXY, XYY) is never complete and depends on
the rate of karyotyped pregnancies.
Controls Selection
A random sample (not case-matched) of about 2% of
the newborns expected in each maternity unit is selected
as controls.
Data Availability and Information Sending to
EUROCAT
Information on maternal drug use, maternal and pater-
nal diseases, and occupations is available for cases and
controls, but it is not sending to the EUROCAT Central
Registry. The REDCB systematically sends data to the
EUROCAT Central Registry on all ‘‘core’’ variables but
two (civil registration status and McKusick code), and on
a ‘‘non-core’’ variable (karyotype).
Denominators Information
Background data on births are available from birth cer-
tiﬁcates and the Barcelona Perinatal Mortality Registry.
Ethics and Consent
The registry is located in a health authority setting
(Barcelona Public Health Agency).
Parental consent is asked for during interview with the
mothers of cases and controls.
Address for Further Information
Joaquı´n Salvador, Servei de Sistemes d’Informacio´ San-
ita`ria (SESIS), Agencia de Salut Pu´blica de Barcelona
(ASPB), Avda. Princep d’Astu´ries, 63, 28, 08012 Barce-
lona, Spain. E-mail: jsalvado@aspb.cat.
SPAIN, BASQUE COUNTRY – FULL MEMBER
History and Funding
Registration of congenital anomalies in the Basque
Country started on January 1, 1990. The registry became
a EUROCAT member in September 1990. The registry is
ﬁnancially supported by the Health Department of the
Basque Government.
Population Coverage
The registry is located in the Basque Country region,
in northern Spain, covering a geographic area of 7260
km2 and a population of 2,162,944 inhabitants. It is a
population-based registry that, therefore, includes all
mothers delivering in the Basque Country excluding any
non-residents. The average number of annual births 2003
to 2008 is 20,174. It is estimated that 1 to 2% of outside
resident mothers deliver in the covered hospitals.
Sources of Ascertainment
Reporting is voluntary, although the capture of data is
now systematic for 80% of cases using the automated
hospital database. There is an active search for cases
(livebirths, stillbirths, and induced abortions), through
multiple sources of information: hospital discharge
records, hospital automated data, neonatal units, special-
ist pediatric department, cytogenetics and pathology lab-
oratories, and private maternity hospitals.
Pediatric cardiology centers supply diagnostic conﬁr-
mation when requested by the registry for speciﬁc cases.
We do not have direct access to cytogenetic laborato-
ries. We ask for the results personally from the geneti-
cists at each of the hospitals involved in the registry.
Usually laboratories supply the list of prenatal and infant
abnormal karyotypes when requested.
Maximum Age at Diagnosis
Routinely reported to the registry up to 1 year of age.
Termination of Pregnancy for Fetal Anomaly
Since March 2010, ‘‘sexual and reproductive health and
abortion’’ in Spain is governed by a new law. Termina-
tion of pregnancy is now legal for certain indications,
including prenatal diagnosis of severe anomaly, at any
time during pregnancy. Data about techniques of prena-
tal screening and diagnosis are systematically collected.
Stillbirth Deﬁnition and Early Fetal Deaths
The ofﬁcial deﬁnition of stillbirth in the Basque Coun-
try and Spain is a gestational age of 22 weeks or a birth
weight of 500 g. Postmortem examination rates are highly
variable in the region. About 90% of autopsies in still-
births and neonatal deaths were performed in the public
maternity hospitals (the remaining 10% of parents did
not give permission). The autopsy rate after termination
of pregnancy is high (70%), but the quality varies,
depending on hospitals.
Exposure Data Availability
Information on maternal drug use, maternal and pater-
nal diseases, outcome of previous pregnancies, and
assisted conception is available.
Denominators and Controls Information
Statistics are provided by the Basque Statistics Institute
(EUSTAT).
Ethics and Consent
No ethics committee approval is required to operate
the registry. No approval is needed for studies that
require identiﬁable patient data. The hospitals have an
ethics committee if further ethical recommendations are
considered necessary.
Legislation complies with the EC95/46 directive with
respect to disease registers and surveillance since 1999.
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There is no national legislation requiring informed con-
sent to register a baby with a congenital anomaly.
Electronic and Web-based Data Capture
Information about all newborns in the Basque Country
is automatically collected and stored in an oracle applica-
tion server. This application is the property of the Health
Department of the Basque Government from which the
registry can complete information for newborns with any
congenital anomaly. We have unrestricted access to the
application. The application follows high levels of secu-
rity speciﬁed in the Ofﬁcial Disposition of June 17, 2005.
Recent Registry Activities and Publications
(2007–2010)
The 10th European Symposium on Prevention of Con-
genital Anomalies was held in Bilbao (Basque Country)
on June 10, 2009. We have a new registry leader since
April 2010.
Registry Contribution to EUROCAT Collaborative
Papers (2007–2010)
Table 2 shows the registry contribution to EUROCAT
studies.
Address for Further Information
Larraitz Arriola, Registro Anomalı´as Conge´nitas CAV,
Subdireccio´n de Salud Pu´blica, Av. Navarra 4, 20013 San
Sebastian, Spain. E-mail: l-arriola@ej-gv.es.
SPAIN, SPAIN HOSPITAL
NETWORK – ASSOCIATE MEMBER
ECEMC–Spanish Collaborative Study of
Congenital Malformations
History and Funding
This is a research program created in 1976 by Professor
Dr. Marı´a Luisa Martı´nez–Frı´as, as a hospital-based case-
control study and surveillance system, with voluntary
participation of hospitals but mandatory subjugation to
the operating rules for those participating. It contributes
to EUROCAT with data since 1980, and is also a member
of the ICBDSR. In January 2002, the ECEMC Program
became integrated into CIAC (Research Center on Con-
genital Anomalies), of the Instituto de Salud Carlos III
(ISCIII), from the Ministerio de Ciencia e Innovacio´n. It is
also directed by Professor Martı´nez–Frı´as. In 2006, the
ECEMC was recognized as an excellent research program
to be integrated into Centre for Biomedical Research on
Rare Diseases. ECEMC has two teratogen information
services since 1991, one for the general population and
another one for physicians. The program is ﬁnanced
mainly by the Spanish Administration and, partially, by
non-governmental organizations.
Population Coverage
Data are obtained from about 70 hospitals distributed
all over Spain. The annual number of births is about
100,000, representing more than 21% of all Spanish births.
Stillbirths of at least 24 weeks or 500 g have been
included since 1980. Data on terminations of pregnancy
due to the presence of congenital anomalies, which
can be legally performed within the ﬁrst 22 weeks of
gestation, can only be gathered in some participating
hospitals.
Sources of Ascertainment
The detection period is the ﬁrst 3 days of life, includ-
ing major and/or minor/mild defects. The information
comes from delivery units and pediatric departments of
the participating hospitals. The pediatric/neonatology
units ask for specialized cardiologic evaluation of
patients in whom cardiac anomalies were prenatally or
neonatally suspected, and those with other congenital
defects. Mothers are interviewed directly by the partici-
pating physicians during those ﬁrst 3 days after the
infant’s delivery to ﬁll in the ECEMC standard protocols,
which include more than 310 data for each child,
whether case or control. The information for each case
and its control is gathered by the same physician. Con-
trols are deﬁned as the next non-malformed infant born
at the same hospital than the case with the same sex of
the malformed infant. In many instances, photographs,
imaging studies, high-resolution bands karyotype, and
molecular analyses when needed (which are performed
at the central group of the ECEMC), and other comple-
mentary studies, are available. ECEMC’s laboratory, to
which the program has direct access, provides karyotype
and molecular analyses for cases the program already
knows about, and some registered cases are studied in
external laboratories. Biologic samples are stored in the
ECEMC registry for those cases for which the collaborat-
ing physicians send them, with the informed consent of
the parents, for diagnosis as well as for further research.
Maximum Age at Diagnosis
Up to 3 days of age. A longer follow-up is achieved in
selected cases.
Termination of Pregnancy for Fetal Anomaly
Up to 1985, termination of pregnancy was illegal in
Spain. From 1985 onward, induced abortions have been
legal but they are registered by the ECEMC only for
some hospitals that can report them. The upper gesta-
tional age limit for termination is 22 weeks in cases of
congenital anomaly.
Stillbirth Deﬁnition and Early Fetal Deaths
The ofﬁcial deﬁnition of stillbirth in the Spain Hospital
Network is 24 weeks or later or weighing at least 500 g.
Stillbirths have been included since 1980. Autopsy rates
in the period from 2007 to 2009 were 58.18% for still-
births and 22.22% for deaths with a congenital anomaly.
Exposure Data Availability
The mother of each reported infant (case or control) is
interviewed within the ﬁrst 3 days after delivery to
obtain data on several exposures (parental occupation,
maternal acute or chronic diseases, drug usage, illicit
drugs, alcohol and tobacco maternal consumption, expo-
sure to other chemical or physical factors), apart from the
other data gathered (family history, obstetrical and de-
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mographic data, among others). It is important to note
that when the pediatricians detect the cases and select
the control children, they are blinded to the different
maternal and family data that they are going to collect.
Denominators and Controls Information
Total number of births by sex and number of twin
pairs in each participating hospital are gathered. Other
background information is obtained from the control
material. The information for controls is obtained with
the same methodology that is used for cases (interview
to the mother) and, as for cases, data on more than 300
variables are gathered.
Registry Description Reference
Martı´nez–Frı´as ML. 2007. Postmarketing analysis of
medicines: methodology and value of the Spanish case-
control study and surveillance system in preventing birth
defects. Drug Safety 30:307–316.
Ethics and Consent
The registry obtained approval to function from the
Ethics Committee of the Instituto de Salud Carlos III,
Ministry of Science and Innovation. National legislation
requires informed consent to register a baby with a con-
genital anomaly. Parental consent is always asked for
and parents have to agree to the inclusion of the child on
the register (opt-in).
Electronic and Web-based Data Capture
Neither electronic nor web-based data capture is used
in this program. All the notiﬁcations are received in
paper forms from the neonatal or delivery units of the
participating hospitals.
Recent Registry Activities and Publications
(2007–2010)
ECEMC, which is organized in three sections (epidemi-
ology, genetics, and clinical teratology), maintains its
international participation in EUROCAT, ICBDSR, and
ENTIS (European Network of Teratology Information
Services). It participates in the activities and several
research projects of Centre for Biomedical Research on
Rare Diseases, as one of its 61 integrating Spanish
research groups. Annually, ECEMC organizes a scientiﬁc
meeting with the attendance of outstanding researchers,
together with representatives from the 70 collaborating
hospitals in the program. During that meeting, the most
burning methodological issues of the program are also
discussed. Every year, ECEMC publishes a report
(ECEMC`s Annual Bulletin), in which some results of its
activity are shown. Such bulletin (http://www.ciber-
er.es/documentos/ECEMC_2009_AF.PDF) is distributed
among 7000 physicians (pediatricians and obstetricians)
from all over Spain.
These are some selected publications of the group for
the period 2007 to 2010 (the complete list can be accessed
through the above detailed link to the ECEMC’s Annual
Bulletin):
Chabchoub E, Rodrı´guez L, Gala´n E, et al. 2007. Molec-
ular characterisation of a mosaicism with a complex chro-
mosome rearrangement: evidence for coincident chromo-
some healing by telomere capture and neo-telomere for-
mation. J Med Genet 44:250–256.
de Frutos CA, Vega S, Manzanares M, et al. 2007. Snail1
is a transcriptional effector of FGFR3 signaling during
chondrogenesis and achondroplasias. Dev Cell 13:872–883.
Gala´n–Go´mez E, Sa´nchez EB, Arias-Castro S, Cardesa-
Garcı´a JJ. 2007. Intrauterine growth retardation, duodenal
and extrahepatic biliary atresia, hypoplastic pancreas and
other intestinal anomalies: further evidence of the Martı´-
nez–Frı´as syndrome. Eur J Med Genet 50:144–148.
Martı´nez–Frı´as ML. 2007. Postmarketing analysis of
medicines: methodology and value of the Spanish case-
control study and surveillance system in preventing birth
defects. Drug Saf 30:307–316.
Martı´nez–Frı´as ML. 2008. The biochemical structure
and function of methylenetetrahydrofolate reductase pro-
vide the rationale to interpret the epidemiologic results
on the risk for infants with Down syndrome. Am J Med
Genet A 146A:1477–1482.
Martı´nez–Frı´as ML, Grupo de trabajo del ECEMC.
2008. Epidemiologic association between isolated skin
marks in newborn infants and single umbilical artery
(SUA). Does it have biological plausibility? Am J Med
Genet A 146A:26–34.
Martı´nez–Frı´as ML, Bermejo E, Rodrı´guez–Pinilla E,
et al. 2008. Does single umbilical artery (SUA) predict
any type of congenital defect? Clinical-epidemiologic
analysis of a large consecutive series of malformed
infants. Am J Med Genet A 146A:15–25.
Martı´nez–Frı´as ML; ECEMC Working Group. 2009. Ep-
idemiology of acephalus/acardius monozygotic twins:
new insights into an epigenetic causal hypothesis. Am J
Med Genet A 149A:640–649.
Martı´nez–Frı´as ML, Bermejo E, Mendioroz J, et al. 2009.
Epidemiologic and clinical analysis of a consecutive series
of conjoined twins in Spain. J Pediatr Surg 44:811–820.
Martı´nez–Frı´as ML. 2010. Can our understanding of
epigenetics assist with primary prevention of congenital
defects? J Med Genet 47:73–80.
Martı´nez–Frı´as ML, de Frutos CA, Bermejo E, et al.
2010. Review of the recently deﬁned molecular mecha-
nisms underlying thanatophoric dysplasia and their
potential therapeutic implications for Achondroplasia.
Am J Med Genet Part A 152A:245–255.
Mastroiacovo P, Lisi A, Castilla EE, et al. 2007. Gastro-
schisis and associated defects: an international study. Am
J Med Genet A 143:660–671.
Rittler M, Lo´pez–Camelo JS, Castilla EE, et al. 2008.
Preferential associations between oral clefts and other
major congenital anomalies. Cleft Palate Craniofac J
45:525–532.
Rodrı´guez L, Martı´nez–Ferna´ndez ML, Mansilla E,
et al. 2008. Screening for subtelomeric chromosome alter-
ation in a consecutive series of newborns with congenital
defects. Clin Dysmorphol 17:5–12.
Rodrı´guez–Pinilla E, Mejı´as C, Prieto–Merino D, et al.
2008. Risk of hypospadias in newborn infants exposed to
valproic acid during the ﬁrst trimester of pregnancy: a
case-control study in Spain. Drug Saf 31:537–543.
Address for further information
Marı´a–Luisa Martı´nez–Frı´as, ECEMC, Centro de Inves-
tigacio´n sobre Anomalı´as Conge´nitas (CIAC), Instituto
de Salud Carlos III, Avda. Monforte de Lemos, 5. Pabello´n
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3, 1a planta, 28029 Madrid, Spain. E-mail: mlmartinez.
frias@isciii.es.
SWEDEN – ASSOCIATE MEMBER
History and Funding
The registry started in 1964 as a trial and was
established in 1965. In 2003, the registry became an asso-
ciate member of EUROCAT. The registry system (data
collection) was changed in 1999. Speciﬁc laws and stat-
utes on national health care registers, which hold perso-
nal data, regulate the activities of the registry. It is run
and ﬁnanced by the National Board of Health and Wel-
fare, the governmental National Research and Develop-
ment Center for Health and Welfare (under the Ministry
of Social Affairs and Health).
Population Coverage
The registry is national and population-based I: all
mothers resident in a deﬁned geographic area. All births
in Sweden are covered, representing approximately
100,000 births annually. Selective terminations of fetuses
with malformations are included since 1999.
Sources of Ascertainment
Since 1999, the register does not receive notiﬁcations
from pediatric cardiology centers. However, information
from detailed cardiovascular examinations could be
attached to the reports sent by the reporting unit (pediat-
ric or obstetric department).
Notiﬁcation to the registry is compulsory. Reports are
obtained from departments of pediatrics, obstetrics,
clinical genetics, and cytogenetic laboratories. The diag-
noses of the malformed cases are often received from
more than one source. Pediatric cardiology centers do
not supply information to the registry, but other sources
of information cover pediatric cardiac surgery. The cyto-
genetic information is obtained through annual reports
from all cytogenetic laboratories in the country, and con-
tains information on all prenatal and infant abnormal
karyotypes.
Aggregated data are transmitted to EUROCAT.
Maximum Age at Diagnosis
Information on malformations is principally reported
before 1 month of age except for congenital heart malfor-
mations, which are reported up to 1 year of age.
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is legal. Termination of
pregnancy for fetal reasons (congenital anomaly) can be
granted after special permission after 18 weeks and up to
23 weeks of gestation from an ethical committee at the
National Board of Health and Welfare.
Stillbirth Deﬁnition and Early Fetal Deaths
The deﬁnition of stillbirths in Sweden is birth after
22 weeks of gestation. Since 1999, all fetal deaths with
congenital malformations >22 weeks of gestation are
registered at the Swedish Registry of Congenital Malfor-
mations.
Exposure Data Availability
Exposure information on all births is available in the
Medical Birth Register since 1973.
Denominators and Controls Information
Epidemiologic background data are available on all
births in the Medical Birth Register and in the Statistics
of Sweden.
Ethics and Consent
The registry does not require ethics committee ap-
proval to collect and store data. The register is ruled
under a special law for the registers of health care run by
the Swedish National Board of Health and Welfare. For
investigations run by other groups of researchers than
those working within the Swedish National Board of
Health and Welfare, approval from ethics committee is
compulsory.
National legislation does not require informed consent
to register a baby with a congenital anomaly.
Electronic and Web-based Data Capture
All reports to the Swedish Register of Birth Defects are
sent by paper forms (September, 2010).
Recent Registry Activities and Publications
(2007–2010)
Information from the register has been used in several
publications, but this is not centrally recorded, and no
publication list is available.
Annual reports have been published by the Swedish
National Board of Health and Welfare in 2007, 2008, and
2009 (covering data on births/terminations in 2006, 2007,
and 2008, respectively). The 2010 annual report is in
preparation covering data from 2009.
Registry Contribution to EUROCAT Collaborative
Papers (2007–2010)
Table 2 shows the registry contribution to EUROCAT
studies.
Address for Further Information
Karin Ka¨lle´n, The Swedish National Board of Health
and Welfare and Department of Reproduction Epidemiol-
ogy Institution of Clinical Sciences, University of Lund,
Sweden. E-mail: karin.kallen@med.lu.se.
SWITZERLAND, VAUD – FULL MEMBER
History and Funding
The Registry of Switzerland was originally established
in collaboration with EUROCAT in 1988. Different canto-
nal registries sent their data to the Central Registry in
Lausanne. The aim at the beginning was to cover the
whole country (80,000 births/year). In the ﬁrst years of
activity, 30 to 81% of births were surveyed. For ﬁnancial
reasons, many cantons had to stop this activity and, in
1993, the Swiss Registry covered 50% of all births in
Switzerland. In 1998, the following cantons were
included in the program: Zurich, Fribourg, Argovie, Tes-
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sin, Vaud, Valais, Neuchatel, and Jura. The registry is
located in the Division of Medical Genetics in the Univer-
sity Hospital of Lausanne. The registry has formerly been
associated with members from the Swiss Academy of
Medical Sciences and from the Swiss Society of Pedia-
trics. The system was ﬁnanced by the Swiss Federal
Agency for Statistics for the Central Registry and by the
cantonal health department for some cantonal registries.
As the level of ascertainment was quite heterogeneous
between the local cantonal registries and their activities
ﬂuctuating according to the years (cf. prevalence rate
<200 per 10,000), it was decided in January 2002 to
restrict the registration to canton of Vaud only and to
change the name of the registry: Registry of Vaud
(Switzerland).
Population Coverage
The registry is population-based I and as such it covers
all mothers resident in the canton of Vaud. The percent-
age of mothers delivering in a hospital outside the regis-
try area is not known precisely, although it is thought to
be very low. The registry covers about 9% of all births in
Switzerland (approximately 7500 births annually). The
changing coverage is detailed above.
Sources of Ascertainment
Reporting is voluntary. Active case ﬁnding and multi-
ple sources of information are used: delivery units, pedi-
atric departments, cytogenetic and genetic counseling,
and pathology units. Data about different methods of
prenatal diagnosis are collected (ultrasound, serum
markers, cytogenetic, and molecular).
Pediatric cardiology centers supply systematic case lists
and diagnostic details to the registry.
The registry is situated in the Department of Medical
Genetics and we thus have direct access to the cytoge-
netic and DNA laboratories; they systematically supply
the registry with abnormal karyotypes and molecular
studies prenatally and postnatally diagnosed.
Twice a year we contact the other laboratories covering
the residual population of the canton to check for anoma-
lies.
There is no upper age limit for registration of a child
with a malformation.
Maximum Age at Diagnosis
There is no upper age limit.
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is legal up to 12 weeks’
gestation under most circumstances but this limit is
extended to 24 gestational weeks if a congenital anomaly
is diagnosed. In the latter circumstance, additional per-
mission must be granted by two further physicians.
Induced abortions after prenatal diagnosis are included
in the register.
Stillbirth Deﬁnition and Early Fetal Deaths
The ofﬁcial stillbirth deﬁnition is a gestation age of
>5 27 weeks or length >5 30 cm, which are included in
the register. Early fetal deaths/spontaneous abortions are
included if they are 20 gestational weeks or more
with no weight restrictions. Autopsy statistics were not
available.
Exposure Data Availability
Information on maternal occupations and diseases,
maternal drug use, and outcome of previous pregnancies
is available for the malformed infants.
Denominators and Controls Information
Background data on births are available from the Serv-
ice Cantonal de Recherche et d’Information Statistique.
Ethics and Consent
The registry does not require ethics committee approval
to collect and store data.
National legislation does not require informed consent
to register a baby with a congenital anomaly. However,
since 2007, according to a national law about genetic
analysis, the parents have to sign informed consent for
these analyses.
Electronic and Web-based Data Capture
We receive some data mainly from pediatricians only
on a paper-based system.
We have no website notiﬁcation system.
Recent Registry Activities and Publications
(2007–2010)
Beretta L, Hauschild M, Jeannet PY, et al. 2007. Atypi-
cal presentation of Prader–Willi syndrome with cerebral
venous thrombosis: association or fortuity? Neuropediat-
rics 38:204–206.
Magyar I, Colman D, Arnold E, et al. 2009. Quantita-
tive sequence analysis of FBN1 premature termination
codons provides evidence for incomplete NMD in leuko-
cytes. Hum Mutat 30:1355–1364.
Martinet D, Filges I, Besuchet Schmutz N, et al. 2008.
Subtelomeric 6p deletion: clinical and array-CGH (com-
parative genomic hybridization) characterization in two
patients. Am J Med Genet A 146A:2094–2102.
Narumi Y, Aoki Y, Niihori T, et al. 2008. Clinical mani-
festations in patients with SOS1 mutations range from
Noonan syndrome to CFC syndrome. J Hum Genet
53:834–841.
Rieubland C, de Viragh PA, Addor MC. 2007.
Uncombable hair syndrome: a clinical report. Eur J Med
Genet 50:309–314.
Registry Contribution to EUROCAT Collaborative
Papers (2007–2010)
Table 2 shows the registry contribution to
EUROCAT studies.
Address for Further Information
Marie–Claude Addor, Registre Vaudois des Anomalies
Congenitales and Swiss Registry for EUROCAT, Division
of Medical Genetics, Maternite, CH-1011 CHUV-Lausanne,
Switzerland. E-mail: marie-claude.addor@chuv.ch. moni-
que.devolz@chuv.ch. Website: www.hospvd.ch/public/
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chuv/genmol/eurocat/euro-home.htm (username: euro-
cat, password: tropic).
UKRAINE – FULL MEMBER
History and Funding
Population-based birth defects surveillance began in
2000 in the framework of the Ukrainian–American Birth
Defects Program funded by the United States Agency for
International Development. The program became an as-
sociate member of ICBDSR in 2001. In 2005, the United
States Agency for International Development component
was completed and the program was assumed by OMNI-
Net, a not-for-proﬁt international organization incorpo-
rated in Ukraine, and is continued as OMNI-Net Ukraine
Birth Defects Program. OMNI-Net represents ﬁve
resource OMNI-centers all of which provide care for chil-
dren with birth defects, promote prevention programs,
participate in parental organizations, and engage in col-
laborative programs with national and international part-
ners.
Program objectives include universal folic acid ﬂour
fortiﬁcation, methods to reduce alcohol impact on child
development in collaboration with partners, and promot-
ing international partnerships.
OMNI-Net personnel are ﬁnanced from regional budg-
ets. The legislation and rules by the Ministry of Health
mandates the reporting of birth defects. Birth defect data
is reported by Oblast Vital Statistics Centrum who aggre-
gates, formats, and forwards the data to the Ministry of
Health.
Population Coverage
Birth defect surveillance annually covers about 28,000
births in two oblasts (provinces) of Western Ukraine –
Rivne and Khmelnytsky, representing approximately 6%
of births in Ukraine. The population is relatively homoge-
neous and stable (data is pooled from these two oblasts).
The registry is of type III (all mothers delivering in the
deﬁned geographic area excluding non-residents of that
area).
Sources of Ascertainment
Relevant hospital admission/discharge summaries are
systematically reviewed. Qualiﬁed registry specialists
also routinely review all medical records of regional pe-
diatric cardiology centers and obtain ascertainment of
diagnostic details. Data from specialty clinics, laborato-
ries (including cytogenetic one), and other services are
explored. Our cytogenetic laboratories are the only ones
in the region and they provide us with study reports.
Pregnancy, obstetrics, delivery, neonatal, and pediatrics
records are reviewed. The information is substantial
regarding service providers located in regional centers,
but limited regarding service providers in rural environ-
ments.
Maximum Age at Diagnosis
Up to 1 year of age.
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is legal and performed by a
physician when: (1) a pregnancy poses danger to health
or life of a pregnant woman; (2) prenatal diagnosis or
other medical evidence indicates high probability of seri-
ous and irreversible damage to a fetus or it is an untreat-
able life-threatening disease; and (3) there is a plausible
suspicion the pregnancy has arisen from a prohibited act.
Up until December 31, 2005, the upper gestational age
limit for termination of pregnancy in Ukraine was 28
weeks and/or 1000 g.
From January 1, 2006, Ukraine redeﬁned the deﬁnition
and the current upper gestational age limit for termina-
tion of pregnancy is 22 weeks and/or 500 g.
Stillbirth Deﬁnition and Early Fetal Deaths
The stillbirth deﬁnition is as follows: fetal death (still-
birth) is a death before the complete expulsion or extrac-
tion of a product of conception. Until January 1, 2006, for
statistical purposes, we include all fetuses weighing 1000
g or more at the moment of birth or/and gestational age
above 28 weeks; spontaneous abortions include fetuses
weighing <1000 g and gestational age <28 weeks.
From January 1, 2006, Ukraine redeﬁned stillbirth deﬁ-
nition as all fetuses weighing 500 g or more at the
moment of birth and/or gestational age above 22 weeks.
In Ukraine, Certiﬁcates of Neonatal Death are NOT
medical documents, they are issued by civil authorities.
Exposure Data Availability
Routine information collection is limited except when
ad hoc circumstances are noted. An expansion of expo-
sure data collection is in progress.
Denominators and Controls Information
Information on all births (live and stillbirths) is avail-
able from birth certiﬁcates gathered by the Regional Vital
Statistics. There are 2 control cases for each birth defect
case.
Background Information
The northern counties (rayons) of one of the two
oblasts are contaminated from the Chernobyl disaster.
Data regarding ionizing radiation pollution in contami-
nated rayons is available by special agreements. Data
from a population-based neonatal registry is also avail-
able by special agreements.
Ethics and Consent
Registration of birth defects and follow-up is an inte-
gral part of health care protocols.
The registry does not require ethics committee
approval to collect and store data.
National legislation does not require informed consent
to register a baby with a congenital anomaly.
Electronic and Web-based Data Capture
Maternity departments transfer data on all newborns,
including newborns with birth defects, to a Central
Regional Newborn Registry Database every month. Web-
based data capture is not used.
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Recent Registry Activities and Publications
(2007–2010)
Bohatyrchuk–Kryvko S, Novak V, Shumlyanski I, et al.
2008. Linking birth defects surveillance with early inter-
vention services-1-st Central and Eastern European Sum-
mit on Preconception Health and Prevention of Birth
Defects. August 27–30, 2008. Budapest, Hungary. Pro-
gram & Abstract Book. p 127.
Dancause KN, Yevtushok L, Lapchenko S, et al. 2010.
Chronic radiation exposure in the Rivne–Polissia region
of Ukraine: implications for birth defects. Am J Hum Biol
22:667–674.
Leoncini E, Botto LD, Cocchi G, et al. 2010. How valid
are the rates of Down syndrome internationally? Findings
from the International Clearinghouse for Birth Defects
Surveillance and Research. Am J Med Genet A
152A:1670–1680.
Kﬁr M, Yevtushok L, Onishchenko S, et al. 2009. Can
prenatal ultrasound detect the effects of in utero alcohol
exposure? A pilot study. Ultrasound Obstet Gynecol
33:683–689.
Kﬁr M, Hull A, Yevtushok L, et al. 2007. Evaluation of
early markers of prenatal alcohol exposure. Abstract of
the platform presentation at the American Institute of
Ultrasound in Medicine Annual Convention (March 15–
18, 2007, New York, NY).
Wertelecki W, Yevtushok L, Zymak–Zakutnya N, et al.
2007. Elevated rates of NTD and conjoined twins in Polis-
sya, a region impacted by Chernobyl. Abstract submitted
to the 48th European Society of Pediatric Research Con-
ference.
Wertelecki W, Afanasyeva N, Baryliak I, et al. 2008.
OMNI-Net BD Ukrainian Consortium: impact and les-
sons learned from ‘‘de-centralized’’ strategies-1-st Central
and Eastern European Summit on Preconception Health
and Prevention of Birth Defects. August 27–30, 2008. Bu-
dapest, Hungary. Program & Abstract Book. p 95.
Wertelecki W, Yevtushok L. 2008. Elevated neural tube
defects (NTD) rates in Ukraine – highest in Polissia-1-st
Central and Eastern European Summit on Preconception
Health and Prevention of Birth Defects. August 27–30,
2008. Budapest, Hungary. Program & Abstract Book.
p 67.
Wertelecki W. 2010. Malformations in a Chernobyl-
impacted region. Pediatrics 125:836–843.
Yevtushok L, Zymak–Zakutnya N, Polishchuk S, et al.
2007. Elevated prevalence of NTD and conjoined twins in
a Chernobyl impacted region of Ukraine. Abstract sub-
mitted to the European Teratology Society.
Yevtushok L, Onishchenko S, Wertelecki W, et al. 2008.
Predictors of binge drinking during pregnancy among
women in Ukraine-1-st Central and Eastern European
Summit on Preconception Health and Prevention of Birth
Defects. August 27–30, 2008. Budapest, Hungary. Pro-
gram & Abstract Book. p 163.
Yevtushok L, Needham K, Lapchenko S, et al. 2008. Di-
etary and activity patterns and implications on birth
defects in the Chernobyl impacted Rivne–Polissia Region
in Ukraine-1-st Central and Eastern European Summit on
Preconception Health and Prevention of Birth Defects.
August 27–30, 2008. Budapest, Hungary. Program &
Abstract Book. p 16.
Zymak–Zakutnya N, Ropotan A, Shumlyanski I, et al.
2008. Reduction of infant morbidity and mortality – Gas-
troschisis as one Index-1-st Central and Eastern European
Summit on Preconception Health and Prevention of Birth
Defects. August 27–30, 2008. Budapest, Hungary. Pro-
gram & Abstract Book. p 165.
Registry Contribution to EUROCAT Collaborative
Papers (2007–2010)
Table 2 shows the registry contribution to EUROCAT
studies.
Addresses for Further Information
Wertelecki W, ‘‘OMNI-Net for Children’’, 36, 16 Lypnya
st., r. 709, Rivne, Ukraine, 33028. Email: omninetukr@
gmail.com
UNITED KINGDOM, EAST MIDLANDS, AND
SOUTH YORKSHIRE – FULL MEMBER
History and Funding
Data collection began on January 1, 1997, and included
any baby delivered on or after the date diagnosed or
suspected of having a congenital anomaly. There is no
exclusion list. EMSYCAR was originally known as Trent
Congenital Anomaly Register (CAR) and funded by the
former Trent National Health Service (NHS) Executive
Regional Research & Development Department. In April
2003, it expanded to include Northamptonshire and
funding transferred to the NHS Primary Care Trusts
within the former region. Since January 1999, the register
has been responsible for contributing data for the region
directly to the National Congenital Anomaly System
(NCAS) organized by the Ofﬁce for National Statistics.
Population Coverage
All mothers normally resident within South Yorkshire
and the counties of Derbyshire, Nottinghamshire, Lin-
colnshire, Leicestershire, Rutland, and Northamptonshire,
irrespective of the actual place of delivery. The annual
number of births for the registry is approximately 74,000.
Sources of Ascertainment
Reporting is voluntary from multiple sources in all the
hospitals across the region, including antenatal clinics,
delivery suites, neonatal screening, neonatal and special
care baby units, cytogenetics laboratories, clinical genet-
ics, pathology, pediatric surgery, and departments of
child health. Registration includes pre-natally diagnosed
fetuses, with no lower age limit, thus including early ter-
minations and fetal losses.
There are three cytogenetic laboratories in the region,
each with a different method of communication with the
registry. One laboratory provides a monthly electronic
list of all abnormal prenatal and infant karyotyptes. One
laboratory provides this on paper notiﬁcation forms,
while the third conﬁrms karyotypes for cases already
notiﬁed to the register. An annual data validation exer-
cise is undertaken with this laboratory to identify missing
cases.
The central pediatric cardiology center situated within
the region provides systematic case lists and diagnostic
details for all surgical and non-surgical cases to the regis-
try on request (usually made annually). Two other cen-
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ters outside the registry area, covering parts of the west-
ern and southern population, supply diagnostic informa-
tion for cases already known to the registry, or neighbor-
ing registers, upon request. A fourth center, also outside
the region but covering part of its northern population,
currently does not supply data, but is expected to rou-
tinely exchange data with EMSYCAR once the new York-
shire CAR becomes fully operational in 2011.
There is no time limit for registration or for updating
diagnostic details.
Maximum Age at Diagnosis
There is, at present, no upper age limit.
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is legal up to 24 weeks’
gestation. There is no upper gestational age limit for ter-
mination if a major anomaly is diagnosed. Terminations
for anomaly reasons and anomalies found at postmortem
after social terminations are included in the register.
Stillbirth Deﬁnition and Early Fetal Deaths
The ofﬁcial stillbirth deﬁnition is fetal death after 24
completed weeks. There is no lower gestational age or
weight limit for anomalies identiﬁed in early fetal deaths.
Exposure Data Availability
Not speciﬁcally requested but recorded if relevant
information is provided by the notiﬁer.
Denominators and Controls Information
The denominator data for births in the region is
provided by the Ofﬁce for National Statistics on an
annual basis.
Ethics and Consent
All United Kingdom registries require ethics committee
approval to collect and store data. This is obtained
centrally from Trent Multicentre Research Ethics Com-
mittee (NHS) and requires renewal every 5 years.
National legislation also requires informed consent, but
United Kingdom registries are exempted from this by
National Information Governance Board (formerly Patient
Information Advisory Board, PIAG) approval. This
allows the Secretary of State for Health to permit a speci-
ﬁed dataset to be collected without individual consent.
This approval requires annual renewal. All parents have
to be made aware that they can request the removal of
personal identiﬁers from their local register should they
wish.
Electronic and Web-based Data Capture
Electronic downloads are received from one of three
cytogenetic laboratories (monthly), and the main pediat-
ric cardiac center (annually). All abnormal scan reports
from the second largest delivery suite are received elec-
tronically, with plans for the largest unit to adopt this
method during late 2010. All other notiﬁcations are paper
based. EMSYCAR does not use web-based data capture.
Recent Registry Activities and Publications
(2007–2010)
Budd J. 2007. ‘‘Regional Congenital Registers in the
UK’’, Obstetrics, Gynaecology and Reproductive Medi-
cine 17:333–334.
Congenital Anomalies in Births 2004–2008. 2010.
http://www2.le.ac.uk/departments/health-sciences/
research/ships/timms/documents/congenital-anomalies-
in-births-2004-2008.pdf.
Draper ES, Rankin J, Tonks AM, et al. 2007. Recrea-
tional drug use: a major risk factor for gastroschisis? Am
J Epidemiol 167:485–491.
Wright J, Budd J, Field D, Draper E. 2010. Epidemiol-
ogy of diaphragmatic hernia: a nine year experience.
Perinatal and Pediatric Epidemiology (in press).
Registry Contribution to EUROCAT Collaborative
Papers (2007–2010)
Table 2 shows the registry contribution to EUROCAT
studies.
Address for Further Information
Elizabeth Draper, Director EMSYCAR, Department of
Health Sciences, University of Leicester, 22-28 Princess
Road West, Leicester, United Kingdom, LE1 6TP. E-mail:
msn@leicester.ac.uk.
Judith Budd, CAR Coordinator, Department of Health
Sciences, University of Leicester, 22-28 Princess Road
West, Leicester, United Kingdom, LE1 6TP. E-mail:
jlsb1@leicester.ac.uk.
UNITED KINGDOM, NORTHERN
ENGLAND – FULL MEMBER
History and Funding
The Northern Congenital Abnormality Survey (United
Kingdom, Northern England) was established in 1985
after a 1-year pilot study. The Northern England register
is funded by the Healthcare Quality Improvement
Partnership until April 2011. The registry is one of four
databases linked through the mother’s details, held at the
Regional Maternity Survey Ofﬁce in Newcastle – the
others being perinatal and infant deaths, diabetic
pregnancy, and multiple births. The Northern England
register has been the source of congenital anomaly data
for our reporting area for United Kingdom National
Statistics from January 2003 to December 2009.
Population Coverage
The Northern England register records all congenital
anomalies that occur in pregnancies of mothers’ resident
in North East England and North Cumbria (population-
based). This area extends from North Cumbria to the
Tees area up to the Scottish border and includes North
Cumbria, Northumberland, Newcastle upon Tyne, North
Tyneside, Gateshead, South Tyneside, County Durham,
Darlington, and Tees. Until 1994, South Cumbria was
included in the reporting area. The population of the cur-
rent area is approximately 3 million. The annual number
of births for the registry area is currently approximately
32,000, which represents about 5% of the total births in
England. Minor anomalies are not reported. The EURO-
CAT list of exclusions is used.
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Sources of Ascertainment
Reporting is voluntary from multiple sources. The
Northern England register has a strong relationship with
clinicians and non-medical staff in all the hospitals in the
region. Sources of reporting include ultrasonographers,
geneticists, midwives, radiographers, obstetricians, pedia-
tricians from a wide range of specialties, pathologists,
cardiologists, fetal medicine specialists, and surgeons.
Cross validations with other regional databases occur
regularly, including the Northern Genetics Service (cyto-
genetics service), the Fetal Medicine Unit at the Royal
Victoria Inﬁrmary (regional tertiary center), and the Pedi-
atric Cardiology database at Freeman Hospital which
supplies case lists and diagnostic details to the register.
The registry receives quarterly downloads of all prenatal
and infant abnormal karyotypes for the population of the
region from the Northern Genetics Service.
Registration includes all anomalies discovered in
fetuses, including early pregnancy losses and termina-
tions after prenatal diagnosis, and babies and children up
to the age of 12. The registry has extremely good ascer-
tainment of late fetal deaths and stillbirths affected by
congenital anomalies as it is run in parallel with the
Northern Perinatal Mortality Survey, which was estab-
lished in 1981. All registered deaths are cross-validated
with U.K. National Statistics annually.
There is no time limit for updating diagnostic detail.
Ascertainment of anomalies diagnosed after the neonatal
period is less complete than those usually diagnosed in
the neonatal period, although there is good ascertainment
of all chromosomal and cardiac anomalies, whenever
diagnosed. Ascertainment of ophthalmological anomalies
is low. Karyotype details of cases with abnormal karyo-
types are now being recorded. These are available for
cases from 2004.
Maximum Age at Diagnosis
Up to 12 years of age.
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is potentially legal, subject
to proper process, for fetuses without identiﬁed anoma-
lies up to 24 weeks’ gestation. There is no upper gesta-
tional age limit for termination if a major anomaly is
diagnosed that is considered to be life threatening for the
newborn baby.
Stillbirth Deﬁnition and Early Fetal Deaths
The ofﬁcial stillbirth deﬁnition is fetal death after 24
completed weeks. There is no lower gestational age or
weight limit for anomalies identiﬁed in early fetal deaths.
Miscarriages under 20 weeks’ gestation that have abnor-
mal karyotypes which have not been detected antenatally
and are not accompanied by structural anomalies are not
included in the database.
Exposure Data Availability
We have good data on exposure to diabetes in preg-
nancy, due to a linked database (Northern Diabetes in
Pregnancy Survey) that has run since 1995. Maternal
drug exposure, whether or not they smoke, and major
medical problems are recorded when available. In mid-
2004, maternal weight and height data were added to the
reporting form.
Denominator Information
At present, denominator data is provided by the U.K.
National Statistics. There is work at the national level to
provide information on gestation for all registered births,
which is currently lacking.
Registry Description Reference
Richmond S, Atkins J. 2005. A population-based study
of prenatal diagnosis of congenital malformation over 16
years. BJOG 112:1349–1357.
Ethics and Consent
The registry requires ethics committee approval to col-
lect and store data and this is granted by the Trent
Multi-center Research Ethics Committee. Approval is
renewed annually.
National legislation requires informed consent to regis-
ter a baby with a congenital anomaly. However, through
its membership of the British Isles Network of Congenital
Anomaly Registers (BINOCARs), the registry collects
non-consented data under Section 251 of the NHS Act
2006 (originally enacted under Section 60 of the Health
and Social Care Act 2001), which allows the common law
duty of conﬁdentiality to be set aside in speciﬁc circum-
stances where anonymous information is not sufﬁcient
and where patient consent is not practicable.
Electronic and Web-based Data Capture
The Northern England register does not have web-
based data capture facilities at present. While cases are
reported electronically, there is no system for uploading
this information directly to the database. Therefore, infor-
mation received electronically is added to the database
manually. Electronic downloads of cases are received via
internal secure email from the regional cleft lip and pal-
ate team (monthly) and the cytogenetic laboratory (quar-
terly). The cases included in these lists are the most
recent available. Cases for cross validation are received
from the Hospital Episode Statistics on an ad hoc basis.
These are hand delivered or sent by courier on an
encrypted disk or memory stick.
Recent Registry Activities and Publications
(2007–2010)
Armstrong BG, Dolk H, Pattenden S, et al. 2007. Geo-
graphic variation and localised clustering of congenital
anomalies in Great Britain. Emerg Themes Epidemiol 4:14.
Bythell M, Bell R, Taylor R, et al. 2008. The contribu-
tion of late termination of pregnancy to stillbirth rates in
Northern England, 1994–2005. BJOG 115:664–666.
Dadvand P, Rankin J, Rushton S, Pless–Mulloli T. 2010.
Association between maternal exposure to ambient air
pollution and congenital heart disease: a register-based,
spatiotemporal analysis. Am J Epidemiol 2011;173:171–82.
Dadvand P, Rankin J, Shirley MD, et al. 2008. Descrip-
tive epidemiology of congenital heart diseases in North-
ern England. Paediatr Perinat Epidemiol 23:58–65.
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Dolk H, Armstrong B, Lachowycz K, et al. 2010. Ambi-
ent air pollution and risk of congenital anomalies in Eng-
land, 1991–1999. Occup Environ Med 67:223–227.
Draper ES, Rankin J, Tonks A, et al. 2009. Congenital
abnormalities: data needed to establish causes. BMJ
339:b3428.
Draper ES, Rankin J, Tonks AM, et al. 2008. Recrea-
tional drug use: a major risk factor for gastroschisis? Am
J Epidemiol 167:485–491.
Fillingham A, Rankin J. 2008. Prevalence, prenatal di-
agnosis and survival of gastroschisis. Prenat Diagn
28:1232–1237.
Glinianaia SV, Rankin J, Wright C. 2008. Congenital
anomalies in twins: a register-based study. Hum Reprod
23:1306–1311.
Hemming V, Rankin J. 2007. Small intestinal atresia in
a deﬁned population: occurrence, prenatal diagnosis and
survival. Prenat Diagn 27:1205–1211.
Irving C, Richmond S, Wren C, et al. 2010. Changes in
fetal prevalence and outcome for trisomies 13 and 18: a
population-based study over 23 years. J Mat-Fet Neonat
Med 2011;24:137–141.
Irving C, Basu A, Richmond S, et al. 2008. Twenty-year
trends in prevalence and survival of Down syndrome.
Eur J Hum Genet 16:1336–1340.
McNally RJ, Rankin J, Shirley MD, et al. 2008. Space-
time clustering of Down syndrome: results consistent
with transient pre-disposing contagious agent. Int J Epi-
demiol 37:1169–1179.
Pharoah PO, Glinianaia SV, Rankin J. 2009. Congenital
anomalies in multiple births after early loss of a concep-
tus. Hum Reprod 24:726–731.
Rankin J, Tennant P, Stothard K, et al. 2010. Maternal
obesity and congenital anomaly risk: a cohort study. Int J
Obes 34:1371–1380.
Rankin J, Cans C, Garne E, et al. 2010. Congenital anoma-
lies in children with cerebral palsy: a population-based re-
cord linkage study. Dev Med Child Neurol 52:345–351.
Rankin J, Chadwick T, Natarajan M, et al. 2009. Mater-
nal exposure to ambient air pollution and risk of congen-
ital anomalies. Environ Res 109:181–187.
Rankin J, Silf KA, Pearce MS, et al. 2008. Congenital
anomaly and childhood cancer: a population-based, re-
cord linkage study. Pediatr Blood Cancer 51:608–612.
Rankin J. 2007. Congenital anomalies in the British
Isles. Congenital diseases and the environment. In: Nico-
lopoulou–Stamati P, Hens L, Howard C, editors. New
York: Springer. pp 359–377.
Swamy R, Embleton N, Hale J. 2008. Sacrococcygeal ter-
atoma over two decades: birth prevalence, prenatal diag-
nosis and clinical outcomes. Prenat Diagn 28:1048–1051.
Tennant PW, Pearce MS, Bythell M, Rankin J. 2010. 20-
year survival of children born with congenital anomalies:
a population-based study. Lancet 375:649–656.
Wren C, Reinhardt Z, Khawaja K. 2008. Twenty-year
trends in diagnosis of life-threatening neonatal cardiovas-
cular malformations. Arch Dis Child Fetal Neonatal Ed
93:F33–35.
Registry Contribution to EUROCAT Collaborative
Papers (2007–2010)
Table 2 shows the registry contributions to EUROCAT
studies.
Contacts for Further Information
Judith Rankin, Register Lead, Regional Maternity Sur-
vey Ofﬁce, 1-2 Claremont Terrace, Newcastle upon Tyne,
NE2 4AE, United Kingdom. E-mail: j.m.rankin@ncl.ac.uk.
Web address: www.rmso.org.uk.
Judith Rankin, Institute of Health & Society, Baddiley-
Clarke Building, Newcastle Univeristy, Richardson Road,
Newcastle upon Tyne, NE4 2AX.
Mary Bythell, Regional Maternity Survey Ofﬁce Coor-
dinator, Regional Maternity Survey Ofﬁce, 1-2 Claremont
Terrace, Newcastle upon Tyne, NE2 4AE, United King-
dom. E-mail: mary.bythell@ncl.ac.uk. Web address:
www.rmso.org.uk.
Martin Ward Platt, Regional Maternity Survey Ofﬁce
Clinical Director, 1-2 Claremont Terrace, Newcastle upon
Tyne, NE2 4AE, United Kingdom. E-mail: m.p.ward-
platt@ncl.ac.uk. Web address: www.rmso.org.uk.
UNITED KINGDOM, THAMES VALLEY – FULL
MEMBER
History and Funding
The Congenital Anomaly Register of Oxfordshire, Berk-
shire, and Buckinghamshire (CAROBB) was awarded
funding by the Department of Health in 2003 to maintain
and expand the previously established Oxford Congenital
Anomaly Register to include Berkshire and Buckingham-
shire. Oxford Congenital Anomaly Register was estab-
lished in 1991. It started to contribute Oxfordshire data to
EUROCAT in 2002 and has now expanded to include
cases for the three counties. CAROBB is an active mem-
ber of BINOCAR.
Population Coverage
 For births 1991 to 2004 – Information is collected on
all malformations suspected prenatally and/or con-
ﬁrmed in fetuses/babies booked for delivery at the
two maternity hospitals in Oxfordshire or in the
community. Cases submitted to EUROCAT must
have an Oxfordshire postcode – this gives the best
approximation available to the unselected local
Oxfordshire population (7000 births).
 For births from 2005 onward – The register uses the
same malformation inclusion criteria to cover the
whole of Oxfordshire, Berkshire, and Buckingham-
shire. This region is deﬁned by the Local Authority
boundaries that make up the three counties. The
population coverage is approximately 30,000 births
per annum.
 For 2005 births – ascertainment in Berkshire and
Buckinghamshire is likely to be lower than would be
expected because systems for registration were still
being established. Therefore, prevalence rates will be
misleading for this year.
Sources of Ascertainment
Data are obtained voluntarily from multiple sources
across the region, such as antenatal clinics, obstetric
ultrasound, delivery suites, special care baby units, cyto-
genetic laboratory, pediatric pathology, and the Down
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syndrome service. Information is collected on all fetuses
identiﬁed antenatally with a suspected congenital anom-
aly or ultrasound soft marker and on all babies born
with a congenital anomaly. The aim is to collect data con-
cerning all infants aged up to age 1 year, but in practice,
this is not achieved. There is under ascertainment of
cardiac, orthopedic, and renal defects diagnosed after the
mother has left the maternity unit and methods to
improve ascertainment are being explored.
Maximum Age at Diagnosis
Up to 1 year of age.
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is legal up to 24 weeks of
gestation with no gestation limit for serious congenital
defects. Cases are ascertained via the prenatal diagnosis
unit and from postmortem reports.
Stillbirth Deﬁnition and Early Fetal Deaths
The deﬁnition of still birth is ‘‘a child born with no
signs of life after complete expulsion from the mother af-
ter the 24th week of pregnancy’’. All stillbirths with a
congenital anomaly are registered. Early fetal deaths/
spontaneous abortions are included with no lower gesta-
tional age limit.
Exposure Data Availability
Information is collected where it is available (not on
every case) on chronic illness in the mother, details of
assisted conception, invasive tests in pregnancy, and
alcohol abuse.
Denominators and Controls Information
Oxford Maternity Data system provides denominator
data for 1991 to 2004 births. The Ofﬁce for National Sta-
tistics (ONS) provide denominators for births after 2005.
Registry Description Reference
www.npeu.ox.ac.uk/carobb/annualreport.
Ethics and Consent
The registry requires ethics committee approval to col-
lect and store data and this comes from Trent, United
Kingdom for all BINOCAR. Approval is renewed every 5
years.
National legislation requires informed consent but the
registry is exempt. Patient Information Advisory Group
(PIAG) approval given for all BINOCAR registries.
Parents have to ask for the removal of the child from the
register (opt-out).
Electronic and Web-based Data Capture
There is direct access to the cytogenetic laboratory
covering the whole area, providing six-monthly electronic
lists of all abnormal karyotypes for prenatal and post-
natal diagnoses. Pediatric cardiology centers covering
part of the registry population supply systematic
electronic case lists to the registry on cases undergoing
surgical procedures. Monthly electronic lists of relevant
pediatric admissions (by ICD10 code) are received from
the tertiary referral center.
Recent Registry Activities and Publications
(2007–2010)
Thames Valley Register activities include regular feed-
back to staff in all contributing hospitals by presenting
local data and encouraging use of the data for audit and
research. Recent collaborations include one with experi-
mental psychologists, clinical and cytogeneticists on a
project concerning sex chromosome trisomes; BINOCAR
collaborations (e.g., with the Fetal Anomaly Screening
Program) to develop a means of monitoring the National
Program and collaboration concerning the future of
national surveillance in England and Wales.
Bishop DV, Barnicoat A, Boyd PA, et al. 2010. Autism
spectrum disorders, language and communication in chil-
dren with sex chromosome trisomies. Arch Dis Child
doi:10.1136/adc.179747.
Dolk H, Armstrong B, Lachowycz K, et al. 2010. Ambi-
ent air pollution and risk of congenital anomalies in Eng-
land, 1991-1999. Occup Environ Med 67: 223–227.
Choudhry MS, Rahman N, Boyd P, Lakhoo K. 2009.
Duodenal atresia: associated anomalies, prenatal diagno-
sis and outcome. Pediatr Surg Int 25:727–730.
Sherwood W, Boyd P, Lakhoo K. 2008. Postnatal out-
come of antenatally diagnosed intra-abdominal cysts.
Pediatr Surg Int 24:763–765.
Nieuwenhuijsen MJ, Toledano MB, Bennett J, et al.
2008. Chlorination disinfection by-products and risk of
congenital anomalies in England and Wales. Environ
Health Perspect 116:216–222.
Zaki M, Boyd PA, Impey L, et al. 2007. Congenital
myotonic dystrophy: prenatal ultrasound ﬁndings and
pregnancy outcome. Ultrasound Obstet Gynecol 29:284–
288.
Choudhry M, Boyd PA, Chamberlain PF, Lakhoo K.
2007. Prenatal diagnosis of tracheo-esophageal ﬁstula and
oesophageal atresia. Prenat Diagn 27:608–610.
Armstrong BG, Dolk H, Pattenden S, et al. 2007. Geo-
graphic variation and localised clustering of congenital
anomalies in Great Britain. Emerg Themes Epidemiol
4:14.
Registry Contribution to EUROCAT Collaborative
Papers (2007–2010)
Table 2 shows the registry contribution to EUROCAT
studies.
Address for Further Information
Patricia Boyd and Cath Rounding, National Perinatal
Epidemiology Unit, University of Oxford, Old Road
Campus, Headington, Oxford OX3 7LG. E-mail: car-
obb@npeu.ox.ac.uk. Website: www.npeu.ox.ac.uk/carobb.
UNITED KINGDOM, WALES – FULL MEMBER
History and Funding
The Congenital Anomaly Register and Information
Service (CARIS) collect data on all cases of congenital
anomaly born to mothers normally resident in Wales.
Data collection commenced on January 1, 1998, and
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includes any baby where pregnancy ended on or after
this date. The Wales Register joined EUROCAT in 1998.
The register is based at Singleton Hospital, Swansea and,
since October 1, 2009, became part of Public Health
Wales NHS trust. The register aims to collect data that
can be used to describe the pattern of congenital anoma-
lies across Wales. This should help:
 Build up and monitor the picture of congenital
anomalies in Wales.
 Assess interventions intended to help prevent or
detect congenital anomalies.
 Plan and coordinate provision of health services for
affected babies and children.
 Assess possible clusters of birth defects and their
causes.
The register has a lead clinician, who is an obstetrician
and a director of information, and who is a consultant in
Public Health.
In 2005, an expert advisory group was set up to help
set objectives for the register. The group consists of a fe-
tal medicine consultant, an obstetrician, a pediatrician, a
medical geneticist, a consultant radiologist, a lay repre-
sentative, a consultant in public health, the director of
Antenatal Screening Wales, and a senior medical ofﬁcer
from the Welsh Assembly Government. The group meets
twice yearly.
Population Coverage
The registry is population-based and covers the entire
country of Wales with an annual number of births of cur-
rently around 35,000.
Sources of Ascertainment
Reporting is voluntary. The register relies upon multi-
source reporting including antenatal clinics, delivery
units, pediatric departments, ophthalmology, cytogenet-
ics, pathology, orthopedics, and maxillofacial and re-
gional centers of pediatric surgery. Each delivery unit
has a nominated coordinator to help ensure good report-
ing. Register staff also visit units to help with data collec-
tion. Registration covers all fetuses with prenatally diag-
nosed anomalies. There is no lower age limit so fetal
losses and early terminations with anomalies are regis-
tered. All live born babies with structural anomalies are
registered if diagnosed before their ﬁrst birthday, but all
chromosomal anomalies and syndromes are registered,
even if diagnosed later.
Babies in North Wales needing specialist services are
referred to Liverpool and in South Wales, they travel to
Bristol for cardiac surgery. Both pediatric cardiology cen-
ters in Cardiff and Liverpool supply systematic case lists
and diagnostic details to the registry, including details of
antenatally-detected cases. These lists cover the whole
population requiring pediatric cardiology services and
are provided annually.
The cytogenetic laboratory in Cardiff provides a down-
load of data of all abnormal karyotypes on a quarterly
basis. This includes details of demographic details, proce-
dure, and reason for karyotying. Cases reported include
antenatal and all children born since 1998. This covers
most of the population. Some cases in North Wales are
karyotyped in Liverpool, while a few cases in Mid Wales
are referred via Shrewsbury to Birmingham. This means
that the register cannot guarantee 100% coverage of the
Welsh population; although many of these cases are
known and reported back to the register.
Maximum Age at Diagnosis
Maximum age at diagnosis is set at 1 year of age. This
is currently under review. Chromosomal anomalies and
syndromes are an exception to this rule. In these cases, it
is often found that a registration has already been made
for other anomalies diagnosed within the ﬁrst year.
Electronic reporting of inpatient data has presented a
challenge, as it has highlighted unreported cases from
years before. It is not always clear precisely when the di-
agnosis was originally made. These cases require follow-
up to ensure that the diagnosis is correct as well as to
verify the time of diagnosis. Regular data downloads
should lessen this problem in the future and give better
ascertainment.
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is legal under certain
grounds up to 24 weeks of gestation. If congenital anom-
aly is diagnosed, there is no upper gestational age limit
for termination in cases of major anomaly. Terminations
of pregnancy for fetal anomaly are registered whatever
the gestational age.
Stillbirth Deﬁnition and Early Fetal Deaths
Stillbirth deﬁnition is 24 weeks’ gestation (late fetal
death after 23 weeks 1 6 days gestation). Stillbirths of 24
weeks or more are registered. Early fetal deaths/sponta-
neous abortions have no lower limit for inclusion on the
register (earliest recorded is 8 weeks’ gestation).
Exposure Data Availability
Exposure information on maternal drug use, smoking,
alcohol, maternal and paternal diseases and occupations,
outcomes of previous pregnancies, and assisted concep-
tion is available. Folic acid supplementation before and
during pregnancy is also collected. Drugs are coded to
the ATC classiﬁcation. Since 2005, body mass index has
also been added to the dataset.
Denominators and Controls Information
Denominator data is obtained from the Ofﬁce for
National Statistics. Where this is not timely or readily
available, then data may be used from the National Com-
munity Child Health System.
Registry Description Reference
The registry’s description and work was most recently
described in our 10th annual report. This is available on:
www.wales.nhs.uk/sites3/Documents/416/Cari-
s%20Ann%20rep%20%28Eng%29%20ﬁnal.pdf.
Ethics and Consent
The registry requires ethics committee approval to
collect and store data and this comes from Leicester
Regional Multicentre Research Ethics Committee, under
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the auspices of the BINOCAR. Approval is renewed ev-
ery 5 years, next due in 2014.
National legislation requires informed consent but the
registry is exempt from this. The register has been
granted exemption under section 251 of the Health Serv-
ice Act 2006. Parents have to ask for the removal of the
child from the register (opt-out).
Information Governance Standards, Policies and
Protocols are Agreed and Set by a Committee
within Public Health Wales
Electronic and Web-based Data Capture
Data are reported electronically to the register from cy-
togenetics, medical genetics, child health system, and
inpatient data. Antenatal ultrasound reports are sent elec-
tronically from 10 delivery units. These are downloaded
monthly. The remaining four units are expected to have
the same system in place by the end of 2010. We will
start work on developing a web-based reporting system
for clinical staff in 2011.
Recent Registry Activities and Publications
(2007–2010)
Oral presentation at the British International Congress
of Obstetrics and Gynaecology. Congenital anomalies in
clomiphene induced pregnancies: review from a congeni-
tal anomaly register (London – July 2007).
CARIS Annual report – Risk factors in pregnancy. Pub-
lished November 2007.
www.wales.nhs.uk/sites3/Documents/416/Caris%20
Ann%20rep%202006.pdf.
Oral presentation at EUROCAT Registers Leaders
Meeting. Update on gastroschisis in Wales (Helsinki –
June 2008).
Oral presentation – International Clearing House of
Birth Defects Surveillance and Research annual confer-
ence. Evaluation of a congenital anomaly register (Padua
– September 2008).
Poster presentation – International Clearing House of
Birth Defects Surveillance and Research annual confer-
ence. Cystic ﬁbrosis in Wales (1998–2007). (Padua – Sep-
tember 2008.)
CARIS Annual report – 10 years of reporting. Pub-
lished November 2008.
www.wales.nhs.uk/sites3/Documents/416/Caris%20
Ann%20rep%20%28Eng%29%20ﬁnal.pdf.
Poster presentation at UKPA conference. Congenital
Anomalies and Socioeconomic deprivation in Wales 1998
to 2007 (Brighton – April 2009).
Poster presentation at EUROCAT Registers Leaders
meeting. Congenital anomalies, smoking and deprivation
in Wales (Bilbao – June 2009).
Draper ES, Rankin J, Tonks A, et al. Congenital abnor-
malities: data needed to establish causes. BMJ 339:b3428.
Oral presentation – International Clearing House of Birth
Defects Surveillance and Research annual conference. Out-
come of antenatally suspected congenital cystic adenoma-
toid malformation of the lungs (CCAM) and sequestration
of the lungs in Wales, United Kingdom: 7 years experience
2000 – 2006 (Salt Lake City – Sept 2009). Abstract to be
published in Birth Defects Research A 2010.
Poster presentation – 9th World Congress of Perinatal
Medicine. Outcome of antenatally suspected sequestra-
tion of lung (Berlin – October 2009).
CARIS Annual Report. Focus on skeletal anomalies.
Published November 2009.
www.wales.nhs.uk/sites3/Documents/416/Caris%20
Ann%20rep%20%28Eng%29%20%286%29.pdf.
Registry Contribution to EUROCAT Collaborative
Papers (2007–2010)
Table 2 shows the registry contribution to EUROCAT
studies.
Address for Further Information
David Tucker, Public Health Wales, Congenital Anom-
aly Register and Information Service for Wales (CARIS),
Level 3 – West Wing, Singleton Hospital, Sketty Lane,
Swansea, SA2 8QA. E-mail: david.tucker2@wales.nhs.uk.
UNITED KINGDOM, WESSEX – FULL MEMBER
History and Funding
The Wessex Antenatally Detected Anomalies Register
(WANDA) was started in 1988 as a local database. In
1994, funding was obtained and the regional register
established under the auspices of the Wessex Clinical
Genetics Service. Funding is provided by each of the 10
districts covered through the genetics budget. The regis-
try joined EUROCAT in 2002, and has sent backdated
data from 1994. From 2001, data have been transmitted
electronically to the ONS. WANDA is an active member
of BINOCAR and the Follow-up of Congenital Anomalies
Long-term study (FOCAL). Data collection is enhanced
by regular specialized meetings in each district. Thus, the
aims of WANDA are to improve communication between
all clinicians involved in the care of pregnant women
and their babies; to monitor clusters and provide relevant
data to allow further investigation and research; to evalu-
ate new and established prenatal screening tests; to moni-
tor incidence and population trends of selected malfor-
mations; to provide data for research into the etiology
and natural history of certain anomalies and for the
investigation of potential teratogens; and to provide data
for health care policies and planning.
Population Coverage
All women living within the old ‘Wessex’ region, Jer-
sey and Guernsey, who deliver within the hospitals in
the region are included (population-based III). Annual
births are approximately 27,000 and the population is 2.8
million.
Sources of Ascertainment
Information is collected on all fetuses in which an
anomaly, a suspected anomaly, or an ultrasound soft
marker, has been detected antenatally. Data are also
ascertained on all babies born with a congenital anomaly
or a genetic condition. Anomalies are accepted at any age
of detection, but in reality, reporting is unreliable if diag-
nosed outside the neonatal period. Exceptions are chro-
mosome errors and surgical conditions for which the
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register has full ascertainment at any age. All cardiac
defects detected antenatally and those that require treat-
ment or further investigation postnatally are included in
the register, hence, small ventricular septal defects, mild
pulmonary stenosis, and other conditions with minimal
or no morbidity are not included. This information is
available directly from the cardiology department.
Reporting of hypospadias is good from January 2001
but was poor until this date.
The cytogenetic laboratories provide data on all abnor-
mal prenatal and infant karyotypes (and now array com-
parative genomic hybridization results) for the entire
population covered by WANDA. Routine downloads are
also sent on all cases every 6 months to ensure no case is
missed.
Data are obtained voluntarily from multiple sources.
Sources used include ultrasonographers, radiologists,
obstetricians, fetal medicine, pediatricians, pediatric
cardiologists, pediatric surgeons, pediatric neurologists,
pediatric pathologists, plastic surgeons, orthopaedic
nurse, CESDI (Conﬁdential Enquiry into Stillbirths and
Deaths in Infancy), central records for Primary Care
Trusts for postnatal cases, cytogenetics, molecular genet-
ics, clinical genetics, pathologists, and biochemistry.
Ascertainment is excellent for anomalies detected antena-
tally but less complete for those diagnosed postnatally.
Both active and passive ascertainment procedures are
used. Data are good where there has been a postmortem
examination, for all signiﬁcant cardiac and chromosomal
defects, and for all conditions requiring surgery such as
abdominal wall defects or clefts. Ascertainment is incom-
plete for neurologic and orthopedic conditions, although
serious efforts are underway to improve these. Cerebral
palsy or isolated hearing or sight impairment are not
included.
Maximum Age at Diagnosis
There is no upper age limit.
Termination of Pregnancy for Fetal Anomaly
Termination of pregnancy is legal up to 24 weeks of
gestation with no gestation limit for very serious congeni-
tal anomalies. Cases are ascertained from the department
of fetal medicine and from postmortem reports.
Stillbirth Deﬁnition and Early Fetal Deaths
The deﬁnition of stillbirth is ‘‘a child born with no
signs of life after complete expulsion from the mother
after the 24th week of pregnancy.’’ All stillbirths with a
congenital anomaly are registered. Early fetal deaths/
spontaneous abortions are included with no lower gesta-
tional age limit.
Exposures Data Availability
Information is collected where it is available (not on
every case) on chronic illness in the mother, details of
assisted conception, invasive tests in pregnancy, and
alcohol abuse. In practice, this information is very under-
reported.
Denominators and Controls Information
Data on the number of births in each district are
provided through the labor wards of each hospital (i.e.,
referring to the births in each hospital to residents of the
region). Maternal age is supplied by ONS with at least a
one year delay. No control information is collected.
Ethics and Consent
National legislation requires informed consent but the
registry is exempt. National Information Governance
Board approval (formerly PIAG) – Health & Social Care
Act 2001 – allows for the Secretary of State for Health to
permit certain data to be collected without consent. How-
ever, parents/patients can opt-out of registers.
Electronic and Web-based Data Capture
The register is able to access other data sources elec-
tronically for information but we do not receive regular
case reports through this route.
Recent Registry Activities and Publications
(2007–2010) Local Studies
Outcome of fetal ‘absent stomach’ or ‘small stomach’
found at routine ultrasound scan.
Prenatal detection rate of postnatally diagnosed esoph-
ageal atresia 1/- tracheo-esophageal ﬁstula.
Long-term outcome of duodenal atresia.
Prenatal detection of heart abnormalities in Wessex.
National Studies
With four other U.K. registers and the Small Areas
Health Authority Unit at Imperial College, ‘chlorination
disinfection byproducts and risk of congenital anomalies
in England and Wales’ study. Complete and published.
The Follow-up of Congenital Anomalies Long-term
study, under the umbrella of the National Perinatal
Epidemiology Unit in Oxford, commenced in 2006 with
funding from Newlife. ‘Etiology of gastroschisis: a pro-
spective case control study to investigate the effects of
lifestyle, dietary, and environmental exposures.’ Case
collection is complete but the control data are still
awaited.
In conjunction with the Department of Experimental
Psychology in Oxford, Clinical Genetics and the local
congenital anomaly registers in Southampton, Oxford,
Bristol, Manchester, and London, and the parental
support group Unique, children aged from 4 to 16 years
who were diagnosed prenatally with a sex chromosome
anomaly were followed up. The ﬁndings from this study
have been published.
We thank the many people throughout Europe
involved in providing and processing information,
including affected families, clinicians, health professio-
nals, medical records clerks, and registry staff.
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Registry Contribution to EUROCAT Collaborative
Papers (2007–2010)
Table 2 shows the registry contribution to EUROCAT
studies.
Address for Further Information
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